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Calcd Calculated 
cc-pVDZ Correlation consistent polarised 
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CE 15-Crown-5 ether 
COSY Correlation spectroscopy (NMR) 
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d Doublet (NMR) 
D Yellow sodium D line (589 nm) 
dd Doublet of doublet 
DBU 1,8-Diazabyciclo[5.4.0]undec-7-
ene
DCC N,N-Dicyclohexylcarbodiimide 
Dec. Decomposition 
DEPT Distortionless enhancement by 
polarisation transfer (NMR)  
DIAD Diisopropyldiazacarboxylate 
DIC Diisopropylcarbodiimide 
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Hz Herz 
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IR Infrared 
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Q Wavelength (IR) 
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t Time 
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TBDS tert-Butyldimethylsilyl 
THF Tetrahydrofurane 
Tf Trifluoromethanesulfonyl 
TfO Trifluoromethanesulfonate 
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TMS Trimethylsilyl 
Tos p-Toluenesulfonyl 
Tosyl p-Toluenesulfonyl 
TOF Time of flight 
Triflyl Trifluoromethanesulfonyl 
UV Ultraviolet 
Vis Visible 
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vw Very weak (IR) 
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1 Introduction and Aim of the Work 
 Carbohydrate molecules have been nearly exclusively assigned as building 
blocks of protective cell wall constituents (for example cellulose and chitin) or as 
energy supply in cell metabolism. Biological information storage and transfer are 
commonly described to be based solely on nucleic acids and proteins. In contrast to 
nucleotides and amino acids, the most abundant type of biomolecules in nature, the 
carbohydrate molecules has been almost completely sidelined in this respect.[1]
 Carbohydrates are unique regarding the complexity of their structures. In 
contrast to the other two major classes of biologically important biopolymers, 
proteins and nucleic acids, oligo- and polysaccharides are built from monomers, 
which have at least two functional groups participating in an oligorimerization 
reaction. In a sugar residue one or more of several different hydroxyl groups can be 
glycosylated, thus also allowing the formation of branched structures. Furthermore, 
the glycosidic linkage can occur in one of two different stereoisomers, the D- or the 
E-glycoside. Consequently, more configurational stereoisomers can be constructed 
from monosaccharides than amino acids or nucleotides.[2]
 However, an important step in the development of carbohydrate research was 
the discovery of the biological importance of glycoconjugates containing a great 
variety of complex oligosaccharides. Carbohydrates habitually exist on cell surfaces 
as glycoprotein or glycolipid conjugates and are engaged in important functional and 
structural functions in various biological recognition processes like for instance, 
cancer metastasis, inflammatory response, innate and adaptive immunity, viral and 
bacterial infections and many other receptor-mediated signalling processes.[3,4]
Moreover, a large number of natural products require glycosylation in order to show 
proper biological performance.[5,6,7] However, the effect of glycosylation on the 
structure and function of natural products is not well understood, mostly due to the 
lack of efficient synthesis methods to cover the structural diversity of 
glycoconjugates required for answering the distinct role of glycosylation in biological 
systems. 
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 With this stimulant biological background, the O-glycosylation, which is a 
crucial organic synthetic pathway to attach a sugar to other sugar moieties or other 
molecules (aglyca), is again becoming more and more important. From a synthetic 
point of view, the efficiency of the O-glycosylation reaction generally involves high 
chemical yields as well as regio- and stereoselectivity. Among them, high 
regioselectivity is easily realised by the selective protection of the hydroxyl groups of 
the glycosyl acceptor. Although great achievements in the development of versatile 
and efficient glycosylation and building block strategies have been made during the 
last years,[8,9] there is still the need for more efficient procedures to prepare 
glycoconjugates. 
 The aim of this work is to develop two new efficient procedures to generate 
the O-glycosydic bond. In the first one, nonafluorobutanesulfonate is used as a 
leaving group for the formation of the glycosyl donor. In the second one, the 
generation of phenyl glycosides through nitro-substitution on aromatic compounds is 
investigated. 
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2 General Part 
2.1 Overview on Glycosylation 
2.1.1 Role of Carbohydrates in Nature 
 Oligosaccharides and glycoconjugates have intrigued biologist for decades as 
mediators of complex cellular events. With respect to structural diversity, they have 
capacities that far exceed proteins and nucleic acids. This structural variance allows 
them to encode information for many important biological processes: specific 
molecular recognition, to serve as determinants for protein folding and stability and 
influence the pharmacokinetics. It is demonstrated that glycosylation is one of the 
most ubiquitous forms of posttranslational modification.[10] Furthermore, the effects of 
altering glycosylation are highly variable and quite unpredictable.[3] Carbohydrates 
also constitute a very important group of molecules by themselves, they are major 
constituents of diverse natural products: secondary metabolites, nucleic acids, 
nucleotides, glycoproteins and glycolipids.[2]
2.1.2 O-Glycosylation Methods 
 Homogeneous and chemically defined glycoconjugates from biological 
sources for the investigation of the biological function are difficult to obtain. For this 
reason the synthesis of structurally defined oligosaccharides is a powerful tool in the 
study of glycobiology. Therefore chemical routes for the production of 
oligosaccharides and glycoconjugates are essential. 
 The chemical synthesis of natural glycoconjugates consists of the 
oligosaccharide synthesis, the aglycon synthesis and their glycosidic linkage to yield 
the target molecule. Commonly, the synthesis of glycoconjugates follows a 
convergent strategy. The two parts are synthesised separately, and the glycosidic 
linkage is formed in an advanced stage. Finally, the use of economic strategies due 
to the difficulty to ensemble monosaccharides has to be considered for the synthesis 
of the oligosaccharide. A convergent strategy makes it possible to reach the goal 
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with better yield than a linear strategy. The armed-disarmed[11] as well as the active-
latent[12] concept can be utilised to facilitate the synthesis. The nonexistence of 
universal conditions for the synthesis of oligosaccharides, as Paulsen in 1982 stated, 
make that “each oligosaccharide synthesis remains an independent problem whose 
resolution requires considerable systematic research and a good deal of know-
how”.[13]
 Since the major historical Koenigs–Knorr method was reported in 1901,[14]
considerable attention has been directed towards the efficiency of the 
O-glycosylation method.[8,9,13,15,16] From a synthetic point of view, the efficiency of the 
O-glycosylation reaction generally involves high chemical yields as well as 
regioselectivity and stereoselectivity. Among them, high regioselectivity is realised by 
the appropriate selective protection of the hydroxyl groups, adapted to the synthetic 
strategy of the glycosyl acceptor. Therefore, many methods have been developed 
focusing on the high chemical yield and the high stereoselectivity of this reaction. 
 One important consideration is the configuration of the anomeric center. In 
fact control of the stereochemical product of nucleophilic substitution (SN1 or SN2) at 
this position is one of the most difficult tasks faced by the synthetic chemist. Many 
factors can play an important role in D/E-stereoselectivity, namely nature of the 
solvent, protecting groups, neighboring group effect,[17] activation method and the 
anomeric effect.[18]
 The most used strategy approach for glycosylation requires the derivatization 
of the anomeric substituent into a leaving group (LG, Scheme 1), whereby the 
intermediate or glycosyl donor can be isolated. In the next step the leaving group is 
activated with an appropriate promoter. The presence of a glycosyl acceptor (Nu) 
during the second step leads to the formation of the anomeric bond or glycoside 
product.[15,16] Many methods have been developed using this pathway. The most 
important ones are summarised in Table 1. 
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O
(R1O)n
OH
O
(R1O)n
LG
O
(R1O)n
Nu
NuH
Derivatization Activation
R1 = Protecting group
Scheme 1 Two step glycosylation strategy 
Table 1 Promoter used for each leaving group in the two step glycosylation strategy
Leaving Group Promoter Comments 
Halide Br or Cl Hg(CN)2,
[19] Ag2O,
[20] Sn(OTf)2
[21] unstable
easy to hydrolyze 
high toxicity of metals 
Halide F SnCl2-AgOCl4,
[22] SiF4,
[23]
BF3·OEt2,
[24] TiF4
[25]
more stable than Br and Cl 
SR’ IDCP,[26] NIS-TfOH,[27] NBS,[28] NIS[29] very versatile 
O-Acyl  FeCl3,
[30] BF3·OEt2,
[31] TMSOTf[32] facile preparation 
OC(NH)R’ BF3·OEt2,
[33] TMSOTf[33] mild reaction conditions 
very versatile 
O(CH2)3CH=CH2 IDCP,
[34] NIS-Et3SiOTf
[34] versatile 
OP(OR’)2 TMSOTf
[35] mild reaction conditions 
 Another concept for the formation of the glycosidic bond is the so called 
dehydrative glycosylation.[36] This consists in the derivatization, activation and 
coupling in one step (Scheme 2). The earliest reaction of this type was carried out by 
Fischer.[37] Since then significant advances have been made in this field, enlarging 
the methods useful for glycosylation. Dehydrative coupling needs mild conditions, a 
set of reagents that react rapidly and completely to form a highly reactive 
intermediate. The generation in situ of the glycosyl donor avoids the unnecessary 
isolation of the donor. A representative set of methods are summarised in Table 2. 
O
(R1O)n
OH
O
(R1O)n
Nu
NuH
Derivatization/Activation/Coupling
R1 = Protecting group
Scheme 2 Direct dehydrative glycosylation[36]
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Table 2 Methods used for the dehydrative glycosylation
Coupling via Reagents Comments 
Protic acids HCl[37] only for simple glycosides 
Lewis acids Yb(OTf)3-MeOCH2CO2H
[38]
Sn(OTf)2-TMS2O
[39]
Ph2Sn=S, AgClO4
[40]
Halides MeSO3H-CoBr2-TBABr
[41]
Sulfonates Tf2O
[42]
NosCl, AgOTf[43]
Oxophosphonium DIAD, PPh3
[44]
Bu3P=O, Tf2O
[45]
very versatile 
facile procedure 
Oxosulfonium Ph2S=O, Tf2O
[46] very versatile 
facile procedure 
Oxotitanium [1,2-benzenediolato(2-)-O,O]-
oxotitanium, Tf2O
[47] 
useful for pyranose 
formation 
Thio-tin Ph2Sn=S, Tf2O
[48] useful for pyranose 
formation 
Isourea Cy-N=C=Ncy, Cucl[49] useful for phenyl 
glycosides 
 There are still three chemical methods, which are very useful for the formation 
of the glycosidic bond, and can not be included in Scheme 1 or Scheme 2. These 
are the glycals, 1,2-anhydrosugar and orthoester methods summarised in Table 3. 
Table 3 Promoter for glycosyl donors different from Scheme 1 or Scheme 2 
Glycosyl donor Promoter Comments 
Glycal IDCP,[50] NIS[51] useful for the synthesis  
2-deoxy-sugars 
1,2-Anhydrosugar ZnCl2
[52] useful for the synthesis  
trans 1,2-glycosides 
Orthoester AgOTf,[53] TrClO4
[54] useful for the synthesis  
trans 1,2-glycosides 
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 Solid-phase synthesis has revolutionised the synthesis of nucleotides and 
peptides, and strong progress has been made in oligosaccharide synthesis. 
Oligosaccharide solid-phase synthesis is more complicated due to the 
stereoselectivity and regioselectivity as well as the difficulty to synthesise branched 
structures. Solid-phase synthesis requires highly efficient reactions that give single 
products and near quantitative yield. For this reason there is still need for more 
efficient procedures to prepare glycoconjugates.[55]
 An alternative to chemical synthesis to form the glycosidic bond is the enzyme 
method. Two kind of enzymes can be used: glycosyltransferases and glycosidases. 
Glycosidases give low yields, but the use of these for transglycosylation using 
fluoride or p-nitrophenyl glycosides as donors show very good results. On the other 
hand, glycosyltransferases produce glycosidic bonds using the same basic approach 
that has been developed by carbohydrate chemists. In general, enzymes do not 
need protecting groups, are specific and efficient, work under mild conditions and 
are environmentally friendly, but some disadvantages must be considered. They are 
difficult to obtain, are not useful for a big range of reactions due to the high 
specificity, and do not work without cofactors, precise pH and temperature.[56]
2.1.3 Sulfonates as Glycosyl Donors 
 Sulfones have great relevance in organic synthetic transformations[57,58] and 
additionally have a wide applicability in diverse fields including agrochemicals,[59]
pharmaceuticals[60] and polymers.[61] Sulfones have been described as “chemical 
chameleons”[62] due to the ability of the sulfonyl group to serve as a temporary 
transformer of chemical reactivity. The RSO2 group activates olefines for nucleophilic 
Michael additions,[63] is an excellent stabiliser of adjacent carbanions[64]and has been 
widely used for cross coupling reactions.[65,66] Although without proper asymmetry 
sulfones can also function as a stereoinducer.[67] The sulfonate function containing 
the RSO2 group has been used in carbohydrate chemistry for the formation of 
glycosyl donors. 
 Glycosyl sulfonates were first reported in 1929 by Helferich et al. The 
toluenesulfonate was obtained by reacting glycosyl chloride with silver 
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toluenesulfonate (Scheme 3) and was described as white powder crystals, which 
were very unstable in solution.[68] Helferich and Gnuchtel synthesised later the mesyl 
glucopyranoside with the same procedure.[69]
 Schuerch and co-workers (Scheme 3) made some experiments with sulfonate 
donors, where a series of glucose, galactose and mannose were examined. Triflyl 
and tosyl glycosides were synthesised at –78 °C and at room temperature following 
the method from Helferich et al. The triflate derivative was reacted with MeOH in 
CH2Cl2 giving E-selectivity with 40% yield. On the other hand, using Et2O as solvent, 
a 82% of DE-mixture was obtained.[70] The same experiments with toluenesulfonate 
glycoside leads to DE-mixtures.[71] Similar procedures were carried out with 
galactose, in which toluenesulfonate gives D-selectivity in contrast to glucose and 
good yields (60%–quant.) using different alcohols and solvents. In the case of triflate 
the D-selectivity and yield were reduced and depending on the solvent E-selectivity 
was obtained.[72] The E-selectivity could be explained by the effect of tight ion 
pairs.[72] From mannose, toluenesulfonate derivatives were synthesised. To 
maximise the strong anomeric effect, nonparticipating electron-withdrawing 
substituents as protecting group (mesyl) were inserted at the C-2 hydroxyl. These 
reactions were carried out in CH3CN, obtainingE-selectivity in good yield (60–
65%).[73] The authors claimed that the resulting strong opposite dipoles control the 
structure of the transition state allowing only pure SN2 reaction leading to the 
substitution on the E-face.[73] Simultaneously Machami and Suami (Scheme 3) 
prepared selectively the D/E-mesyl derivatives from glucose. Reaction of the 
glycosyls donors with alcohols under SN2 conditions lead to the E/D-products in good 
yields (70–95%).[74]
O
R1O
Cl
Ag OR2
O
R1O
O
R1ONuH
Nu
R1 = Protecting group, R2 = Tf, Tos, Mes
OR2
Scheme 3 Schuerch, Mashami and Suami method to synthesise glycosyl sulfonates
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 Leroux and Perlin (Scheme 4) investigated the formation of 
trifluoromethanesulfonates from glucose, also at low temperature and in CH2Cl2, but 
with unsatisfactory yields. They discovered that upon addition of Bu4NBr in the 
reaction mixture the D-glucopyranosyl bromide could be formed in a few minutes. 
When the C-2 hydroxyl was protected with a participating group an orthoester was 
isolated. As in the previous case, adding Bu4NBr gave the D-brominated glucosyl 
donor which was again isolated. Both products suggested the formation of a 
E-trifluoromethanesulfonyl donor. The same authors also examined the mesyl 
glycosides formed from Mes2O, in which the reaction with MeOH gives an 
DE-mixture in good yields (87%, 61% with addition of Bu4NBr). They suggested that 
according to the DEpercentage, the DE-mesylates existed in equilibrium and that 
the displacement of E occurs more rapidly to produce more D-glycoside.[75]
R1 = Protecting group, R2 = Mes, Tf
O
R1O
O
R1O
O
R1ONuH
NuOH
R22O
Bu4NBr Br
Scheme 4 Method of Leroux and Perlin 
 Similar studies with Tf2O were carried out by Pavia and co-workers
[76]
(Scheme 5) but in the absence of base. They found that depending on the presence 
of the acceptor in the reaction mixture different products were formed. In the 
absence of the acceptor, trehalose derivatives were predominantly formed with D-
Dconfiguration and in a very good yield (>95%). This type of reaction with acceptors 
was also studied, giving good yields (55–90%) and D-selectivity.[77] 
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O
R'O
O
R'O
O
R'O
OH
Tf2O
O
R'O
OTf
O
OR'
O
R' = Protecting group
Nu
NuH
Scheme 5 Method of Pavia and co-workers 
 Leroux and Perlin (Scheme 6) studied the reaction of sugars with mesyl or 
tosyl chloride. In the reaction of 2,3,4,6,-tetra-O-benzyl-glucopyranose with mesyl or 
tosyl chloride in the presence of a base in CH2Cl2, the formation of the 
glucopyranosyl chloride could be observed, giving D/E mixtures after addition of the 
donor.[75] Szeja et al. (Scheme 6) obtained good results in the case of tosyl chloride, 
but the reaction was carried out under phase-transfer conditions.[78] As pointed out in 
Scheme 6, Koto et al.[79] investigated the reaction of p-nitrobenzenesulfonyl chloride 
(NosCl) and glycosyl donors in the presence of silver triflate and Et3N. The selectivity 
was dependent on the absence or presence of N,N-dimethylacetamide, being E and 
Drespectively. The formation of D-glycosides was associated with the formation of a 
N,N-dimethylacetamide E-intermediate, only allowing the nucleophilic substitution 
from the D face.[43] 
O
R1O R
2Cl
O
R1O
Cl
O
R1ONuH
Nu
R1 = Protecting group,   R2 = Mes, Tos,   R3 = Tos, Nos
Leroux and Perlin
O
R1O
O
R1O
OR3
O
R1ONuH
Nu
OH
OH
R3Cl
Koto and Szeja
Scheme 6 Synthesis of glycoconjugates with sulfonyl chlorides
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 Crich and co-workers found out, through NMR studies,[80] that the reaction 
developed for Kahne et al. (Scheme 7) had a triflate glycoside as an intermediate. In 
this reaction, a thioglycoside was oxidised to give the glycosyl sulfoxide. Treatment 
of this sulfoxide with Tf2O in the presence of one acceptor lead to the corresponding 
D/E-glycosides.[81] Finally, Crich and co-workers (Scheme 7) developed a method to 
generate the glycosidic bond in a one-pot reaction, starting from thioglycosides, 
using Tf2O and benzenesulfenyl triflate. They also proved that the D-triflate glycoside 
was the intermediate.[80] More recently Wong et al. used N-(phenylthio)-H-
caprolactam in combination with Tf2O to activate the phenylglycoside.
[82] The 
selectivity depended on the used protective group and could be D[83] or E[80] selective 
in the case of mannose. The same protecting group effect was observed in the case 
of glucose, giving D-glucoside[84] or E-glucoside[85] selectively. 
O
R1O
O
R1ONuH
Nu
O
R1O
OTf
R1 = Protecting group,  R2 = Alkyl, Phenyl
SR2
O
R1O SR2
O
Tf2O
Tf2O, PhSOTf
Route a: Kahne et al.
Route b: Crich et al.
Scheme 7 Synthesis of glycoconjugates from thioglycosides and sulfoxides via glycosyl triflate 
 Kim et al. (Scheme 8) developed a new method for glycosylation based on the 
activation of 2-(hydroxycarbonyl)benzyl glycosides with Tf2O in CH2Cl2 at low 
temperature. However they did not give any proof of the proposed mechanism.[86]
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O
R1O
O
O
R1O
O
R1ONuH
Nu
R1 = Protecting group
OH
O
OTf
Tf2O
Scheme 8 Mechanism proposed by Kim et al. based on activation of 2-(hydroxycarbonyl)benzyl 
glycosides
2.1.4 Direct O-Alkylation and O-Arylation 
 Direct O-alkylation (Scheme 9) with 1-hydroxysugars was investigated for the 
first time by Purdier et al. in 1903.[87] This method turned to be important for the 
synthesis of a variety of glycosides.[88] Using this methodology for the synthesis of 
glycoconjugates, the stability of the anions, ring-chain tautomerism and reactivity of 
the three O-deprotected hydroxyls must be considered. The mainly used leaving 
groups for this reaction were sulfonates due to the low reactivity of the iodide.[89]
 Even with high reactivity of the E-anion in comparison with the D-anion, high 
temperature is needed for the synthesis of E-conjugates in order to accelerate the 
D/E-anomerisation.[90] On the other hand, carrying out the reaction at low 
temperatures decelerates the anomerisation and the presence of bulky substituents 
at O-6 favor the D-selectivity.[90] Nevertheless, this methodology has limited general 
applicability to the synthesis of glycoconjugates. 
O
OR1
R2O
R2O
R1O OH
NfO R3
N3
OTBDS
O
OR1
R2O
R2O
R1O
O R3
N3
OTBDS
NaH, RT
Et2O
R1 = Ac,  R2 = 2,3,4,5-tetra-O-acety-E-D-galactosyl,  R3 = Alkyl
+
Scheme 9 Direct alkylation of 1-hydroxysugars and sulfonated aglycon[91]
 Direct anomeric O-arylation (Scheme 10) of protected or unprotected sugars 
with electron-deficient aromatic compounds leading directly to aryl and 
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heteroaromatic compounds has been shown to be efficient.[92,93,94] The aromatic 
nucleophilic substitution take advantage of the excellent leaving group character of 
fluoride or chloride in halogenated heteroaromatic and substituted nitro- or 
dinitrobenzenes. Moreover, phenylglycosides containing a very electron-poor phenyl 
or heteroaromatic ring can be used as glycosyl donors.[92,93,95]
 The selectivity of this aromatic nucleophilic substitution depends on many 
aspects. Solvent plays an important role. Reactions carried out in DMF or DMSO, in 
the presence of a base, give almost exclusively D-products, due to the anomerisation 
process that occurs after formation of the phenylglycosides, forming the 
thermodynamically most stable product.[96,97] The anomerisation effect could be 
suppressed using less polar solvents, namely CH2Cl2 or toluene.
[92,93] In the case of 
toluene crown ethers are needed to solubilize the formed salts. The used base can 
also influence the selectivity. Huchel et al. found that E-product was obtained 
independent from the base used, with toluene or CH2Cl2 as solvents. This was 
explained due to the high nucleophilicity of the E-anion when comparing with the 
D-anion.[93] On the other hand, Petersen et al. observed that using a mixture of 
Li2CO3 and 4-(N,N-dimethylamino)pyridine or 1,4-dimethylpiperazine in CH2Cl2 D-
and E-selectivity were respectively obtained. The explanation given by the authors 
for these results were the effect of different basicity of the used bases.[92]
O
(R1O)n
OH
O
(R1O)n
R1 = Protecting group
EWD
F
EWD
O
+
Scheme 10 Direct O-arylation of a carbohydrate
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2.2 Glycosylation with Nonafluorobutanesulfonyl and 
Unexpected Reactions 
2.2.1 Aim of this Work and Synthetic Strategies 
 Sulfonate characteristics as glycosyl donors for the effective synthesis of 
glycoconjugates presented in chapter 2.1.3 and the advantages of nonafluoro-
butanesulfonyl fluoride (NfF) when comparing with Tf2O (chapter 2.2.2) encouraged 
to investigate the generation of glycosyl donors with NfF.  
Three strategies were thought to be useful for the generation of the 
glycosylnonaflate, starting from: 
1. commercially available NfF (2a),
2. nonafluorobutanesulfonyl-1H-1,2,3-benzotriazole (6a), 
3. nonafluorobutanesulfonic acid 1H-1,2,3-benzotriazol-1-yl ester (25a). 
 The first methodology was envisaged in order to establish the synthetic 
possibilities for the glycosyl nonaflate. The use of reagents for sulfone transfer was 
very attractive, since commercially available fluorides are less reactive, need more 
basic conditions and nucleophiles that are sufficiently nucleophilic or not sterically 
encumbered. Numerous transfer reagents are described in the literature for the 
sulfonyl group, under mild conditions, starting from benzene derivatives or 
heterocycles, such as nitro- or dinitrophenyl triflates and nonaflates,[98,99]
N-phenyltrifluoromethanesulfonamide,[100,101] N-(2-pyridyl)triflylimidate,[102] triflyl-
imidazole,[103,104] 1-tosyl-1,4-dihydropyridine derivatives,[105,106] indole derivatives[107]
and the more studied sulfonylbenzotriazoles, which are used for a wide variety of 
synthetic transformations, as accurately focused in chapter 2.2.4. For this reason, 
benzotriazoles were the heterocycles of choice for the nonaflyl group transfer. 
 Concerning the monosaccharide, a C1-OH unprotected carbohydrate was 
necessary to generate the glycosyl nonaflate. All other carbohydrate moiety hydroxyl 
groups had to be protected with a stable protecting group (PG). Moreover, in order to 
minimize the influence of the PG in the D/E-stereoselectivity, a non-participating 
C2-OH PG seemed to be appropriate. For these reasons benzyl was selected to be 
the glucose hydroxyls protecting group, in positions C-2, C-3, C-4 and C-6, which 
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allowed the reaction in a wide variety of conditions and with different bases. The 
resulting 2,3,4,6-tetra-O-benzyl-(D/E)-D-glucopyranose was the used carbohydrate 
for the optimisation reactions. The glycosyl acceptor selected for the optimisation 
was methanol due to the low steric effect and good accessibility. 
2.2.2 Overview on the Uses of Nonafluorobutanesulfonyl Fluoride 
 The use of perfluoroalkyl sulfonates had considerably extended the possibility 
for new synthetic pathways.[108,109] Moreover, nonafluorobutanesulfonyl esters are 
very good leaving groups, being twice as fast as their trifluoromethane ester 
analogues in hydrolysis reactions.[110]
 The strong electron-withdrawing effect of nonaflate has found many 
applications namely for alkylations,[91] fluorination,[111] dehydration of alcohols and 
phenols,[112] dienophiles for Diels-Alder reactions,[113] vinyl cation generation[114] and 
epoxy formation.[115] The main advantages of NfF when compared with Tf2O are its 
stability when being exposed to air and moisture and no loss of half of the molecule 
during the reaction. 
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2.2.3 Nonafluorobutanesulfonyl Fluoride for Glycosylation 
 Initially, the formation of the glycosyl nonaflate was carried out using 
commercially available NfF (2a). Several reactions were conducted to optimise the 
glycosylation of 2,3,4,6-tetra-O-benzyl-(D/E)-D-glucopyranose[116] (1) with MeOH. 
The use of low pKa bases, namely pyridine and Et3N, did not lead to any product and 
strong bases like NaH were needed for the glycosyl nonaflate generation. 
Experiments carried out at –78°C, a temperature that was supposed to be optimal, 
were unsuccessful and therefore the experiments had to be performed at higher 
temperatures. DMF and 1,2-dimethoxyethane (glyme) were used as solvents when 
NaH was the base, however glyme showed to be the best solvent. The formation of 
the glycosyl nonaflate lead immediately to trehalose formation if a glycosyl acceptor 
was not present in the solution. On the other hand, in the presence of the glycosyl 
acceptor it was involved in the reaction with the glycosyl nonaflate. These results 
were comparable to the ones observed by Pavia et al. using Tf2O.
[76] Both reactions, 
the formation of trehalose and the glycosylation with methanol were optimised. 
2.2.3.1 Methyl 2,3,4,6,-tetra-O-benzyl-(DE)-D-glucopyranoside 
 The experiments summarised in Table 4 were performed adding the reagents 
in a different order, to find the optimal conditions for the reaction in Scheme 11. 
O
BnO
BnO
BnO
BnO OH
O
BnO
BnO
BnO
BnO OMe
MeOH, NfF (2a), NaH
Glyme
1 3D, 3E
Scheme 11 Glycosylation reaction with MeOH using NfF for the glycosyl donor formation
 Since the experiments that were carried out at –78 °C (not indicated in Table 
4) in order to form first the glycosyl nonaflate and then the glycoconjugate were 
unsuccessful, the reactions were performed at 0 °C, however without an 
improvement (entries 1,2 and 4-6). Only the formation of EE-trehalose (4c; entry 3) 
or methyl-glucopyranosides 3D and 3E (entry 7) were observed when the order 
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changed in which the reagents were added. Despite the good results from entry 7, 
the large amount of needed glycosyl acceptor was not satisfactory and other 
conditions had to be investigated. Better results were observed at –20°C in the 
presence of 15-crown-5 ether (entries 8–14), in which the amount of glycosyl 
acceptor and NfF (2a) were progressively reduced (entries 8–14). Best results were 
obtained in the presence of a stoichiometric amount of 15-crown-5 and NaH based 
on glycosyl-donor and acceptor, 50% excess of glycosyl acceptor and 2a at  
–20 °C (entry 14). 4 was observed at least as a shadow by TLC (entries 3, 7–14). 
After reaction optimisation at –20 °C other temperatures were tested with worse 
results (not indicated in Table 4), in which low reactivity or formation of by-products 
were observed at lower or higher temperatures, respectively. 
 Further investigations in this field were carried out in our working group.[117]
This reaction was optimised in a bigger scale and with different glycosyl acceptors. 
Best conditions turned out to be the same as described in entry 15 giving in this case 
72% yield, surprisingly with a different D/E-selectivity (D:E, 3:2). Under the same 
conditions and using MeCN as solvent a 79% yield (D:E, 3:2) was obtained. When 
2,3,4,6-tetra-O-benzyl-D-D-glucopyranose (1) was added dropwise to the reaction 
mixture, in MeCN, E-selectivity (D:E = 1:10) was observed, in a 27% yield. Isopropyl- 
and tert-butyl alcohol were also used as glycosyl acceptors giving 56% (D:E , 3:2) 
and 37% (D:E, 3:2) yields, respectively. 
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Table 4 Optimisation reactions carried out for the formation of methyl glucopyranosides 3D and 3E
T[qC] 1st Comp. 2nd Comp. 3rd Comp Results 
1 0 2.8 eq NfF 1a and 2 eq NaH 12 eq MeOH no reactionb
2 0 2.8 eq NfF and
cat. NaBr 
1a and 2 eq NaH 5 eq MeOH no reactionb
3 0 2.8 eq NfF, 
5 eq MeOH 
and 
cat. NaBr 
1a and 2 eq NaH  1 and traces of 4cb
4 0 5 eq NaH and 
3.7 eq NfF 
1a 5 eq MeOH no reactionb
5 0 2.8 eq NfF 1a, 2 eq NaH 
and 2 eq CE  
5 eq MeOH no reactionb
6 0 1.5 eq NaH 
and 1.5 eq CE 
1a and 3 eq NfF 5 eq MeOH no reactionb
7 0 1, 5 eq NaH 
and 2 3 eq CE 
5 eq MeOH 3.7 eq NfF 3D + 3E
(65%;1:2) 
8 –20 1, 2 eq NaH 
and 2 eq CE 
5 eq MeOH 2.8 eq NfF as in entry 7b
9 –20 1, 3 eq NaH 
and 3 eq CE 
2 eq MeOH 2.8 eq NfF 4c + 3D + 3E
(46%; 4:7:12) 
10 –20 1, 3 eq NaH 
and 1.5 eq CE 
2 eq MeOH 2.8 eq NfF 
11 –20 1, 3 eq NaH 
and 2 eq CE 
2 eq MeOH 2.8 eq NfF 
3D + 3E
(~60–70%)b
conversion of 1 was 
better when bigger 
amount of CE was used 
12 –20 1, 2eq NaH 
and 2 eq CE
1 eq MeOH 2.8 eq NfF 3D + 3E and 1
(~30%)b
13 –20 1, 2.5 eq NaH 
and 2.5 eq CE
1.5 eq MeOH 2 eq NfF 3D + 3E and 1
(~40–50%)b
14 –20 1, 2.5 eq NaH 
and 2.5 eq CE
1.5 eq MeOH 1.5 eq NfF 3D + 3E
(70%;1:2) 
Reactions were carried out overnight (otherwise stated) under argon; After base addition the 
subsequent components were added after 40 min; 100 mg of 1 were used; a 1 was dissolved in 
glyme; b Observed by TLC. 
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2.2.3.2 2,2’,3,3’,4,4’,6,6’-Octa-O-benzyl-(DDDEEE)-trehalose 
 The experiments summarised in Table 5 were performed to optimise the 
reaction in Scheme 12. The reactions were conducted at room temperature, since 
low temperatures give less product yield (entry 8) or no reaction (entry 9). The 
presence of 15-crown-5 ether also had a very important role, since only in its 
presence the formation of the product could be observed (entries 3–8, 10, 11). 
Stoichiometric amounts were necessary to obtain trehalose 4 in moderate yields, in 
which a 50% excess of base and NfF were needed. 
O
BnO
BnO
BnO
BnO OH
NfF (2a), NaH
Glyme
1
O
BnO
BnO
BnO
BnO
O
BnO
BnO
BnO
BnO
O
BnO
BnO
BnO
BnO
O
O
4a
4b
4c
1
1'
1
1
1
O
BnO
OBn
OBn
OBnO
OBnO
OBn
OBn
OBn
O
BnO
OBn
OBn
OBn
1
Scheme 12 Trehalose (4) formation using NfF for the glycosyl donor formation
Table 5 Optimisation reactions carried out for the formation of trehaloses 4a, 4b and 4c 
 TqC NaH NfF 15-Crown-5 Results 
1 RT 2 eq 1.5 eq --- no reactiona
2 RT 1 eq 2 eq --- no reactiona
3 RT 1.2 eq 2 eq 0.25 eq 4b
4 RT 1.2 eq 1.2 eq 0.5 eq 4b
5 RT 2 eq 0.5 eq 0.5 eq 4b
6 RT 2 eq 0.75 eq 0.5 eq 4b
7 RT 2.5 eq 2 eq 0.5 eq 4a + 4b + 4c (~20%)a
8 0 2.5 eq 2 eq 0.5 eq 4b
9 –20 2.5 eq 2 eq 0.5 eq no reactiona
10 RT 1.2 eq 1.2 eq 1 eq 4a + 4b + 4c (~40%)a
11 RT 1.2 eq 1.5 eq 1 eq 4a + 4b + 4c (57%) (0.5:1:4)c
Reactions were carried out overnight under argon; All components were mixed and 2a was added 
40 minutes later drop wise; 100 mg of 1 were used; a Observed by TLC; b Observed as a shadow by 
TLC; c Isolated yield. 
2 General part 
20 
2.2.3.3 Reaction Mechanisms 
 When the reaction was carried out in a small scale either for the formation of 3
or 4 E-selectivity was observed. One proposed mechanism involves the formation of 
the D and E glycosyl nonaflate. This intermediate (Scheme 13) reacts under SN2
conditions with sodium methoxide, giving an inversion of the anomeric center. This is 
a reasonable explanation for the presence of D-anomer majority in the initial reaction 
mixture, which is converted to E-anomer after SN2 reaction. 
O
BnO
BnO
BnO
BnO OH
O
BnO
BnO
BnO
BnO OSO2C4F9
NfF (2a), NaH
Glyme
1
Scheme 13 Intermediate under SN2 conditions 
 Carrying out the same reaction in a big scale (realised in our working 
group[117]) gave an anomeric ratio in which the D-anomer was majoritary (D/E, 3:2). 
This means that the previously proposed mechanism could not be applied. Instead 
the proposed mechanism was SN1 through an intermediate (Scheme 14) that was a 
glycosyl cation. 
O
BnO
BnO
BnO
BnO OH
O
BnO
BnO
BnO
BnO
OSO2C4F9
NfF (2a), NaH
Glyme
1
Scheme 14 Intermediate under SN1 conditions 
 Another mechanism that could be proposed involves the formation of the 
nonafluorobutanesulfonic acid methyl ester, which reacts with the anomeric salt, 
giving the methylglycoside. With this mechanism it is also expected to obtain the 
D-methyl glucopyranoside, since low temperatures favour the reaction of the 
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D-anomeric-free hydroxyl. This reaction is competitive and can be observed by the 
formation of dimethyl ether gas during the reaction. 
 The formation of trehalose 4 can only be explained for the first two proposed 
mechanisms SN1 or SN2. For a SN2 mechanism, two carbohydrate molecules are 
needed, the first reacting with 2a to form the glycosyl nonaflate, starting from the 
D-form, and the second substituting the nonaflate, starting from the E-form. Since the 
probability that one carbohydrate reacts, starting from the D-form and the other from 
the E-form to give a EE-major product is low, this mechanism was not considered. 
The most probable mechanism is a SN1 reaction, in which the glycosyl cation 
intermediate is formed after nucleophilic attack of the D- or E-glucose to 2a. This 
intermediate can now be substituted by another glucose, probably the most 
nucleophilic E-glucose, giving EE- or DE-anomers as major products. The fact that 
the EE-product has majority could be explained by the presence of tight ions, in 
which the most probable stable tight ion of the nonaflate is proximate to the D-side. 
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2.2.4 Nonafluorobutanesulfonyl-1H-1,2,3-benzotriazole 
 Benzotriazole (Bt) has been widely utilised as a synthetic auxiliary in a 
multitude of reactions.[118,119,120,121,122,123,124] Benzotriazole is an inexpensive, stable, 
and biologically innocuous compound,[119] which can be easily introduced into 
organic molecules. After conferring its multiple activating influences for carrying out 
precise transformation reactions, it can be easily removed and can generally be 
recycled. The early results in the chemistry of benzotriazole have been 
described.[122]
N-Sulfonylbenzotriazoles are know for a long time, but only in the last years 
they have been used as starting material for many interesting reactions like, for 
instance, acyl group activation to preparare acid derivatives when the corresponding 
halides are not easy to synthesise,[125,126,127,128,129] preparation of thioacids and 
derivatives thereof with Grignard reagents,[130,131] as intermediates for the 
benzotriazolyl activation of aromatics[132] and heteroaromatics,[133] mild reagents for 
sulfonamides synthesis,[134,135] reagents for the formation of arylsulfonates,[134]
dehydration of aldoximes and amides for nitrile synthesis,[136] formation of 
N-imidobenzotriazoles via a benzotriazole-mediated Beckmann rearrangement of 
oximes,[137] activation of alcohols to prepare alkyl benzotriazoles[133,138] and formation 
of C-sulfonyl bonds.[139]
 The preparation of N-sulfonylbenzotriazoles derivatives was previously 
realised through diazotation of the corresponding N-(2-aminophenyl)-
sulfonamides,[140] N-stannylation of the benzotriazole and subsequent destannylation 
with the corresponding sulfonyl chloride,[141] azide trapping of benzynes.[142] Actually, 
the synthesis of N-sulfonylbenzotriazoles generally involves the use of sulfonyl 
halides (normally chloride)[138,143] or anhydride[130] in the presence of a base. 
2.2.4.1 Synthesis of 1-nonafluorobutanesulfonyl-1H-1,2,3-benzotriazole (6a) 
 Compound 6a was tried to be synthesised under mild conditions starting from 
1H-benzotriazole (5a) and nonafluorobutanesulfonyl fluoride (2a) but could only be 
obtained in a very low yield (Table 6). BuLi was found to be necessary to obtain 6a
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in a good yield, with THF as solvent. Better yield (89%) was obtained in a reaction 
carried out in glyme as solvent at reflux. Compound 6a decomposes in the presence 
of light, therefore, it should be synthesised and cromatographed in the dark, as well 
as kept in a refrigerator. The compound was characterised by its spectral properties 
and elemental analyses (see experimental part). 
Table 6 Optimisation reaction for the synthesis of 6a
Solvent Base t [h] T [°C] Yield 6a [%] 
CH2Cl2 pyridine 24 reflux 4 
Et2O Et3N 3 RT 5 
Et2O/THF 1:1 BuLi 72 reflux 73 
THF BuLi 4 RT 71 
Glyme BuLi 3 reflux 89 
2.2.4.2 Reaction of 6a with Carbohydrates 
 The glycosidic bond formation with MeOH and 2,3,4,6-tetra-O-benzyl-D-D-
glucopyranose (1) was carried out by activation of the C1-OH as a sulfonate, 
transferring the sulfonyl-group from 6a to 1. Different conditions, bases and solvents 
were used without success. Due to the difficulty of this two step-reaction in one-pot, 
it was thought that a primary investigation for the nonaflyl group transfer was 
necessary. Under these premises reactions with phenol (7a) were carried out, since 
phenyl sulfonates are stable products. 
2.2.4.3 Reactions with Phenol (7a) 
 The reaction of 6a with phenol (7a) was attempted in the presence of several 
bases and the results are summarised in Table 7. NaH and toluene was found to be 
the base and solvent of choice, respectively. Surprisingly, the major product isolated 
after aqueous work-up was an orange product which was shown by spectral and 
analytical analyses to be the azo compound 8a. Although both ortho- and para-
substituted azo compounds can be expected, the structure of the major product was 
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unambiguously assigned to be the ortho-substituted azo compound 8a, as supported 
by its X-ray crystallographic analysis (see crystal data). Only a very small amount 
(ca. 5%) of the para-substituted derivative 8b was isolated by column 
chromatography. Obviously, the triazole ring underwent an unexpected ring-opening 
reaction by nucleophilic attack of the phenoxide anion. 
Table 7 Optimisation reaction of 6a with phenol (7a) for the synthesis of 8a
Base Solvent t [h] T [°C] Yield [%] 
Et3N CH2Cl2 24 RT no reaction 
NaH CH2Cl2 6 RT 74 
NaH Toluene 6 RT 76 
 Experiments conducted in other solvents, as summarised in Table 8 resulted 
in the para-substituted azo compound 8b, the structure of which was proven by X-
ray crystallographic analysis (see crystal data). Yield was moderate when 
conducting the reaction in DMF. This dipolar aprotic solvent probably blocks the 
ortho positions by coordinating the oxygen atom of the phenolate anion, thus 
directing the reaction to proceed virtually exclusively to the para product 8b.
Table 8 Comparison of solvents and products 
Solvent Base T 8a [%] 8b [%] 
Toluene NaH RT 76 < 5 
CH2Cl2 Na-phenolate RT 44 6 
THF NaH RT 31 18 
DMF NaH RT --- 47 
MeOH NaOH Reflux --- 10 
 Many reactions with different sulfonyl substituted benzotriazoles, results of 
which are summarised in Table 9, were carried out under the same reaction 
conditions as described for the synthesis of compound 8a (Table 7, entry 3). The 
experiment with 6b[130] was a mixture of the ortho-coupled azobenzenes 9a
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(Tf = SO2CF3) with a free phenolic group and its corresponding 
trifluoromethanesulfonate ester 9b (OTf instead OH), the structure of which was 
proven by X-ray analysis (see crystal data). Pure 9a could only be obtained after 
HPLC reverse phase separation of the mixture. On the other hand, the reaction with 
a double amount of 6b lead to 9b in an almost quantitative yield. The tosyl 6c[138]
and mesyl 6d[143] substituted benzotriazoles gave the expected phenyl sulfone esters 
10 and 11.
Table 9 Reactions of phenol (7a) with different substituted benzotriazoles 
Benzotriazole derivative Product Yield 
N
N
NHNf
HO
N
N
NHNf
N
N
NHTf
HO
OH
OTos
OMes
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
Nf
Nf
Tf
Tos
Mes
N
N
NHTf
TfO
76%
47%
75% 1:3a
95% 0:1b
96%
91%
8a
8b
9a
10
11
6a
6a
6b
6c
6d
9b
a Proportion 7a:6b = 1.3 eq:1 eq; b Proportion 7a:6b = 1 eq:2 eq 
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2.2.4.4 Reactions with Phenol Derivatives 
 Also a set of azobenzenes listed in Table 10 were prepared by this method 
using 6a and different phenols. The authentication of the ortho coupling in the 
reaction of benzotriazole 6b with phenols in toluene is proven by the formation of 
products 7b, 7c, 7f and 7h from 2-methyl-, 3-methyl-, 2-tert-butyl-, and 2-
methoxyphenol, respectively. 7f and 7h gave more than 70% of the corresponding 
ortho-coupled products 16 and 18, respectively, while 3-methylphenol quantitatively 
resulted in the ortho coupled azobenzene 13 (92%) and the other ortho regioisomer 
(8%; NMR). 2-Naphthol behaved in a typical way similar to a diazotization reaction 
and gave the ortho-product, whereas 1-naphthol showed opposite regioselectivity  
compared to that obtained in classical diazomethane reactions. 2,6-dimethylphenol 
(7e) having the ortho position blocked, reacts in para position giving 15 in 76% yield. 
In the presence of deactivating substituents like in p-nitrophenol (7k) and 
3,4-dicyanophenol (7l) no reaction was observed. 
 The diazo compounds exhibit various colors depending upon the substituents 
(see UV-Vis in experimental part). The ortho structure of the coupled products can 
be easily detected by the chemical shift of the phenolic OH group, which appears in 
the downfield at G = 11–16 ppm, as a result of a hydrogen-bonding interaction with 
the neighbouring nitrogen atom. In contrast, the phenolic OH group of the para
product was found within the normal range of G = 5–6 ppm. The neighbouring 
nitrogen effect also makes possible that the salt of 8a, in a two phase system 
(EtOAc/H20 pH > 7), is more soluble in organic solvents than water when compared 
to the para-azophenol 8b (Figure 1). This effect increased with the extension of the 
conjugation (compounds 19 and 20a) and is independent of the substituents, as can 
be observed in 20d.[144]
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Table 10 Reaction of 6a with a different phenols 
Reagent Product Yield Reagent Product Yield 
OH
N
N
NHNf
HO
OH
N
N
NHNf
OH
N N
NHNf
HOOH
OH
N N
NHNf
HO
OH
N N
NHNf
HO
N
N
NHNf
HO
OH
N N
NHTf
HO
OH
OH
N N
NHNf
HO
Cl
Cl
OH
N N
NHNf
HO
OMe
OMe
OH
N N
NHNf
HO
C4H9-t
C4H9-t
63%
90%
79%
70%
94%
92%
76%
79%
86%
90%
7c
7e
7g
7j
7l
13
15
17
19
7b
7d
7f
7h
12
14
16
18
OH
O2N
OHNC
NC
No reaction No reaction
7j
7i
7k
20b20a
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 [1] [2] [1] [2] [1] [2] [1] [2] [1] [2] 
Figure 1 Solubility of ortho and para azo compounds in H2O/EtOAc [1] pH = 14 and [2] pH = 1 
2.2.4.5 Ring Opening Reaction Mechanism 
 The benzotriazole ring is extremely stable and only rarely ring cleavage takes 
place, giving raise to products of nitrogen extrusion. For example, Grignard reagents 
open and modify the triazole ring and give a variety of products.[145] Other methods 
for opening the benzotriazole ring are by thermolysis, photolysis and pyrolysis.[146,147]
However, no actual ring opening of benzotriazole that has led to isolable 
azobenzenes has been reported so far.[122]
 Although the presence of a strong electron-withdrawing substituent at N1 on 
benzotriazole has been shown to weaken the N1–N2 bond, thus leading to ring 
opening of the benzotriazole, they give products of nitrogen extrusion,[122]
rearrangement[148,149] or undergo a Dimroth rearrangement when a 4-amino 
substituent is present.[150]
 The mechanism for the azo compound formation is outlined in Scheme 15. 
The mesomeric anion formed by the reaction of NaH with phenol attacks at the N2 
position of the benzotriazole moiety. The presence of the highly electron-withdrawing 
nonafluorobutanesulfone group then results in the opening of the ring, which leads to 
8a after protonic shift and acidic work-up. The formation of the para isomer can be 
considered to occur in a similar manner. 
N
N
NHNf
OH
9b
N
N
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N
N
NHNf
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N
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N
N
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Scheme 15 Reaction mechanism through nucleophilic attack to 6a
Another possibility for the formation of 8a is a nucleophilic attack of the phenolate 
anion at the sulfur atom (Scheme 16),[151] thus resulting in ring opening of the 
triazole moiety by a rearrangement reaction. However, this will lead only to the ortho-
substituted product 8a. A mechanism involving a free diazonium intermediate 
existing in equilibrium with the benzotriazole 6a’ (Scheme 17) structure was also 
scrutinised. 
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Scheme 16 Reaction mechanism involving attack of the phenoxide anion at the sulfur atom 
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Scheme 17 Reaction mechanism involving a free diazonium intermediate 
 The existence of a free diazonium species in equilibrium with the 1,2,3-
triazole ring is known in the parent 1,2,3-triazole substituted with a sulfonyl group at 
N1. This equilibrium was confirmed by 1H NMR spectroscopic studies.[152,153,154] In 
the benzotriazole series two compounds can be conceived to be in equilibrium with 
the diazo structure. 1-Nitrobenzotriazole[155] was shown to react with amines; for 
example, piperidine gave an isolable piperidinium salt from the ring-opened 
benzotriazole. There was also a report[156] on the reversible thermochromic 
behaviour of 1-cyanobenzotriazole, which is yellow in the melt and colorless in the 
crystalline state. No chemical evidence was obtained to indicate that the colour 
might arise from ring opening to give the diazo-N-cyanoimine form, and no reactions 
of the cyano compound were reported. Experiments carried out with 
1-nitrobenzotriazole by treating it with indolizine derivatives at room temperature 
were interpreted as an electron-transfer process and the same process is attributed 
to the reaction of amines with 1-nitrobenzotriazole.[157] Temperature-dependent NMR 
investigations were carried out to find out whether an equilibrium with a diazo 
structure does exist in the 1-nonafluorobutanesulfonyl-1H-benzotriazole 6a. The 
signals in the aromatic region of the spectrum for molecule 6a did not change when 
the sample was heated in DMF-d6 up to a temperature of 100 °C. Spectra were 
recorded every 10 °C starting from ambient temperature. Above 100 °C the 
compound started to decompose to give a dark solution. No analysis of this sample 
could be carried out, as the sample completely decomposed. Coupling reactions 
were carried out at room temperature and on the basis of timedependent NMR data 
it could be concluded that no free diazonium intermediate participates in the 
reaction. Also, no vibration corresponding to the N=N group could be found in the IR 
spectrum of 6a. It is considered that, as far as the mechanism is concerned, the one 
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shown in Scheme 15 is more probable, however, the other mechanism via the diazo 
structure cannot be completely ruled out at present.  
 Computer calculations were performed for a series of 1-substituted 
benzotriazoles to study the influence of the substituent to the azo-character of this 
molecule. For R = H, CH3, NO2, SO2CH3 (6d), SO2CF3 (6b), SO2C4F9 (6a) a 
conformation search with Spartan’02[158] was performed using molecular mechanic 
calculations with MMFF (Merck Molecular Force Field). The structures were 
optimised using ab initio QChem[159] program and the values are summarised in 
Table 11 and Table 12. 
 Only the distances of these theoretical calculations that were thought to be 
important for the azo character are summarised. It represents the enlargement of the 
distance between N1 and N2 and the contraction of the N2 and N3 bond. It was 
found that 1-cyano-1H-benzotriazole has the largest azo character, followed by 1-
triflyl- and 1-nonaflyl substituents. However, this theoretical outcoming was not 
proven in the laboratory. When comparing mesyl- and triflyl- or nonaflyl-
benzotriazole, a 1.5 pm difference was observed for the N1íN2 distance. Moreover, 
this different azo-character was proven chemically. Despite the different reactivity 
observed for triflyl- and nonaflylbenzotriazole, no difference was observed in these 
theoretical calculations. 
Table 11 Calculated energies [H] for the different 1-substituted-1H-benzotriazoles 
R MP2/cc-pVDZa MP2/cc-pVTZb
H –394.744788 –395.229771 
CH3 –433.929058 –434.469032 
CN –486.728547 –487.311957 
NO2 –598.738914 –599.446388 
SO2CH3 (6d) –981.610097 –982.462435 
SO2CF3 (6b) –1278.711991 –1279.882441 
SO2C4F9 (6a) –1990.484117 --- 
a Calcd with Spartan’02; b Calcd with Qchem.
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Table 12 Selected bond distances [pm] for the different 1-substituted-1H-benzotriazoles 
MP2/cc-pVDZa MP2/cc-pVTZb
R
R-N1 N1-N2 N2-N3 R-N1 N1-N2 N2-N3 
H 101.51 135.77 131.91 100.45 134.67 130.90 
CH3 144.91 136.04 132.21 143.77 134.85 131.29 
CN 135.55 139.14 130.40 133.88 137.97 129.36 
NO2 144.52 136.28 131.20 142.48 135.15 130.10 
SO2CH3 (6d) 176.40 136.75 131.64 171.52 136.00 130.37 
SO2CF3 (6b) 172.61 138.31 130.68 168.16 137.83 129.31 
SO2C4F9 (6a) 172.62 138.35 130.68 --- --- --- 
a Calcd with Spartan’02; b Calcd with Qchem.
 The aromatic azo compounds behave differently[160,161] in many of their 
reactions compared to the aliphatic diazo compounds.[162,163] Aromatic azo 
compounds are the largest and most important group of dyes used in the dye 
industry.[160,164,165,166,167,168] They have also found use in diazo-type photocopying 
processes and diazosulfonates are beneficial as fungicides.[168] Although aromatic 
azo compounds are only represented to a marginal extent in pharmaceutical 
preparations,[169] azo groups have recently been included as substituents in some 
polycyclic compounds used as probes for chemical genetic studies.[170] Some other 
recent applications include their use for color marking of substrates in combinatorial 
chemistry[171] and in photosensitive nanocomposites.[172]
 Aromatic azo compounds are still manufactured by the single most important 
synthetic route, that is, diazotization of aromatic amines followed by coupling with 
suitable acceptors.[160,164–168] In classical diazotization reactions, that is treating 
diazonium salt with an aromatic phenol or aniline derivative, the attack is usually at 
the position para to the activating OH group. If this position is hindered, coupling will 
sometimes take place in the ortho position, albeit at a much slower rate.[166]
 The Wallach rearrangement of azoxybenzenes[173,174] affords predominantly 
p-hydroxyazobenzenes. The thermolysis of 1:1 complexes of azoxybenzenes with 
SbCl5 was reported
[173,174] to give o-azobenzenes, but only in two instances good 
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yields were obtained. The drawback of this reaction is that it requires the use of a 
harsh chemical (SbCl5) and the prior preparation of azo compounds by a normal 
azo-coupling reaction and then oxidation to azoxybenzenes. Of the two reported 
patent procedures, one describes the formation of the ortho-substituted azo-coupled 
product of 1-naphthol in a heterogeneous H2O-organic solvent mixture (for example, 
H2O-CH2Cl2) in 26% yield
[175] and the other leads to ortho products only under strong 
alkaline conditions.[176,177] In the latter case, the intermediate formation of the 
mesomeric o-benzoquinone diazide is probably responsible for the ortho
coupling.[177]
 These variations in the reaction conditions have been done only in the case of 
1-naphthol to obtain various types of substituted azo dyes useful in the dye industry. 
Bearing in mind the above mentioned literature data, there exists no expedient direct 
method for the preparation of ortho-azobenzenes by a straight coupling reaction. 
Besides diazotization of aromatic amines, there are only a few methods, for 
example, diazotization of aryl hydrazines, transfer of an azo group by tosyl azides, 
known for the preparation of azobenzenes.[160,178,179]
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2.2.5 Unsymmetrically Fused 1,2,3,-triazole-zincphthalocyanine 
 Phthalocyanines (Pcs), as well as their analogues, e.g. porphyrazines (Pzs) 
and naphthalocyanines (Ncs), attract much attention because of their electronic 
structure features, giving rise to a plethora of applications in materials 
science.[180,181,182] The properties of phthalocyanines can be widely modulated via 
changes in their chemical structure, introducing different coordinated elements into 
the cavity of the macrocycle or in the periphery when appropriate substituents are 
present, varying axial and peripheral ligands and substituents, changing the 
symmetry of the macrocycle, etc. 
 Unsymmetrical phthalocyanines, despite the comparatively complicated 
preparation methods, are gaining more consideration recently because of their high 
potential for modern applications,[183,184] e.g. in molecular electronics, mostly as self-
assembled, highly-ordered thin films.[185,186,187] For these reasons, macrocyclic 
synthons useful for various unsymmetrical functionalizations of phthalocyanines are 
of special interest.  
 Based on sulfonated benzotriazole ring opening previously described (chapter 
2.2.4), it was envisaged an application of this methodology in order to modify the 
previously reported unsymmetrical zincphthalocyanine with a fused 1,2,3-triazole.[188]
Only one report on the synthesis of a modified phthalocyanine containing azo groups 
has been reported so far, namely the template tetramerization of 4-[4-
(diethylamino)phenylazo]phthalonitrile.[189] 
2.2.5.1 Synthesis of Naphthyl-azoconjugated Phthalocyanines 
 The zincphthalocyanine fused 1,2,3-triazole (5b)[188] was derivatised with a 
triflyl rest, since the synthetic conditions to introduce the nonaflyl rest (utilisation of 
BuLi under reflux) are not appropiate in phthalocyanine synthesis. The advantage of 
triflyl is the easy addition under mild conditions. On the other hand, only the most 
active 2-naphtol (7i), as provided in chapter 2.2.4.3 could be satisfactory used for the 
ring opening.  
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 Addition of Tf2O (2b) either to a mixture of 5b and pyridin in CH2Cl2 or to 5b
and Na2CO3 in CH2Cl2 at 0 °C were efficient methods for the synthesis of the desired 
Pc 6e in 88 and 93% yield respectively (Scheme 18). For the ring opening a small 
variation from the method described earlier was applied, since Pcs can not tolerate 
the use of strong bases for a long time. For this particular case, a big excess of 2-
naphthol was previously stirred with NaH to form the naphtholate salt and then the 
phthalocyanine was added. With a very short reaction time, only 15 minutes, 20c
was obtained in a 86% yield after chromatographic separation.  
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Scheme 18 Synthesis of compounds 6e and 20c
 Both compounds could be characterised unambiguously (see experimental 
part). The only weak point was the elemental analysis that showed 0% of sulfur, 
which can be associated to the possible formation of a sulfurzinc salt. Due to the fact 
that compound 20c was a mixture of Pcs with different grades of protonation (from 
neutral, zwitter ion, once and twice protonated and deprotonated), the addition of 
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Et3N to the deuterated solvent for 
1H- and 13C-NMR measurements gave better 
resolved spectra. More details about the interesting spectroscopic properties that 
compound 20c exhibits, indicating high acidity of the hydroxy group, especial 
behaviour in different solvents and photodecomposition mechanism of 20c in
chloroform and tetrahydrofuran are explained in the literature [190]. 
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2.2.6 Phosphorus Ylides 
 Phosphorus ylides have found use in a wide variety of interesting reactions in 
synthetic chemistry, especially in the preparation of naturally occurring products and 
compounds with biological and pharmacological activity.[191] These compounds have 
attained great significance as widely used reagents for linking synthetic building 
blocks with the formation of carbon–carbon double bonds.[192] Moreover, outstanding 
achievement in the development of phosphorus ylides chemistry demonstrate that 
they not only react with carbonyl compounds but also can be used in many 
nucleophilic reactions being comparable to Grignard reagents in regard to the variety 
of their possible reactions.[193] 
 Arylazomethylenetriphenylphosphoranes are stabilised phosphorus ylides that 
can be synthesised from alkyltriphenylphosphoranylidenes and arenediazonium 
salts[194] or from hydrazonoyl halides by reaction with triphenylphosphine and Et3N
via nitrile imine.[195] These kind of compounds are used for heterocyclic synthesis, 
namely indazolines,[196] oxycinnoline,[196] benzodiazepine,[197,198] pyrazoles[197] and 
tetrazolium salts.[199]
 In order to exploit the arenediazonium salt character of the 
nonafluorobutanesulfonyl-1H-benzotriazole (6a) and using the same approach 
described above, the ring opening previously described in chapter 2.2.4.3 was 
appied using phosphorus ylide derivatives.  
2.2.6.1 Synthesis with Benzyltriphenylphosphonium Salts 
The synthesis was achieved by reacting 6a with different substituted 
benzyltriphenylphosphoranylidene (Scheme 19).  
PPh3
X N
N
N
Nf
N
N
NHNf
PPh3
NaH
THF
6a
22
21' a
R R
X = Cl or Br
Scheme 19 Synthetic strategy for the synthesis of arylazomethylenephenylphosphoranes;  
a Synthesised from 21 (see experimental part) 
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 The synthesis and purification of the benzylphosphonium salts was carried out 
starting from the corresponding benzyl compounds 21 with the methods known  from 
literature.[200,201] The compounds were dissolved in dry THF and NaH was added to 
form the benzylphosphorus ylidene. Addition of 6a to the solution lead immediately 
to the arylazomethylenephosphoranylidenes, the results of which are summarised in 
Table 13. Purification was carried out by chromatography on silica gel with EtOAc as 
eluent. All compounds were yellow or orange coloured . 
Table 13 Structure, numbering and yield form the synthesised arylazomethylenephenylphosphoranes 
Phosphorus ylides Phosphoranylidenes Yield 
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 Due to the fact that arylazomethylenephosphoranylidenes 22 can be 
protonated with HCl and isolated as colorless salts in their hydrazone form,[194]
compounds 22’a and 22’d were dissolved in EtOAc and HCl gas was introduced 
(Scheme 20). Surprisingly, the hydrazone salts did not precipitate and only after 
evaporation of the solvent the white products precipitated as white solids. Moreover, 
NMR experiments could be carried out in deuterated chloroform without remarkable 
differences in comparing with other 22 products. 
N
N
NHNf
PPh3
N
N
NHNf
PPh3H Cl
HCl (gas)
EtOAc
22'a 22a
Scheme 20 Protonation of the arylazomethylenephosphoranylidenes 22’a
2.2.6.2 Synthesis with Alkyl Triphenylphosphonium Salts 
 (Carbethoxymethyl)triphenylphosphonium bromide (23a) is described in the 
literature as a compound that can react with arenediazonium salts [194] and 
afterwards with acetylene derivatives to form pyrazoles.[197] For the synthetic interest 
that these compounds possess, the arylazomethylenephosphoranylidene derivative 
24a was synthesised. For the phosphorane formation, NaH was used and after 
30 minutes the reaction was finished, obtaining the phosporanylidene derivative 24a
with a 83% yield (Scheme 21). 
PPh3
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NHNf
PPh3
NaH
THF, 83%
6a
24a
23a
O
OEt
OEt
O
+
Scheme 21 Synthesis of compound 24a
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 Methyltriphenylphosphonium bromide (23b) needs BuLi as a base for the 
deprotonation and formation of methylenetriphenylphosphorane. The reactions of 
phosphorus ylidenes with arenediazonium salts described above are, according to 
the literature,[194-199] carried out in an alcohol solution or aqueous alcohol. These 
conditions do not allow the utilisation of strong bases, like BuLi. Due to the stabilised 
azo character of 6a, the easy handling and the solubility in all organic solvents, some 
reactions can be carried out with the use of strong bases. Under these reaction 
conditions, 23b can generate methylenetriphenylphosphorane as described in the 
literature,[202] starting from 23b with BuLi in dry THF. 24b was isolated and 
unambiguously characterised as a two times azosubstituted arylazomethyltriphenyl-
phosphoranylidene (Scheme 22). 
PPh3
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N
N
N
Nf
BuLi
THF, 44 %
6a
24b
23b
2
N N
PPh3
NN
NHNf
NHNf
+
Scheme 22 Synthesis of compound 24b
The same procedure was applied for ethyltriphenylphosphonium bromide (23c) and 
isopropyltriphenylphosphonium iodide[203] (23d), in order to obtain monosubstitution, 
but several by-products were observed by TLC and the workup of the reaction 
mixture was not carried out. No explanation was found for the differently observed 
reactivity with these three similar derivatives. 
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2.2.7 Synthesis of Glucosyl 1H- and 2H-benzotriazoles 
 Glucosyl-1H-, 2H-benzotriazoles and their derivatives have been described as 
unusual nucleosides for the treatment of the cancer.[204,205,206,207,208] They were 
previously synthesised by condensation of 1-TMS-benzotriazole with 
peracetylatedglucopyranoside in vacuum,[209] reaction of glycosyl bromide with 
mercury salts[210] or silver salts[206,211] of benzotriazole, activation of glycosyl halides 
with Hg(CN)2 and benzotriazole,
[206,212] glucosyl azide with benzines[208] and the 
trichloroacetimidate method.[213] In all cases E-selectivity was obtained and the 
products were 1H- and 2H-benzotriazoles. The regioselectivity of 1H- or 
2H-benzotriazole depended on the method, being 1H-benzotriazole when 
1H-benzotriazole salts or TMS-benzotriazole were used as well as glycosyl azides 
and benzines. On the other hand, the trichloroacetimidate method or activation of the 
glycosyl halide with Hg(CN)2 and 1H-benzotriazole lead predominately to 
2H-benzotriazole. 
 The synthesis of these kinds of compounds can be achieved with sulfonyl 
benzotriazoles. This is a literature known activation method for alcohols applied for 
tosylbenzotriazole, in absence of other nucleophiles.[133] Using this method, the 
alcoholate reacted with the sulfonyl-benzotriazole and lead to the sulfonate ester 
which was substituted for the 1H-benzotriazole giving the desired compound. Due to 
the different results obtained by the reaction of nonaflyl- (6a), triflyl- (6b) and tosyl-
1H-benzotriazoles (6c) with phenols, it was anticipated that the optimisation 
reactions had to be carried out with 6c and then applied for 6a and 6b.
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Scheme 23 Synthesis of glycosyl 1H-and 2H-benzotriazoles with different sulfonylbenzotriazoles 
 The results of this optimisation process with 6c are summarised in Table 14. 
As can be seen, no reaction was observed when weak bases were used (entries 1–
4). The reaction can only be carried out with strong bases like NaH (entries 5–9). 
Comparing entries 4 and 5, best selectivity was obtained when the carbohydrate was 
added to the solution (entry 5) containing sulfonylbenzotriazole and NaH. The 
resulting products with E-configuration were a 1:1 mixture of 1H- or 2H-
benzotriazoles. This selectivity might be due to the fact that 1 has mainly 
D-configuration. As a consequence the formed intermediate tosylglucopyranoside 
has D-configuration. The hypothetic substitution of the sulfonate under SN2
conditions would lead to a E-anomer exclusively. Using 6b as a reagent good yields 
were obtained but no D/E-selectivity was observed (entry 7). The most likely 
intermediate is a glycosyl cation. This could be due to the fact that glycosyltriflate is 
only stable at low temperatures. No selectivity was observed for 1H- or 2H-
benzotriazole. Nonaflylbenzotriazole (6a) did not react at room temperature (entry 8). 
After heating the mixture to reflux the solution became dark because of 
decomposition of 6a. E-Selectivity was exclusively observed when 6a was used, 
which led to the assumption that higher temperatures, when compared to 6b,
allowed for the formation of the E-configuration through a glycosyl cation 
intermediate. 
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Table 14 Optimisation reaction of 1 and 6c and results for 6a and 6b
T [qC] R Base Solvent t [h] Results 
1 RT Tos (6c) Et3N THF 12 no reaction 
2 70 Tos (6c) Et3N THF 12 no reaction 
3 RT Tos (6c) K2CO3 CH2Cl2 12 no reaction 
4 45 Tos (6c) K2CO3 CH2Cl2 12 no reaction 
5 RT Tos (6c) NaH THF 6 55% (25D, 26D, 26E; 5:1:10) 
6a RT Tos (6c) NaH THF 6 74% (25D, 25E, 26E; 1:10:10) 
7a RT Triflyl (6b) NaH THF 6 66% (25D 26D, 26E; 3:1:3) 
8 RT Nonaflyl (6a) NaH THF 12 no reaction 
9b 70 Nonaflyl (6a) NaH THF 0.5 21% (25E, 26E; 3:2) 
a 1 was added drop wise; b After 30 minutes at 70°C 6a was completely decomposed. 
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2.2.8 Nonafluorobutanesulfonic acid benzotriazol-1-yl ester 
 1-Hydroxybenzotriazole (HOBt, 27) active esters are most frequently used for 
peptide bond formation.[214] The procedure is fast and can be applied for liquid-phase 
as well as solid-phase synthesis. HOBt can be used in combination of DCC or DIC, 
making the formation of almost all peptide bonds possible.[215] Modifications in the 
phenyl ring of benzotriazoles result in more effective and reactive reagents for bond 
formation.[216,217] Moreover, modifications in the hydroxy function of the hydroxy-
benzotriazole results in phosphonium[218,219] and uronium salts,[220,221] which are very 
effective for the formation of active esters under mild conditions. 
 HOBt sulfonic acid esters and derivatives have also been investigated for 
peptide bond formation.[222,223,224,225] Some of them are comparable to phosphonium 
or uronium salts, with the advantage that sulfonic esters from HOBt are soluble in 
nonpolar solvents, thus increasing the range of conditions in which the activation can 
be carried out. Activation of acids to form other acid derivatives is also possible, 
namely esters[226] and thio esters[227]. The sulfonyl group transfer from HOBt to 
phosphodiester or to amines for the formation of triesters[228,229] or 
sulfonamides,[230,231] respectively, has already been investigated. No investigations 
were carried out for the alcohol activation through sulfones transferred from HOBt. 
For this reason the formation of the nonafluorobutanesulfonyl-HOBt has been 
envisaged as a new method for the activation of alcohols. 
2.2.8.1 Synthesis of nonafluorobutanesulfonic acid benzotriazol-1-yl ester 
(28a) 
 The synthesis of 28a was attempted starting from HOBt (27) and NfF (2a) with 
several bases, as summarised in Table 15. Only the use of strong bases lead to a 
major product, although in low yield. The isolated major product was 28b (Scheme 
24) and not the expected 28a. This could be unambiguously characterised by 
spectral and analytical data. 
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Scheme 24 Formation of 28b after possible rearrangement of 28a
Table 15 Optimisation reactions carried out for the synthesis of 28b
Solvent Base t [h] T [°C] Yield [%] 
CH2Cl2 Et3N 72 RT --- 
CH2Cl2 lutidine 72 RT --- 
CH2Cl2 collidine 72 RT --- 
THF NaH 24 reflux 17 
THF NaH 12 RT 26 
THF NaH 12 reflux 32 
2.2.8.2 Reactions of HOBt Derivatives (31) with Tf2O (2b) 
 The triflate homologue 29a synthesis was carried out in CH2Cl2, using pyridine 
or Na2CO3 at room temperature obtaining a yield increase to 41 and 49%, 
respectively. Both compounds contain a 5% of 29b that could be eliminated after 
crystallisation. The structure of 29a could be proven by X-ray analysis (see crystal 
data).
 In order to explore the new synthetic pathway of HOBt, 1-hydroxy-
benzotriazole derivatives (31) were synthesised. The 1-hydroxybenzotriazole 
derivatives were synthesised in a similar way as described in the 
literature,[232,233,222,234] starting from the respective o-chloronitrobenzene (30). The 
formed products were protonated with HCl, filtered and recrystallised from a mixture 
of H2O, EtOH and toluene.  
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 New experiments were carried out with Tf2O (2b) at –78 °C, applying the 
method for the formation of the 1H-benzotriazole homologue (6b),[130] since reactions 
carried out with new compounds at room temperature were not successful and other 
by-products were visible by TLC. The active ester was formed at –78 °C. This was 
observed by TLC, but isolation of the active ester failed. When the reaction mixture 
was warmed up to room temperature, the active ester rearranged giving a mixture of 
two products (29a and 29b) that were not possible to be separated (Scheme 25).  
N
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N
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N
Na2CO3, Tf2O (2b)
CH2Cl2
27 29b
H
N
N
N
OTf 29a
TfO
Scheme 25 Synthesis of 29a and 29b (93%, 66:33) after reaction of 27 with 2b
 The same procedure as used for the synthesis of 29a and 29b was applied to 
the new benzotriazoles, the results of which are summarised in Table 16. At –78 °C 
all reactions gave the active esters, which decomposed after warm up to RT. The 
time needed for the completion of the reaction can be used to estimate the stability 
of the active ester. The HOBt derivative 31e and HOAt (31g) were the most stable of 
all HOBt derivatives. Their active esters were visible by TLC for at least 1 day and in 
case of 31g no product could be isolated. All compounds isolated through column 
chromatography or HPLC were completely and unambiguously characterised. In the 
13C-NMR spectra only tertiary carbons, as broad signals, could be observed and in 
some cases the doublet or quadruplet from the CF3. This phenomena is caused by 
proton delocalisation of the triazole. 
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Table 16 Reactions of Tf2O (2b) with different substituted 1-hydroxy-benzotriazoles (31)
HOBt derivatives Product Yield, Ratio 
N
N
N
OH
31a
H
N
N
N
32a
H
N
N
N
32bOTf
OTf
N
N
N
OH
31b
H
N
N
N
32c
TfO
N
N
N
OH
31c
H
N
N
N
33a
H
N
N
N
33b
ClCl
OTf
Cl
TfO
N
N
N
OH
31d
H
N
N
N
34a
H
N
N
N
34b
Cl
TfO
Cl
OTf
Cl
N
N
N
OH
31e
H
N
N
N
35a
H
N
N
N
35b
H
N
N
N
35c
OTf
F3C F3C
TfO
F3C
OTf
F3C
N
N
N
OH
31f
H
N
N
N
36
OTf
Cl
Cl
Cl
Cl
H
N
N
N
32b
OTf
90%, 55:45a
88%, 70:30a
88%, 60:40
75%, 40:60
89%, 20:40:40b
73%
N
N
N
N
OH
31g
0%
a Isolated as a mixture, the percentage was calcd in NMR; b Compounds separated in the HPLC, 
percentage calcd in HPLC. 
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2.2.8.3 Reaction Mechanisms 
 The first mechanism proposed for the reaction of HOBt (27) with 2a involved 
the formation of a sulfonyl active ester as intermediate that could not be isolated. 
The rearrangement of this intermediate gave 28b (Scheme 26). 
N
N
N
OH
N
N
N
O
S
O
OC4F9
N
N
N
H ONf
N
N
N
ONf
NaH, NfF (2a)
27
H
28b
Scheme 26 Proposed rearrangement for the formation of 28b
 A second mechanism with a cation intermediate was proposed, since more 
products were isolated by using Tf2O. The cation is generated by splitting up the 
triflate from the sulfonyl active ester (Scheme 27). Therefore, all positions in the 
benzene ring are activated for a subsequent triflate nucleophilic attack (Scheme 27). 
Rearomatisation and protonation of the triazole would lead to the desired product. 
When position 6 from HOBts was blocked with methyl (31b) or chlorine (31d) the 
sulfonated substitution took place at positions 5 and 7. Moreover, in case of 
6-trifluoromethyl-HOBt (31e) also position 4 was substituted, due to the meta
activation of trifluoromethyl. When 5-methyl-HOBt (31a) reacted, substitution in 
positions 4 and 7 took place. The products isolated from 31a and 31e indicate a 
strong activation of the triazole ring. 4-Chloro-HOBt (31c) reacted in position 5 and 7 
while 4,6-dichloro-HOBt (31f) reacted exclusively at position 4, which has a lower 
steric effect. On the other hand no substitution was observed with HOAt (31g).
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N
N
N
OH
Tf2O, Na2CO3 N
N
N
OTf
N
N
N
27
SO2CF3O
N
N
N
N
N
N
+     NaTfO
N
N
N
H OSO2CF3
N
N
N
OTf
H
29a
N
N
N
N
N
N
N
N
N
Scheme 27 Proposed ionic mechanism, only illustrated the formation of one isomer 29a 
2.2.8.4 Derivatisation of 28b 
 Compound 28b was derivatised in the triazole ring using 2a to prove which 
triazole regioisomer or regioisomers could be obtained. The nonaflated benzotriazole 
37 was synthesised following the method used in chapter 2.2.4.1 (see experimental 
part). Only one of the two possible sulfonated products was obtained. To know which 
of the isomers was the synthesised the benzotriazole ring opening was carried out. It 
led to 38 in a 60% yield. This compound was unambiguously characterised as a 
sulfone ester with an azo function in ortho and a sulfonamide function in meta (see 
crystal data). This result permitted to assign the correct structure to 37.
C4F9SO2F, BuLi
Glyme
N
N
N H
ONf
N
N
N
ONf
Nf
Phenol, NaH
Toluene
ONf
NHNf
N
N
HO28b 37
38
31% 60%
Scheme 28 Synthesis of compounds 37 and 38
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2.3 Aromatic Nitro Substitution 
2.3.1 Introduction in Photodynamic Therapy 
 Photodynamic therapy (PDT) is a rapidly growing methodology to treat the 
age related macular degeneration, various skin disorders, and an increasing number 
of cancers that are accessible to irradiation with visible light.[235] In general terms, the 
PDT concept is that the therapeutic compound has low toxicity until it is activated by 
light, whereupon it becomes very reactive and toxic or it activates other indigenous 
molecules to become reactive and toxic.[236]
 Porphyrin type compounds (e.g. porphyrins and/or phthalocyanines) 
photosensitise the formation of the highly reactive singlet oxygen via transfer of 
energy from the triplet excited state of the porphyrinoid to the triplet ground state of 
oxygen. Singlet oxygen is a potent oxidant that reacts with numerous biomolecules 
such as double bonds in lipids, bases of nucleic acids, aromatic amino acids, both 
phosphate backbone and subcellular organelles.[237]
 Phthalocyanines (Pcs) are known for more than seven decades. These 
compounds have been extensively studied as advanced materials for various 
applications,[238,239] including photobiological and medical.[240] They own a higher 
efficiency to generate reactive oxygen species than porphyrins,[241] also possessing 
low dark toxicity.[242] Pcs are expected to exhibit strong photochemical and 
photodynamic activities appearing as a very promising kind of second generation 
photosensitisers for photodynamic therapy (PDT).[243] 
 Because the balance between hydrophobicity and hydrophilicity is 
acknowledged as a significant aspect for the design of new photosensitisers for 
PDT,[244] diverse research groups synthesised a variety of new porphyrinoid-
carbohydrate conjugates,[245,246,247,248,249] assuming that the presence of the 
carbohydrate moiety could improve the membrane interaction, therefore increasing 
their tumour selectivity. Nonetheless, the related carbohydrate conjugates were not 
studied for their affinity to target a particular protein. Moreover, various types of 
glucose transporters are specific for different monosaccharides in cancer cells.[250,251]
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Therefore it is reasonable to expect a cellular uptake enhancement of the complexes 
through glycoconjugation, which may increase the photodynamic activity.  
 Taking into account the significance of the premises referred above and the 
fact that, phthalocyanine-carbohydrate conjugates are quite uncommon, only the 
synthesis and characterisation of a phthalocyaninato zinc(II) complex peripherally 
substituted with four glucose moieties[252] and a phthalocyaninato silicone (IV) 
complex axially substituted with two galactose moieties have been reported so 
far.[253]
 The aim of this particular work was the synthesis of dicyanophenyl 
carbohydrates linked via the anomeric carbon, which are precursors for the 
synthesis of phthalocyanines, as well as the synthesis of unprotected 
phthalocyanines. 
2.3.2 Aromatic Nitro Substitution 
 For the synthesis of 3,4-dicyanophenyl-O-glucoside known methods for the 
preparation of the phenyl glycosides were applied, using 3,4-dicyanophenol (7l).
These methods were: BF3·OEt2
[254] or PTSA[255] activation of penta-O-acetyl-glucose; 
TMSOTf[256] activation of 2,3,4,6-tetra-O-benzoyl-glucose trichloroacetimidate and 
reaction with 2,3,4,6-tetra-O-benzoyl-glucose (30b) under Mitsunobu[257] conditions. 
None of the above mentioned methods gave the desired arylated glycoside though. 
 The strategy that seemed to be more attractive was the substitution of the 
nitro group from the 4-nitrophthalonitrile (40). This method has already been widely 
used for the synthesis of oxoarylphthalonitriles.[258] The nucleophilic displacement of 
the nitro group from an activated aromatic substrate has been well investigated.[259]
In general, nucleophilic displacement of a nitro group from an activated aromatic 
substrate can be effectively carried out with a variety of strong nucleophiles under 
dipolar aprotic solvent conditions. For example, alcoholates,[260,261,262] thiolates[260,263]
and sulfinates[260] effectuate a synthetically practical displacement of a nitro group 
from carbonyl,[260,261,262,263,264] nitro,[260,264] cyano,[260,261,262,263,264] sulfone,[260] and 
aryl[263] activated substrates in DMF, DMSO, or HMPA at room temperature. 
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Furthermore, nitro groups are comparable to fluoro groups as leaving group in SNAr 
reactions.[259] 
2.3.2.1 Nitro Substitution with 4-nitrophthalonitrile (40) 
 The displacement of the nitro group from 4-nitrophthalonitrile (40) for the 
synthesis of oxoarylphthalonitrile derivatives is normally carried out with a high 
excess of K2CO3 in DMF.
[258] For the synthesis of 3,4-dicyanophenyl carbohydrates it 
was expected that this reaction could take place under mild conditions due to the 
high nucleophilicity of the 1-OH of the sugar unit. The reaction between 40 and 
2,3,4,6-tetra-O-benzyl-(D/E)-D-glucopyranose (1) was investigated. The stability of 
the benzyl groups was exploited and the reaction was carried out using NaH as base 
and DMF as a solvent. The reaction was completed in 1 h and the product obtained 
was 3,4-dicyanophenyl-2,3,4,6-tetra-O-benzyl-(D/E)-D-glucopyranose (41) in 
quantitative yield (Table 17). Initially, the obtained D/E ratio of 90:10 was surprising, 
but this could be explained by an anomerisation process that took place during the 
reaction using DMF[97] or DMSO[96] as a solvent. The mechanism given for the 
anomerisation involves the retro aromatic nucleophilic substitution at the phenyl 
moiety of 41 caused by the attack of a solvent molecule. The glucose moiety could 
anomerise and substitute again the solvent molecule, giving mainly the 
thermodynamically favoured D-anomer of 41.[96] The nitro substitution was then 
carried out using THF as solvent, where theoretically the anomerisation can not take 
place. At room temperature no reaction was observed but after heating for 12 hours 
41 was obtained also in quantitative yield and with D/E ratio 1:2. 
 The reaction conditions using DMF as a solvent, were repeated first using 
2,3,4,6-tetra-O-benzoyl-(D/E)-D-glucopyranose (39b)[265] and then 2,3,4,6-tetra-O-
acetyl-(D/E)-D-glucopyranose (39c)[266] and K2CO3 as base (Table 17). In both cases 
quantitative yields were obtained as well as high D-selectivity. The reaction in THF 
could not be repeated in these two particular cases due to the instability of the 
protecting groups under such conditions. 
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Table 17 Nitro substitution using 40, DMF as solvent and K2CO3 as base.  
Carbohydrate 
reagent 
3,4-dicyanophenyl 
product 
Yield (%) 
Ratio (D:E)
OBnO
BnO
BnO
BnO
OH
OBnO
BnO
BnO
BnO
O
CN
CN
OBzO
BzO
BzO
BzO
OH
OBzO
BzO
BzO
BzO
O
CN
CN
OAcO
AcO
AcO
AcO
OH
OAcO
AcO
AcO
AcO
O
CN
CN
OAcO
AcO
PhthN
AcO
OH
OAcO
AcO
PhthN
AcO
O
CN
CN
OAcO
AcO
AcO
AcO
OAcO
AcO
AcO
AcO
S
CN
CNSH
O
BzO
BzO
BzO
OBz
O
BzO
BzO
BzO
OBz
S
CN
CNO
O
BzO
BzO
BzO
SH O
O
BzO
BzO
BzO
99%, 90:10a
99%, 33:66b
99%, 91:9
99%, 91:9
50%, 0:100
99%, 0:100
99%, 0:100
1 41D/41E
39c 43D/43E
39e 45E
39b 42D/42E
39d 44E
39f 46E
1'
1''
1'
1''
1'''
1
1''
1
1
1
1
1''
1''
1''
1''
a NaH as base. b NaH as base and THF as solvent 
 A special example was 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-(D/E)-D-
glucopyranose[267,265b] (39d). Under the same conditions as for 39b or 39c, the 
reaction led only to the E-product (44E), probably due to the fact that, although 39d is 
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an O-nucleophile, it is sterically hindered by the presence of the phthalimido 
protecting group at position 2 which strongly promotes the formation of the found 
E-anomeric linkage. 
 Also the formation of thiophenyl-glycosides was thought to be interesting 
because no such thermodynamic equilibrium can take place in case of 1-thio sugars. 
1-thioglucose[266a,268] 39e and 1-thiolactose 39f were tested obtaining as predicted 
quantitative yields with E-selectivity (Table 17). 
 Anomeric mixtures were separated by preparative HPLC for determining the 
anomeric ratio and all anomers were unambiguously assigned by NMR 
spectroscopy. The geminal coupling constants between H-1 and H-2 were calculated 
for the determination of D- or E-anomers (see experimental part). 
2.3.2.2 Nitro Substitution with Monoactivated Nitrobenzenes 
 Additionally, monoactivated nitrobenzenes were tested for this efficient 
glycosylation method as well, namely o-dinitrobenzene (48) and p-nitrobenzonitrile 
(49). Due to the nucleophilicity of the carbohydrate moieties it was expected that the 
nitro substitution would also work well in the case of substituted phenyl compounds 
having only one additional electron withdrawing group. However, SNAr reactions in 
DMF using K2CO3 or DBU as base failed completely. At room temperature, no 
reaction took place whereas at elevated temperatures decomposition of the starting 
materials occurred. Solely NaH as base gave the desired substitution products at 
room temperature (Scheme 29 and Table 18). 
ORO
RO
RO
RO
OH
ORO
RO
RO
RO
O
NO2
NO2
NO2
48
+
DMF
Base
R = Benzyl (1), Benzoyl (39b) and Acetyl (39c)
Scheme 29 Optimisation reaction using 48 and different carbohydrates 
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Table 18 Optimisation for the nitro substitution of 48 using  DMF as solvent 
 T [qC] R Base Time Results 
1 RT 39c 4 eq K2CO3 over night no reaction 
2 100 39c 4 eq K2CO3 over night no reaction 
3 150 39b 1.2 eq K2CO3 over night dec. of 1 (TLC) 
4 RT 39b 1.2 eq DBU over night no reaction 
5 100 39b 1.2 eq DBU over night dec. of 1 (TLC) 
6 RT 1 1.2 eq NaH 15 min. 50, 92% [D:E, 3:1; (HPLC)] 
 A significantly lower anomeric selectivity for arylations in case of glucose 1
and galactose 47b[269] with less activated nitro substituted benzenes (48 and 49) was 
observed (Table 19). This can be explained in terms of a slower or less possible 
retro nucleophilic substitution of the carbohydrate moiety caused by attack of a 
solvent molecule, when compared with phthalonitrile aglycon. In the case of 
mannose nucleophile 47c,[270] only D-anomers 52D and 55D were found, due to the 
strong anomeric effect. 
 Anomeric mixtures were separated by preparative HPLC in the case of 
2-nitrophenyl derivatives for determining the anomeric ratio and all anomers were 
unambiguously assigned by NMR spectroscopy (see experimental part). The D/E
mixture from 4-cyanophenyl derivatives could not be separated. For this reason the 
D/E ratio was determinated by NMR and only representative 13C-NMR signals are 
given. 
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Table 19 Nitro substitution using 48 and 49
Carbohydrate 
reagent 
nitrophenyl- 
derivative 
phenyl- 
glycoside 
yield (%) 
ratio (D/E)
OBnO
BnO
BnO
BnO
OH
OBnO
BnO
BnO
BnO
O
O
BnO
BnO OH
O
BnO
BnO O
OBnO
BnO
BnO
OH
OBnO
BnO
BnO
O
94%, 75:25
92%, 75:25
89%, 100:0
1 50D/50E
47c 52D
47b 51D/51E
OBn
OBn OBn
OBnOBn OBn
NO2
NO2
NO2
NO2
NO2
NO2
NO2
NO2
NO2
OBnO
BnO
BnO
BnO
OH
OBnO
BnO
BnO
BnO
O
O
BnO
BnO OH
O
BnO
BnO O
OBnO
BnO
BnO
OH
OBnO
BnO
BnO
O
82%, 75:25
84%, 75:25
84%, 100:0
1 53D/53E
47c 55D
47b D/54E
OBn
OBn OBn
OBnOBn OBn
CN
CN
CN
CN
CN
CN
O2N
O2N
O2N
48
48
48
49
49
49
1
1''
1 1''
1
1''
1 1''
1 1''
1
1''
DMF was used as solvent and NaH as base 
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2.3.3 Synthesis of Phthalocyanines 
 The synthesis of tetraglucose substituted zinc phthalocyanine (56c) was 
initially carried out using the classic phthalocyanine template reaction with protected 
dinitriles 41 and 42 (The Pc are synthesised starting from the D/E mixture), to obtain 
Pcs 56a and 56b respectively (Scheme 30) and subsequently deprotecting these 
compounds to obtain 56c.
 Tetra-O-benzyl-glucose PcZn 56a was prepared in 58% yield, starting from 
41. Deprotection of the benzyl group however, turned out to be difficult, even by 
catalytic hydrogenation with Pd/C. Benzoyl as protecting group in 42 to form 56b
revealed to be less stable under the template conditions. The formation of the 
template was only possible at 160 °C, resulting in a lower yield and deprotection of 
some benzoyls, as observed by MALDI-TOF. Further deprotection of the 
carbohydrate moieties from 56b was then tried under Zemplén conditions in order to 
obtain 56c. This could only partially be accomplished since, as we confirmed by 
MALDI-TOF at least two or more benzoyl groups could not be removed completely, 
since the partially deprotected Pc precipitates in MeOH. 
N N
N
NN
N
N
N
Zn
ORO
RO
RO
RO O
CN
CN
ORO
RO
RO
RO O
O
O
OR
RO OR
RO
O
O
OR
ORRO
OR
O 56a R = Benzyl
56b R = Benzoyl
41 R = Benzyl
42 R = Benzoyl
1 32 1'
O
RO
OR
OR
OR
Scheme 30 Protected glucose PcsZn 56a and 56b; Reagents and conditions: a) n-pentanol, 
Zn(Ac)2·2H2O,150 °C, 5 hours; b) DMAE, Zn(Ac)2·2H2O, 160 °C, 5 hours 
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 Another strategy was used for the synthesis of 56c in order to obtain a better 
yield. Since Pcs are usually prepared in high boiling alcohols, such as pentanol, it 
was thought that the phthalocyanine template reaction could also be carried out 
starting from unprotected 3,4-dicyanophenyl carbohydrates. The deprotection of 39
was carried out under Zemplén conditions and the deprotected sugar were used 
directly without purification (see experimental part). By reacting unprotected 
3,4-dicyanophenylglucopyranoside in butanol it led to the desired compound but in a 
low yield, since the dicyanophenyl derivative was not very soluble in butanol at 
100 °C and the formed Pc precipitated immediately after formation, together with 
some unreacted starting material. A better solubility of the unprotected 
dicyanophenyl glycoside was observed when reacting it in DMAE at 100 °C, but the 
yield (12%) was not satisfactory as well. The optimum conditions were found to be 
using a mixture of butanol and DMAE (1:2). Under these conditions the 
dicyanophenylglycoside was soluble at 100 °C but the formed Pc could precipitate 
from the reaction mixture. In this conditions the yield increased to 51% (Table 20). 
 Also the Pcs from thioglucose and thiolactose derivatives were formed (Table 
20). Both were synthesised using DMAE as solvent giving 15% and 10% yield 
respectively. 
 Pure Pcs 56c, 56d and 56e were only possible to obtain after reverse phase 
HPLC. The classical physical purification methods proved to be insufficient. 
Spectroscopic data of Pc compounds 56 are in full agreement with common 
substituted phthalocyanines. Since 56 is a mixture of isomers,[271] their 1H-NMR and 
13C-NMR (recorded in DMSO-d6) showed typical chemical shifts for these kinds of 
compounds, with the difference that the phthalocyanine protons appear at higher 
ppm values (see experimental part), when compared with other oxo substituted 
Pcs.[271] This is due to the deshielding effect of the carbohydrate moieties. When 
comparing with compounds 6e and 20c the aggregation is higher, probably due to 
the nature of the used substituents in both cases. While in the cases of 56c, 56d,
and 56e the substituents are unprotected carbohydrates which tend to aggregate 
more, in the case of 6e and 17c (chapter 2.2.5.1) the substituent is di-tert-
butylphenoxy, which is a much less aggregation-like substituent. The UV/Vis spectra 
of 56 are also characteristic for zinc substituted phthalocyanines, with a Q-band 
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maximum approximately at 680 nm. MALDI-TOF measurements confirmed 
unambiguously the molecular mass of compounds 56.
Table 20 Synthesis of phthalocyanine-carbohydrate conjugates 
3,4-dicyanophenyl- 
carbohydrate 
Pc yield (%) 
OAcO
AcO
AcO
AcO
O
OAcO
AcO
AcO
AcO
S
O
BzO
BzO
BzO
OBz
O O
BzO
BzO
BzO
S
43D/43E
45E
46E
12%
51%a
56c
56d
56e
CN
CN
CN
CN
CN
CN
15%
10%
Reagents and conditions: 1. NaOMe, MeOH; 2. DMAE, Zn(Ac)2·2H2O, 100 °C, 12 hours 
a DMAE/n-butanol (2:1), Zn(Ac)2, 100 °C, 24 hours 
N N
N
NN
N
N
N
Zn R
R
R
OHO
HO
HO
HO
O
OHO
HO
HO
HO
S
O
HO
HO
HO
OH
O O
HO
HO
HO
S
56c
56d
56e
R =
R =
R =
R 12
3
1'
1'
1'1''
6 7 8
4
5
Figure 2 Structure of the Pcs synthesised without protecting groups 
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3 Summary 
 The thesis has been divided in two main sections. The first section deals with 
the generation of glucosyl nonafluorobutanesulfonate donors (cf. Scheme 13 and 14, 
p. 20). In the second section the direct 1-OH arylation via aromatic nitro 
displacement was described (cf. Scheme 29, p. 54). 
 In the first section three methods were investigated for the attainment of 
glycosyl nonaflate donors. First, the generation of donors were carried out using the 
commercially available nonafluorobutanesulfonyl fluoride (2a). Trehalose (4) was 
obtained when no other nucleophile was present in the reaction mixture (cf. Scheme 
12, p. 19). On the other hand, addition of 2a to a solution where other nucleophiles 
were present resulted in trehalose and the respective D/E-glycosides (3) formation 
(cf. Scheme 11 p. 16). 
 Second, nonafluorobutanesulfonyl-1H-benzotriazole (6a) was used for the 
transfer of nonaflyl group. 6a was synthesised in 89% yield by treating lithium 
benzotriazolate with 2a in glyme under reflux. No reaction was observed between 
carbohydrates and 6a using different conditions. Reaction of 6a with phenol (7a) in 
toluene led surprisingly to the azo compound 8a (cf. Table 9, p. 25). However, 
carrying out the azo formation in DMF the ring opening proceeded almost exclusively 
to the para-product 8b (cf. Table 8 and 9, p. 24). This methodology, when applied 
with other phenols, resulted in a new synthetic pathway for the formation of ortho-
azoarenes through benzotriazole ring opening (cf. Table 10, p. 27). Reaction of 
triflylbenzotriazole (6b) with phenol in toluene led to a mixture of two ortho-coupled 
azobenzenes, with a free phenolic group and its corresponding trifluoromethane-
sulfonate (OTf instead OH). Under the same reaction conditions tosyl- (6d) or mesyl-
1H-benzotriazoles (6c) led to the corresponding phenyl sulfonic esters (cf. Table 9, 
p. 25). Some reaction mechanisms were proposed and computer calculations were 
realised in order to study the benzotriazole ring opening mechanism (cf. p. 29-32) 
 The ring opening of perfluoroalkanesulfonyl-1H-benzotriazole was exploited 
for the derivatisation of unsymmetrical phthalocyanine. An unsymmetrical 
phthalocyanine containing a benzotriazole moiety 5b could be sulfonated with 
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trifluoromethane anhydride (cf. Scheme 18, p. 35). Subsequently, the ring opening 
was carried out with 2-naphthol in a good yield (86%). 
 Phosphorus ylides were also used as nucleophiles for the benzotriazole ring 
opening. Under similar conditions to the Wittig reaction, benzyl- and (carbethoxy-
methyl)phosphoranylidenes 21’ and 23a gave the corresponding methylazo-
phosphranylidenes generally in good yields (63–90%) (cf. Table 13, p. 38; Scheme 
21 p. 39). On the other hand, methylphosphoranylidenes (23b) led to the twice 
substituted methylazophophoranylidene 24b (cf. Scheme 22, p. 40). 
 The synthesis of 1H- and 2H-benzotriazole glucopyranosides could be 
achieved using sulfonyl-benzotriazoles. Reactions between tosyl- (6c), trylflyl- (6b)
or nonaflylbenzotriazoles (6a) and 2,3,4,6-tetra-O-benzyl-D/E-D-glucopyranose (1)
led to 1H- and 2H-benzotriazole glycosides 25 and 26. Despite the low reactivity and 
decomposition from 6a, when compared to 6b and 6c, high E-selectivity was 
observed (cf. Table 14, p. 43).
 The third reagent studied for the transfer of nonaflyl was the nonafluoro-
butanesulfonic acid 1-benzotriazole-1-yl ester (25a). By reacting hydroxy-
benzotriazole (27) with 2a for the formation of the active ester 25a an interesting 
rearrangement occurred leading to 28b formation, an aryl benzotriazolesulfonic ester 
(cf. Scheme 24, p. 45). Similar phenomena occurred when the reaction was carried 
out with Tf2O (2b), with the difference that two aryl sulfonates were isolated (cf. 
Scheme 24, p. 45). The new synthetic pathway was applied to a set of HOBts (cf. 
Table 16, p. 47). A cationic mechanism was proposed instead of the initial 
rearrangement. 29b was derivatised with 2a in order to obtain the 
sulfonylbenzotriazole 37 and subsequently proceeding to the ring opening (cf. 
Scheme 27, p. 49).  
 In the second topic of the thesis, the synthesis of deprotected carbohydrates 
linked to phthalocyanines, with are attached via the anomeric carbon, was carried 
out. For this purpose the carbohydrate dicyanophenyl phthalocyanine precursors 
were synthesised by an aromatic nitro displacement. This allowed the formation of 
O- and S-phenylglucosides from 4-nitrophthalonitrile (40) (cf. Table 17, p. 53). The 
nitro aromatic substitution was conducted in DMF under very mild conditions and 
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good yields. The reactions with O-glycosides occurred generally with a high 
D-selectivity. The preparation of the benzyl protected sugar zinc(II) phthalocyanines 
56a was carried out under classical template conditions (cf. Scheme 30, p. 57). 
Special synthetic conditions were needed for the synthesis of phthalocyanines linked 
to deprotected carbohydrate moieties, instead (cf. Table 20 and Figure 2, p. 59). 
Furthermore, the nitro substitution was also applied to monoactivated 
p-nitrobenzonitrile (48) and o-dinotrobenzene (49). Although the D-selectivity was 
lower, the yield was still high (cf. Table 19, p. 56). 
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4 Experimental Part 
4.1 General Comments 
Commercially available reagents were used as acquired. Additional purification 
proceedings are described in the respective synthetic procedures. All solvents were 
purified and/or dried according to literature methods. The following equipment was 
used for the analysis and characterization of the compounds: 
Melting Point 
Büchi B-540. The melting points are uncorrected. 
Optical Rotations  
Perkin-Elmer Polarimeter 341. The optical rotations were recorded at 20 °C as 
solutions in CHCl3 (unless otherwise stated) using a 1 dm quartz cell.  
IR Spectroscopy 
Bruker Tensor 27: solid substances were grounded with KBr and pressed to pellets, 
liquid compounds were measured directly. 
UV/Vis Spectroscopy 
Shimadzu UV 2102 PC: The absorption spectra of the compound were recorded as 
solutions in CH3CN (unless otherwise stated) using a 1 cm quartz cell.  
NMR Spectroscopy 
1H NMR Spectra were recorded on Bruker AC 250 (250 MHz), Bruker Avance 400 
(400 MHz) and Bruker AMX 600 (600 MHz). 13C NMR Spectra were recorded on 
Bruker AC 250 (62.9 MHz), Bruker Avance 400 (100 MHz) and Bruker AMX 600 
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(151 MHz). The deuterated solvent was used as an internal standard. Chemical 
shifts are reported in part per million (ppm) relative to the internal standard. The 
correlation between the signals was made by using increments, comparison with 
known related compounds, DEPT-spectra and two dimensional correlation 
experiments 1H1H-COSY and 1H 13C-COSY . Coupling constants are given in Hertz.  
Mass Spectrometry 
EI: Finnigan MAT TSQ 70 with direct inlet, temperature of ion source 200 °C, 
electron energy 70 eV; FAB: Finnigan MAT TSQ 70 using xenon atoms for the 
ionisation and 3-nitrobenzyl alcohol as the matrix; FD: Finnigan MAT 711 A; HRMS:
Finnigan MAT 711 A; MALDI-TOFF: Bruker Autoflex, the spectra were measured 
with Į-cyano-m-hydroxycinnamic acid as matrix for phthalocyanines and 2c-(4-
hydroxyphenylazo)benzoic acid for other compounds. 
Elemental Analysis 
Elemental analysis was performed on HEKAtech GmbH Euro EA 3000 analyzer.  
Crystallographic Structure 
Crystallographic structures were determined on Enraf-Nonius CAD 4 diffractometer 
(Cu-KD-radiation, O = 154.184 pm) and Stoe IPDS diffractometer (Mo-KD-radiation 
graphite monochromated, O = 71.073 pm). SHELXS-97[272] and SHELXL-97[273] were 
used for the solution and refinement of the crystal structures. PLATON[274] and 
DIAMOND[275] were used for the molecular graphics of the crystal structures. 
Thin Layer Chromatography (TLC) 
POLYGRAM® SIL G/UV254 plates from Macherey & Nagel. The detection was 
conducted with the UV-lamp and/or carbonisation after spraying with a solution of 
5% H2SO4 in EtOH.  
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Preparative Column Chromatography  
The column size was selected depending on the amount of compound and was 
carried out with silica gel (0.032–0.063 mm) from Macherey & Nagel. The eluents 
are given in each reaction procedure. 
High Performance Liquid Chromatography (HPLC) 
Preparative HPLC was performed on Sykam system using an Grom Saphir Si; 5 Pm;
 u 20 mm. Analytical HPLC were performed on Sykam system using an Grom 
Saphir Si; 5 Pm; 250 u 6 mm. The eluents used were n-heptane and EtOAc. Reverse 
phase HPLC were performed on waters system using a GROM SIL 120 ODS-4HE; 
10 Pm; 250 u 20 mm. 
Chemicals 
1-Bromo-2,2-dimethylpropane (Aldrich), 1-hydroxy-7-azabenzotriazole (Aldrich), 
1-hydroxybenzotriazole (Aldrich), 15-crown-5 (Fluka), 1,2-dinitrobenzene (Aldrich), 
1,3,5-trichloro-2-nitrobenzene (Fluka), 2-acetamido-2-deoxy-D-glucose (Glycon), 
2,3-dichloronitrobenzene (Aldrich), 2,5-dichloronitrobenzene (Aldrich), 
2,6-dimethylphenol (Acros), 3-chloro-4-nitrotoluene (Acros), 3-chlorobenzyl bromide 
(Aldrich), 4-chlorobenzyl chloride (Aldrich), 4-chloro-3-nitro-benzotrifluoride (Aldrich), 
4-chloro-3-nitrotoluene (Aldrich), 4-chlorophenol (Aldrich), 4-methoxybenzyl chloride  
(Aldrich), 4-nitrobenzonitrile (Aldrich), 4-nitrobenzyl chloride (Aldrich), 4-nitrophenol 
(Riedel de Haen), 4-nitrophthalonitrile (Fluka), 2-tert.-butylphenol (Aldrich), 
butyllithium solution in hexane (Aldrich), benzotriazole (Aldrich), benzyl chloride 
(Fluka), (carbethoxymethyl)triphenylphosphonium bromide (Aldrich), Dowex 50WX8 
400 ion-exchange resin (Acros), (ethyl)triphenylphosphonium bromide (Aldrich), 
D-(+)-glucose (Fluka), lactose-monohydrate (Merk), methanesulfonyl chloride 
(Aldrich), methyl-D-D-glucopyranose (Fluka), nonafluorobutanesulfonyl fluroride 
(Aldrich), p-toluenesulfonyl chloride (Acros), sodium hydride (Fluka), triethyl 
phosphonoacetate (Aldrich), trifluoromethane sulfonic anhydride (Aldrich). 
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4.2 Experimental Procedures 
4.2.1 Related to Chapter 2.2.3 
Synthesis of methyl 2,3,4,6-tetra-O-benzyl-(D/E)-D-glucopyranoside (3D/3E)
2,3,4,6-Tetra-O-benzyl-D-D-glucopyranose (1;[116] 100 mg, 0.19 mmol), NaH (22 mg, 
0.5 mmol, 60% suspension in oil) and 15-Crown-5 (91 Pl, 0.5 mmol) were dissolved 
at –20° in dry glyme. After 40 minutes MeOH (12 Pl, 0.3 mmol) was added and the 
reaction mixture was stirred for another 10 minutes Nonafluorobutanesulfonyl 
fluoride (2a; 50Pl, 0.3 mmol) was added drop wise and the reaction mixture was 
stirred overnight. At the end of this period, the reaction was poured into H2O (10 ml) 
and CH2Cl2 (5 ml). The aqueous layer was extracted with CH2Cl2 (3 u 5 ml). The 
combined organic layers were washed with H2O (3 u 5 ml). After drying (Na2SO4), 
filtration and removal of the solvent, the crude product was purified by 
chromatography on silica gel [eluent: toluene/EtOAc, 10:3] to give 23 mg 3D + 49 mg 
3E; yield: 72 mg [70%; D/E, (1:2)]. 
Methyl 2,3,4,6-tetra-O-benzyl-D-D-glucopyranoside (3D)[276]
White powder; > @ q20
D
D  +18.4° (c = 0.3, CHCl3), (Lit.[276] > @ q20DD  17.8°, (c = 1, CHCl3)). 
1H NMR (250 MHz, CDCl3): G= 3.36 (s, 3 H, H-CH3), 3.50–3.56 (dd, 1 H, J2-1 = 3.7, 
J2-3 = 9.6 Hz, H-2), 3.60–3.76 (m, 4 H, H-4, H-5, H-6), 3.91–4.00 (s, 1 H, J3-4 = 8.8, 
J3-4 = 9.6 Hz, H-3), 4.45 (d, 1 H, J = 11.8 Hz, H-CH2), 4.54–4.66 (m, 3 H, H-1, 
H-CH2), 4.74–4.83 (m, 2 H, H-CH2), 4.95 (d, 1 H, J = 11.1 Hz, H-CH2), 7.09–7.13 (m, 
2 H, H-2Ar), 7.23–7.34 (m, 18 H, H-2Ar, H-3Ar, H-4Ar). 
13C NMR (62.9 MHz, CDCl3): G= 55.1 (C-CH3), 68.5 (C-6), 70.1 (C-5), 73.4, 73.5, 
75.0, 75.7 [C-CH2], 77.7 (C-4), 79.9 (C-2), 82.1 (C-3), 98.2 (C-1), 127.5, 127.6, 
127.7, 127.82, 127.87, 127.9, 128.1, 128.34, 128.36, 128.4 [C-2Ar, C-3Ar, C-4Ar] 
137.9, 138.2, 138.3, 128.8 [C-1Ar]. 
FAB-MS: m/z = 577.1 [M + Na]+.
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Methyl 2,3,4,6-tetra-O-benzyl-E-D-glucopyranoside (3E)[276]
Colorless oil; > @ q20
D
D  +12.1° (c = 0.3, CHCl3), (Lit.[276] > @ q20DD  11.4°, (c = 1, CHCl3)). 
1H NMR (250 MHz, CDCl3): G= 3.40–3.79 (m, 9 H, H-2, H-3, H-4, H-5, H-6, H-CH3),
4.31 (d, 1 H, J1-2 = 7.9 Hz, H-1), 4.50–4.64 (m, 3 H, H-CH2), 4.70 (d, 1 H, J = 
11.1 Hz, H-CH2), 4.78 (d, 1 H, J = 11.1 Hz, H-CH2), 4.81 (d, 1 H, J = 10.8 Hz, 
H-CH2), 4.89–4.94 (m, 2 H, H-CH2), 7.13–7.17 (m, 2 H, H-2Ar), 7.23–7.37 (m, 18 H, 
H-2Ar, H-3Ar, H-4Ar). 
13C NMR (62.9 MHz, CDCl3): G= 57.1 (C-CH3), 68.9 (C-6), 73.5, 74.7 [C-CH2], 74.9 
(C-5), 75.0, 75.7 [C-CH2], 77.9 (C-4), 82.3 (C-2), 84.7 (C-3), 104.7 (C-1), 127.60, 
127.62, 127.7, 127.8, 127.9, 127.0, 128.1, 128.3, 128.4 [C-2Ar, C-3Ar, C-4Ar], 
138.1, 138.2, 138.5, 138.6 [C-1Ar]. 
FAB-MS: m/z = 577.1 [M + Na]+.
Synthesis of 2,2’,3,3’,4,4’6,6’-octa-O-benzyl-(DDDEEE)-trehalose (4a/4b/4c) 
2,3,4,6-Tetra-O-benzyl-D-D-glucopyranose (1;[116] 100 mg, 0.18 mmol), NaH (9 mg, 
0.24 mmol, 60% suspension in oil) and 15-Crown-5 (35 Pl, 0.2 mol) were dissolved 
in dry glyme. After 40 minutes nonafluorobutanesulfonyl fluoride (2a; 55 Pl, 0.3 
mmol) was added drop wise. The reaction mixture was stierred overnight. At the end 
of this period, the reaction was poured into H2O (10 ml) and CH2Cl2 (5 ml). The 
aqueous layer was extracted with CH2Cl2 (3 u 5 ml). The combined organic layers 
were washed with H2O (3 u 5 ml). After drying (Na2SO4), filtration and removal of the 
solvent, the crude product was purified by chromatography on silica gel [eluent: 
toluene/EtOAc, 10:3] to give 38 mg 4c + 20 mg 4b + 9 mg 4a; yield 54 mg [57%; 
EE/ED/DD (4:1:0.5)]. 
2,2’,3,3’,4,4’,6,6’-Octa-O-benzyl-DD-trehalose (4a)[277]
Colorless oil; > @ q20
D
D  +81.0° (c = 0.5, CHCl3), (Lit.[277] > @ q20DD  + 82°, (c = 0.7, CHCl3)). 
1H NMR (400 MHz, CDCl3): G= 3.47–3.55 (m, 4 H, H-2, H-5), 3.66–3.78 (m, 8 H, 
H-3, H-4, H-6), 4.52 (d, 2 H, J = 12.1 Hz, H-CH2), 3.57–3.61 (m, 4 H, H-CH2), 4.52 
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(d, 2 H, J = 11.1 Hz, H-CH2), 4.79 (d, 2 H, J = 10.8 Hz, H-CH2), 4.82 (d, 2 H, J = 
10.9 Hz, H-CH2), 4.89 (d, 2 H, J1-2 = 7.8 Hz, H-1), 4.94 (d, 2 H, J = 10.8 Hz, H-CH2), 
4.01(d, 2 H, J = 10.8 Hz, H-CH2), 7.18–7.37 (m, 40 H, H-2Ar, H-3Ar, H-4Ar). 
13C NMR (100 MHz, CDCl3): G= 68.9 (C-6), 73.4, 74.6 [C-CH2], 75.0 (C-5, C-CH2), 
75.6 (C-CH2), 77.7 (C-4), 82.2 (C-2), 84.6 (C-3), 99.3 (C-1), 127.50, 127.55, 127.6, 
127.7, 127.8, 127.9, 128.2, 128.3, 128.4 [C-2Ar, C-3Ar, C-4Ar], 138.2, 138.3, 138.5, 
138.6 [C-1Ar]. 
FAB-MS: m/z = 1085.3 [M + Na]+.
2,2’,3,3’,4,4’,6,6’-Octa-O-benzyl-DE-trehalose (4b)[277]
Colorless oil; > @ q20
D
D  +47° (c = 0.3, CHCl3), (Lit.[277] > @ q20DD  + 46°, (c = 1.9, CHCl3)).
1H NMR (250 MHz, CDCl3): G= 3.40–3.77 (m, 10 H, H-2, H-4, H-6, H-2’, H-3’, H-4’, 
H-5’, H-6’), 4.02–4.16 (m, 10 H, H-3, H-5), 4.27 (d, 1 H, J = 12.1 Hz, H-CH2), 4.44–
4.58 (m, 6 H, H-1’, H-CH2), 4.62–4.66 (m, 2 H, H-CH2), 4.71–4.91 (m, 7 H, H-CH2), 
5.09 (d, 1 H, J = 11.3 Hz, H-CH2), 5.14 (d, 2 H, J1-2 = 3.2 Hz, H-1), 7.10–7.35 (m, 
40 H, H-2Ar, H-3Ar, H-4Ar). 
13C NMR (62.9 MHz, CDCl3): G= 68.0 (C-6), 68.9, 71.2 (C-5), 73.1, 73.3, 73.4, 74.5, 
74.9 [C-CH2], 75.0 (C-5’, C-CH2), 75.5, 75.6 [C-CH2], 77.6 (C-4’), 77.7 (C-4), 79.7 
(C-2), 81.7 (C-2’), 82.0 (C-3), 84.7 (C-3’), 99.5 (C-1), 104.2 (C-1’), 127.3, 127.50, 
127.57, 127.63, 127.69, 127.7, 127.81, 127.85, 127.88, 127.9, 128.0, 128.1, 128.27, 
128.29, 128.32, 128.34, 128.36 [C-2Ar, C-3Ar, C-4Ar], 138.0, 138.1, 138.2, 138.5, 
138.6, 138.7, 138.8 [C-1Ar]. 
FAB-MS: m/z = 1085.3 [M + Na]+.
2,2’,3,3’,4,4’,6,6’-Octa-O-benzyl-EE-trehalose (4c)[277]
Colorless oil; > @ q20
D
D  +81.3° (c = 0.5, CHCl3), (Lit.[277] > @ q20DD  + 82°, (c = 0.7, CHCl3)). 
1H NMR (250 MHz, CDCl3): G= 3.44–3.50 (dd, 2 H, J6a-6b = 1.2, J6a-6b = 10.7 Hz, 
H-6a), 3.57–3.63 (dd, 2 H, J6b-6a = 3.0, J6b-6a = 10.7 Hz, H-6b), 3.64–3.71 (dd, 2 H, 
J2-1 = 3.6, J2-3 = 9.5 Hz, H-2), 3.72–3.81 (t, 2 H, J4-3/4-5 = 9.5 Hz, H-4), 4.08–4.16 (t, 
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2 H, J3-2/3-4 = 9.5 Hz, H-3), 4.21–4.45 (m, 2 H, H-5), 4.45 (d, 2 H, J = 12.1 Hz, 
H-CH2), 4.54 (d, 2 H, J = 10.8 Hz, H-CH2), 4.59–4.65 (m, 4 H, H-CH2), 4.76 (s, 4 H, 
H-CH2), 4.86–4.96 (m, 4 H, H-CH2), 5.07 (d, 2 H, J = 11.1 Hz, H-CH2), 5.32 (d, 2 H, 
J1-2 = 3.6 Hz, H-1), 7.18–7.24 (m, 4 H, H-2Ar), 7.27–7.44 (m, 36 H, H-2Ar, H-3Ar, 
H-4Ar). 
13C NMR (62.9 MHz, CDCl3): G= 68.3 (C-6), 70.8 (C-5), 72.8, 73.6, 75.1, 75.7 
[C-CH2], 77.8 (C-4), 79.5 (C-2), 81.9 (C-3), 94.5 (C-1), 127.5, 127.6, 127.7, 127.9, 
128.0, 128.1 [C-2Ar, C-3Ar, C-4Ar], 138.0, 138.3, 138.5, 139.0 [C-1Ar]. 
FAB-MS: m/z = 1085.3 [M + Na]+.
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4.2.2 Related to Chapter 2.2.4 
1-Nonafluorobutanesulfonyl-1H-1,2,3-benzotriazole (6a) 
A 1.6 M solution of BuLi in n-hexane (9.4 ml, 15 mmol) was added slowly to a stirred 
solution of 1H-benzotriazole (5a; 1.8 g, 15 mmol) in anhydrous dimethoxymethane 
(50 ml) at 0 °C under argon. After 1 h, nonafluorobutanesulfonyl fluoride (2a; 4.75 ml, 
22.4 mmol) was added dropwise. The reaction mixture was stirred under reflux for 
ca. 3 h, while the progress of the reaction monitored by TLC. After completion of the 
reaction, the mixture was cooled to room temperature, and diluted with Et2O (100 
ml). The organic layer was washed with aq sat. NH4Cl solution (2 u 50 ml), and H2O
(1 u 50 ml). After drying (Na2SO4), filtration and removal of the solvent, the crude 
product was purified by chromatography on silica gel under protection from light 
[eluent: petroleum ether/EtOAc, 4:1] to give 6a; yellow solid; yield: 5.33 g (89%); 
mp 46.1–46.8 °C (petroleum ether/EtOAc). 
IR (KBr): Q = 1356, 1193 (SO2), 1271, 1138, 1028 cm–1 (CF). 
UV/Vis (MeCN): O (Hmolí1dm3cmí1) = 211 (10700), 253 (5480), 293 (1480), 409 nm 
(352).
1H NMR (250 MHz, CDCl3): G= 7.55–7.64 (t, 1 H, J4-5/5-6 = 8.2, Hz, H-5), 7.75–7.85 
(t, 1 H, J4-5/6-7 = 8.12 Hz, H-6), 7.98 (d, 1 H, J4-5 = 8.2 Hz, H-4), 8.23 (d, 1 H, J6-7 = 
8.2 Hz, H-7). 
13C NMR (62.9 MHz, CDCl3): G = 111.8 (C-4), 121.4 (C-7), 127.2 (C-5), 131.9 (C-6), 
132.1 (C-8), 145.3 (C-9).  
EI-MS: m/z = 400.9 [M]+, 182.0 [M – C4F9]
+.
Anal. calcd for C10H4F9N3O2S: C, 29.94; H, 1.00; N, 10.47, S, 7.99. Found: C, 30.06; 
H, 0.93; N, 10.36; S, 8.16. 
4-Hydroxyphthalonitrile (7l) [278]
K2CO3 (41.00 g, 300 mmol) was added to a solution of benzyl alcohol (6.20 ml, 
60 mmol) and 4-nitrophthalonitrile (31; 7.00 g, 40 mmol) in DMF (100 ml). The 
mixture was heated and stirred at 80 °C for 6 h. At the end of this period, the mixture 
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was cooled down to room temperature and poured into ice water (1 l). The product 
was filtered and recrystallised from EtOH. A solution of 4-benzyloxyphthalonitrile 
(8.9 g, 38 mmol) in EtOAc (200 ml) was added to a suspension of 10% Pd/C (300 
mg) in EtOAc (100 ml). The solution was stirred under H2 for 6 h. The catalyst was 
removed from the solution by filtration over Celite. The EtOAc was evaporated and 
the product was dissolved in a 5% aq solution of NaOH, filtered and the filtrate was 
neutralised with concentrated HCl to give yield 7l. Brownish powder; 4.6 g (85%); 
mp 211.5–213 °C (H2O); Lit:
 [278] 208– 210 °C. 
1H NMR (250 MHz, DMSO-d6): G = 7.16–7.22 (dd, 1 H, J5-3 = 2.5, J5-6 = 8.6 Hz, H-5), 
7.37 (d, 1 H, J3-5 = 2.5 Hz, H-3), 7.89 (d, 1 H, J6-5 = 8.6 Hz, H-6).  
13C NMR (62.9 MHz, MeOH-d4): G = 107.74 (C-4), 118.17 (C-6), 118.82 (C-3, C-5), 
119.64 (C-2), 123.38 (C-1CN), 128.11 (C-2CN), 164.57 (C-1).  
EI-MS: m/z = 143.9 [M]+.
Reaction of 3 with Phenols in the Presence of NaH; General Procedure  
NaH (0.12 g, 3 mmol, 60% suspension in oil) was added to a stirred solution of the 
appropriate phenol (3 mmol) and 1-[(nonafluorobutane)sulfonyl]-1H-1,2,3-
benzotriazole (6a; 1 g, 2.5 mmol) in anhydrous toluene (50 ml) at room temperature 
under argon. The mixture was stirred for the given time (see below) while controlling 
the progress of the reaction by TLC. At the end of this period, EtOAc (100 ml) and 
H2O (25 ml) were added and the suspension was treated with conc. HCl, till the 
colour of the organic phase changed from red to orange-red. The aqueous phase 
must remain colourless during this time. The organic phase was separated, dried 
(Na2SO4), filtered, and the solvent was evaporated. The crude product was purified 
by chromatography over silica gel [eluent: petroleum ether/EtOAc (30:1) containing 
1% AcOH]. 
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Nonafluoro-N-{2-[(E)-2-(2-hydroxyphenyl)diazenyl]phenyl}-1-butane-
sulfonamide (8a)  
Prepared from phenol 7a. Reaction time: 7 h. Yellow solid; yield: 0.94 g (76%); 
mp 134.2–135.1 °C (petroleum ether).  
IR (KBr):ҏ Q = 3441 (NH, OH), 1349, 1184 (SO2), 1285, 1252, 1135 cm–1 (CF).  
UV/Vis (MeCN): O (Hmolí1dm3cmí1) = 250 (11700), 321 (12000), 395 nm (8320). 
1H NMR (600 MHz, CDCl3):ҏ G = 7.06 (d, 1 H, J5’-6’ = 8.6 Hz, H-6’), 7.08í7.12 (dd, 1 H, 
J = 7.3, 7.9 Hz, H-5’), 7.37–7.44 (m, 2 H, H-4, H-4’), 7.44–7.50 (m, 1 H, H-5), 7.75 
(d, 1 H, J3’-4’ = 7.9 Hz, H-3’), 7.82–7.87 (m, 2 H, H-3, H-6), 11.86 (s, 1 H, N-H), 12.00 
(s, 1 H, OH). 
13C NMR (151 MHz, CDCl3): G = 118.7 (C-6’), 120.4 (C-3), 120.8 (C-5’), 126.1 (C-4), 
129.8 (C-1), 130.3 (C-6), 131.4 (C-4’), 132.4 (C-5), 134.8 (C-3’), 135.9 (C-1’), 137.3 
(C-2), 153.1 (C-2’). 
EI-MS: m/z = 494.9 [M]+, 212.1 [M – C4F9O2S]
+.
Anal. calcd for C16H10F9N3O3S: C, 38.80; H, 2.03; N, 8.48; S 6.47. Found: C, 38.62; 
H, 1.99; N, 8.33; S, 6.52. 
Nonafluoro-N-{2-[(E)-2-(4-hydroxyphenyl)diazenyl]phenyl}-1-butane-
sulfonamide (8b) 
Synthesised from phenol 7a. This reaction was carried out in DMF and the crude 
was chromatographed with petroleum ether/EtOAc (10:1) as eluent. Reaction time: 
12 h. Orange solid; yield: 0.58 g (47%); mp 129.5–130 °C (petroleum ether/toluene). 
IR (KBr):ҏ Q = 3500 (NH, OH), 1352, 1199 (SO2), 1281, 1233, 1134 cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) 250 (11300), 358 nm (19000). 
1H NMR (400 MHz, CDCl3):ҏ G = 5.56 (s, 1 H, OH), 6.94–6.99 (m, 2 H, H-2’, H-6’), 
7.29–7.35 (ddd, 1H, J4-6 = 1.4, J4-3 = 7.6, J4-5 = 8.7 Hz, H-4), 7.40–7.46 (ddd, 1H, 
J5-2 = 1.6, J5-6 = 7.9, J5-4 = 8.7 Hz, H-5), 7.77–7.85 (m, 3H, H-3, H-3’, H-5’), 7.88–
7.93 (dd, 1H, J6-4 = 1.4, J5-6 = 7.9 Hz, H-6), 11.20 (s, 1 H, N-H). 
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13C NMR (100.6 MHz, CDCl3): G = 116.2 (C-3’, C-5’), 119.2 (C-6), 125.0 (C-2’, C-6’), 
125.6 (C-5), 125.7 (C-3), 131.3 (C-2), 131.9 (C-4), 139.1 (C-1), 145.7 (C-1’), 159.4 
(C-4’). 
EI-MS: m/z = 495.0 [M]+, 212.1 [M – C4F9O2S]
+.
Anal. calcd for C16H10F9N303S: C, 38.80; H, 2.03; N, 8.48; S, 6.47. Found: C, 38.94; 
H, 1.97; N, 8.40; S, 6.53. 
Trifluoro-N-{2-[(E)-2-(2-hydroxyphenyl)diazenyl]phenyl}-1-methanesulfonamide 
(9a)
The title compound was isolated as a by-product being 9a the major product; Yellow 
solid; yield: 0.35 g (58%); mp 132–133.4 °C  
9b; Synthesised from phenol (7a) and 1-trifluoromethanesulfonyl-1H-benzotriazole 
(6b;[130] 0.63 g, 2.5 mmol). Reaction time: 12 h. The crude product was purified by 
chromatography over silica gel [eluent: petroleum ether/EtOAc (10:1)]. Orange solid; 
yield: 0.15 g (19%); mp 111.2–112 °C (petroleum ether/EtOAc). For analytical 
purposes the title compound was separated by preparative reverse phase HPLC. 
IR (KBr):ҏ Q = 3451 (NH, OH), 1384, 1209 (SO2), 1289, 1228, 1139 cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 243 (10900), 321 (12500), 387 nm (7900). 
1H NMR (250 MHz, CDCl3): G = 6.92–7.12 (m, 2 H, H-5', H-6’), 7.27–7.49 (m, 3 H, 
H-4, H-5, H-4’), 7.64–7.84 (m, 3 H, H-3, H-6, H-3’), 12.08 (s, 1 H, N-H,O-H). 
13C NMR (62.9 MHz, CDCl3): G = 118.7 (C-6’), 120.7 (C-5’, C-3), 122.3 (C-1), 125.9 
(C-4), 129.7 (C-6), 131.4 (C-3’), 132.3 (C-4’), 134.7 (C-5), 136.0 (C-1’), 137.6 (C-2), 
153.2 (C-2’). 
EI-MS: m/z = 345.0 [M]+, 212.1 [M – CF3O2S]
+.
Anal. calcd for C13H10F3N3SǜCF3COOH: C, 39.22; H, 2.41; N, 9.15; S, 6.98. Found: 
C, 39.29; H, 2.39, N, 9.25; S, 6.89. 
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Trifluoromethanesulfonic Acid 2-[(2-Trifluoromethanesufonylaminophenyl)-
diazenyl]phenyl Ester (9b) 
NaH (0.08 g, 2.0 mmol, 60% suspension in oil) was added to a stirred solution of 
phenol (7a; 0.2 g, 2.0 mmol) and 1-trifluoromethanesulfonyl-1H-benzotriazole 
(6b;[130] 1 g, 4 mmol) in anhydrous toluene (50 ml) at room temperature under argon. 
The mixture was allowed to stir for 12 h while controlling the progress of the reaction 
by TLC. At the end of this period, EtOAc (100 ml) and H2O (25 ml) were added and 
the suspension was treated with conc. HCl, till the colour of the organic phase 
changed from red to orange. The aqueous phase must remain colourless during this 
time. The organic phase was separated, dried (Na2SO4), filtered, and the solvent 
was evaporated. The crude product was purified by chromatography over silica gel 
[eluent: petroleum ether/EtOAc (10:1)]. Yellow solid; yield 0.90 g (95%); mp 132.7–
133.4 °C (petroleum ether/EtOAc).
IR (KBr):ҏ Q = 3422 (OH), 3277 (NH), 1365, 1200 (SO2), 1285, 1229, 1139 cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 203 (23400), 233 (11400), 326 nm (16700). 
1H NMR (250 MHz, CDCl3): G = 7.31–7.39 (m, 1 H, H-5’), 7.45 (dd, 1 H, J3-5 = 1.5, 
J3-4 = 8.2 Hz, H-3), 7.48–7.65 (m, 3 H, H-4, H-5, H-4’), 7.72–7.82 (m, 2 H, H-6, H-6’), 
7.96 (d, 1 H, J3’-4’ = 8.1 Hz, H-3’), 9.00 (s, 0.9 H, N-H). 
13C NMR (62.9 MHz, CDCl3):ҏҏ G =117.6 (C-6), 119.5 (C-3’), 120.7 (C-6’), 122.8 (C-3), 
126.5 (C-5’), 129.1 (C-4), 133.5 (C-5), 134.1 (C-2’), 134.2 (C-4’), 141.3 (C-1’), 143.8 
(C-2), 147.9 (C-1). 
EI-MS: m/z = 476.9 [M]+, 344.1 [M+ – CF3O2S], 211.1 [M – C2F6O4S2]
+.
Anal. calcd for C14H9F6N3O5S2: C, 35.22; H, 1.90; N, 8.80; S, 13.43. Found: 
C, 35.17; H, 2.01; N, 8.69; S, 13.04. 
Toluone-4-sulfonic acid phenyl ester (10)[279]
NaH (0.12 g, 3 mmol, 60% suspension in oil) was added to a stirred solution of 
phenol (7a; 0.28 g, 3 mmol) and 1-(toluene-4-sulfonyl)-1H-benzotriazole (6c;[138] 0.68 
g, 2.5 mmol) in anhydrous toluene (50 ml) at room temperature under argon. The 
mixture was allowed to stir for 12 h while controlling the progress of the reaction by 
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TLC. At the end of this period, EtOAc (100 ml) and H2O (25 ml) were added. The 
organic phase was washed with H2O (2 x 25 ml), separated, dried (Na2SO4), filtered, 
and the solvent was evaporated. The crude product was recrystallised from 
n-hexane. White solid; yield: 0.59 g (96%); mp 94.6–95.3 °C (n-hexane). (Lit.[279]
95.8–97.5 °C (EtOH)). 
1H NMR (250 MHz, CDCl3): G = 3.42 (s, 3 H, H-CH3), 6.97 (d, 2 H, J2’-3’,6’-5’ = 8.6 Hz, 
H-2’, H-6’), 7.18–7.32 (m, 5 H, H-2, H-3, H-4, H-5, H-6), 7.69 (d, 2 H, J3’-2’,5’-6’ = 
8.6 Hz, H-3’, H-5’). 
13C NMR (62.9 MHz, CDCl3): G = 21.7 (C-CH3), 122.4 (C-2, C-6), 127.0 (C-4), 128.5 
(C-3, C-5), 129.6 (C-3’, C-5’), 129.35 (C-2’, C-6’), 132.5 (C-1’), 145.3 (C-4’), 149.7 
(C-1). 
Methanesulfonic acid phenyl ester (11)[280]
NaH (0.12 g, 3 mmol, 60% suspension in oil) was added to a stirred solution of 
phenol (7a; 0.28 g, 3 mmol) and 1-methanesulfonyl-1H-benzotriazole (6d;[143] 0.49 g, 
2.5 mmol) in anhydrous toluene (50 ml) at room temperature under argon. The 
mixture was allowed to stir for 12 h while controlling the progress of the reaction by 
TLC. At the end of this period, EtOAc (100 ml) and H2O (25 ml) At the end of this 
period, EtOAc (100 ml) and H2O (25 ml) were added. The organic phase was 
washed with H2O (2 x 25 ml), separated, dried (Na2SO4), filtered, and the solvent 
was evaporated. The crude product was recrystallised from n-hexane. White solid; 
yield: 0.42 g (91%); mp 60.5–61 °C (n-hexane) (Lit.[280] 61–62°C (EtOH)). 
1H NMR (250 MHz, CDCl3): G = 3.11 (s, 3 H, H-CH3), 7.23–7.45 (m, 5 H, Ar-H). 
13C NMR (62.9 MHz, CDCl3): G = 37.3 (C-CH3), 121.9 (C-2, C-6), 127.4 (C-4), 130.0 
(C-3, C-5), 149.3 (C-1). 
Nonafluoro-N-{2-[(E)-2-(2-hydroxy-3-methylphenyl)diazenyl]phenyl}-1-butane-
sulfonamide (12) 
Synthesised from 2-methylphenol (7b). Reaction time: 3 h. Orange solid; yield: 0.8 g 
(63%); mp 96.3–98.4 °C (pentane/toluene). 
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IR (KBr): Q = 3459 (OH), 3284 (NH), 1355, 1185 (SO2), 1264, 1228, 1144 cm-1 (CF).
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 219 (15600), 245 (10200), 325 (9900), 411 
nm (7500). 
1H NMR (250 MHz; CDCl3): G = 2.98 (s, 3 H, H-CH3), 7.05–6.97 (t, 1 H, J5’-6’/5’-4’ = 
7.6 Hz, H-5’), 7.31 (d, 1 H, J4’-5’ = 7.4 Hz, H-4’), 7.43–7.35 (ddd, 1 H, J4-6 = 1.5, J4-3 = 
7.5, J4-5 = 9.1 Hz, H-4), 7.50–7.43 (ddd, 1 H, J5-3 = 1.7, J5-6 = 7.5, J5-4 = 9.1 Hz, H-5), 
7.56–7.63 (dd, 1 H, J6’-4’ = 1.3, J6’-5’ = 7.9 Hz, H-6’), 7.80–7.90 (m, 2 H, H-6, H-3), 
12.15 (s, 0.7 H, OH), 12.19 (s, 0,9 H, NH). 
13C NMR (62.9 MHz; CDCl3): G = 15.3 (C-CH3), 120.2 (C-3), 120.3 (C-4’), 126.1 
(C-4), 128.0 (C-3’), 129.2 (C-6’), 129.9 (C-1), 130.6 (C-6), 132.3 (C-5), 135.6 (C-1’), 
135.9 (C-4’), 137.1 (C-2), 151.6 (C-2’). 
EI-MS: m/z = 509 [M]+, 226.2 [M – C4F9O2S]
+.
Anal. calcd for C17H12F9N3O3S: C, 40.09; H, 2.37; N, 8.25; S, 6.30. Found: C, 40.12; 
H, 2.41; N, 8.24; S, 6.28. 
Nonafluoro-N-{2-[(E)-2-(2-hydroxy-4-methylphenyl)diazenyl]phenyl}-1-
butanesulfonamide (13) 
Synthesised from 3-methylphenol (7c). Reaction time: 3 h. This product was 
recrystallyzed from pentane/toluene (4:1) without previous chromatography. Yellow 
solid; yield: 1.17 g (92%); mp 132.7í133.0 °C (pentane/toluene). 
IR (KBr): Q = 3419 (NH, OH), 1351, 1183 (SO2), 1282, 1228, 1137 cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 255 (22800), 325 (19300), 412 nm (18700). 
1H NMR (250 MHz, CDCl3): G= 2.41 (s, 3 H, H-CH3), 6.85í6.97 (m, 2 H, H-3’, H-5’), 
7.34í7.50 (m, 2 H, H-4, H-5), 7.59í7.65 (d, 1 H, J6’-5’ = 8.1 Hz, H-6’), 7.77–7.90 (m, 
2 H, H-6, H-3), 11.97 (s, 1 H, NH), 12.13 (s, 1 H, OH). 
13C NMR (62.9 MHz, CDCl3): G = 22.2 (C-CH3), 118.9 (C-3’), 120.3 (C-3), 122.3 
(C-5’), 126.1 (C-4), 129.2 (C-4’), 130.6 (C-6), 131.5 (C-6’), 132.0 (C-5), 134.4 (C-1), 
137.2 (C-1’), 146.9 (C-2), 153.2 (C-2’). 
EI-MS: m/z = 509 [M]+, 226.1 [M – C4F9O2S]
+.
HRMS: m/z calcd for C17H12F9N3O3S: M = 509.04551; Found: 509.05092. 
4 Experimental part 
77 
Nonafluoro-N-{2-[(E)-2-(2-hydroxy-5-methylphenyl)diazenyl]phenyl}-1-butane-
sulfonamide (14) 
Synthesised from 4-methylphenol (7d). Reaction time: 3 h. Orange solid; yield: 
1.15 g (90%); mp 126.7–127.1 °C (petroleum ether/toluene). 
IR (KBr): Q = 3456 (NH, OH), 1353, 1182 (SO2), 1281, 1246, 1135 cm-1 (CF).
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 208 (30500), 257 (24700), 319 (15000), 419 
(12500). 
1H NMR (400 MHz, CDCl3): G = 2.39 (s, 3 H, H-CH3), 6.97 (d, 1 H, J3’-4’ = 8.9 Hz, 
H-3’), 7.22–7.26 (dd, 1 H, J4’-6’ = 2.2, J4’-3’ = 8.9 Hz, H-4’), 7.37–7.42 (ddd, 1 H, J4-6 = 
1.8, J4-5 = 7.7, J4-3 = 9.3 Hz, H-4), 7.44–7.50 (ddd, 1 H, J5-3 = 1.8, J5-4 = 7.7, J5-6 = 
8.4 Hz, H-5), 7.52 (d, 1H, J6’-4’ = 1.8 Hz, H-6’), 7.83–7.88 (m, 2 H, H-6, H-3), 11.75 
(s, 1 H, N-H), 12.11 (s, 0.9 H, OH). 
13C NMR (100.6  MHz, CDCl3): G = 20.3 (C-CH3), 118.4 (C-3’), 120.1 (C-3), 125.9 
(C-4), 129.6 (C-1), 130.3 (C-5’), 130.5 (C-6), 130.9 (C-6’), 132.2 (C-5), 135.6 (C-1’), 
135.9 (C-4’), 137.1 (C-2), 150.9 (C-2’). 
EI-MS: m/z = 509 [M]+, 226.1 [M – C4F9O2S]
+.
Anal. calcd for C17H12F9N3O3S: C, 40.09; H, 2.37; N, 8.25; S, 6.30. Found: C, 40.25; 
H, 2.39; N, 8.23; S, 6.29. 
Nonafluoro-N-{2-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)diazenyl]phenyl}-1-
butanesulfonamide (15) 
 from 2,6-dimethylphenol (7e). Reaction time: 12 h. The crude was 
chromatographied with petroleum ether/EtOAc (4:1). Yellow solid; yield: 1 g (76%); 
mp 133.5–133.9 °C (petroleum ether/toluene). 
IR (KBr):ҏ Q = 3568 (OH), 3280 (NH), 1358, 1187 (SO2), 1293, 1230, 1143 cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 251 (11800), 370 nm (17400). 
1H NMR (400 MHz, CDCl3): G = 2.33 (s, 6 H, H-CH3), 5.17 (s, 1 H, OH), 7.28–7.34 
(ddd, 1 H, J3-6 = 1.3, J4-5 = 8.2, J4-3 = 9.3 Hz, H-4), 7.37–7.43 (ddd, 1 H, J5-3 = 1.6, 
J5-6 = 7.7, J5-4 = 8.2 Hz, H-5), 7.55 (s, 2H, H-2’, H-6’), 7.77–8.82 (dd, 1 H, J3-5 = 1.6, 
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J3-4 = 8.4 Hz, H-3), 7.87–7.92 (dd, 1 H, J6-4 = 1.3, J6-5 = 7.7 Hz, H-6), 11.56 (s, 1 H, 
N-H). 
13C NMR (100.6 MHz, CDCl3): G = 15.9 (C-CH3), 119.2 (C-3), 123.7 (C-2’, C-6’), 
124.1 (C-3’,C-5’), 125.6 (C-4), 126.4 (C-6), 130.9 (C-1), 131.6 (C-5), 139.1 (C-2), 
144.8 (C-1’), 156.3 (C-4’). 
EI-MS: m/z = 523 [M]+, 240.2 [M – C4F9O2S]
+.
Anal. calcd for C18H14F9N3O3S: C, 41.31; H, 2.70; N, 8.03; S, 6.13. Found: C, 41.31; 
H, 2.69; N, 7.94; S, 6.10. 
Nonafluoro-N-{2-[(E)-2-(3-tert-butyl-2-hydroxyphenyl)diazenyl]phenyl}-1-
butanesulfonamide (16) 
Synthesised from 2-tert-butylphenol (7f). Reaction time: 2 h. Orange solid; yield: 
1.09 g (79%); mp 88.7–91.3 °C (pentane/toluene). 
IR (KBr): Q = 3441 (OH, NH), 1352, 1190 (SO2), 1262, 1237, 1140 cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 245 (11300), 326 (11600), 411 nm (8990).  
1H NMR (250 MHz, CDCl3): G= 1.47 (s, 9 H, CH3), 6.99–7.07 (m, 1 H, H-5), 7.34–
7.42 (ddd, 1H, J4-6 = 1.7, J4-3 = 7.9, J4-5 = 9.4 Hz, H-4), 7.43–7.52 (m, 2 H, H-4’, H-5), 
7.57–7.63 (dd, 1 H, J6’-4’ = 1.7, J6’-5’ = 7.9 Hz, H-6’), 7.83–7.91 (m, 2 H, H-6, H-3), 
12.01 (s, 1 H, OH), 12.62 (s, 1 H, NH). 
13C NMR (62.9 MHz, CDCl3): G = 29.5 (C-CH3), 35.32 (C-tert), 120.1 (C-5’), 120.2 
(C-3), 126.1 (C-4), 128.9 (C-6’), 129.7 (C-6), 130.2 (C-1), 132.2 (C-4’), 132.4 (C-5), 
136.2 (C-3’), 137.1 (C-1’), 139.4 (C-2), 153.3 (C-2’). 
EI-MS: m/z = 551.1 [M]+, 268.1 [M – C4F9O2S]
+.
HRMS: m/z calcd for C20H18F9N3O3S: M = 551.09246; found: 551.09654. 
Nonafluoro-N-{2-[(E)-2-(5-chloro-2-hydroxyphenyl)diazenyl]phenyl}-1-
butanesulfonamide (17) 
Synthesised from 4-chlorophenol (7g). Reaction time: 3 h. Yellow solid; yield: 1.04 g 
(79%); mp 145.4–145.8 °C (petroleum ether/toluene). 
 IR (KBr):ҏҏQ = 1354, 1182 (SO2), 1286, 1242, 1135 cm-1 (CF).
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UV/Vis (CH3CN): O (H molí1dm3cmí1) = 203 (19800), 251 (9550), 322 (11900), 
400 nm (8320). 
1H NMR (400 MHz, CDCl3): G = 7.04 (d, 1 H, J3’-4’ = 8.8 Hz, H-3’), 7.37 (dd, 1 H, 
J4’-6’ = 2.6, J4’-3’ = 8.8 Hz, H-4’), 7.40–7.45 (ddd, 1 H, J4-3 = 1.3, J4-5 = 7.7, J4-3 = 
9.3 Hz, H-4), 7.44–7.50 (ddd, 1 H, J5-3 = 1.8, J5-4 = 7.7, J5-6 = 8.4 Hz, H-5), 7.52 (d, 
1 H, J6’-4’ = 2.6 Hz, H-6’), 7.82–7.88 (m, 2 H, H-6, H-3), 11.36 (s, 1 H, OH), 11.61 (s, 
1 H, N-H). 
13C NMR (100.6 MHz, CDCl3): G = 120.0 (C-3’), 120.7 (C-3), 125.5 (C-5’), 126.3 
(C-4), 129.5 (C-6’), 129.6 (C-6), 130.1 (C-1), 133.1 (C-5), 134.4 (C-4’), 136.2 (C-1’), 
137.6 (C-2), 151.7 (C-2’).  
EI-MS: m/z = 529 [M]+, 246.0 [M – C4F9O2S]
+.
Anal. calcd for C16H9ClF9N3O3S: C, 36.27; H, 1.71; N, 7.93; S, 6,05. Found: 
C, 36.37; H, 1.70; N, 8.05; S, 5.99. 
Nonafluoro-N-{2-[(E)-2-(2-hydroxy-3-methoxyphenyl)diazenyl]phenyl}-1-
butanesulfonamide (18) 
Synthesised from 2-methoxyphenol (7h). Reaction time: 3 h. Yellowish brown solid; 
yield 0.8 g (70%); mp 134í135 °C (pentane/toluene). 
IR (KBr): Q = 3442 (OH), 3239 (NH), 1352, 1187 (SO2), 1259, 1236, 1138 cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 222 (23500), 333 (13400), 407 nm (8400). 
1H NMR (250 MHz, CDCl3): G = 3.94 (s, 3 H, H-CH3), 6.99–7.06 (m, 2 H, H-4’, H-6’), 
7.34–7.42 (m, 2 H, H-4, H-5’), 7.43-7.52 (ddd, 1 H, J5-3 = 1.7, J5-4 = 7.4, J5-6 = 9.1 Hz, 
H-5), 7.84–7.92 (m, 2 H, H-6, H-3), 11.06 (s, 1 H, NH), 11.96 (s, 0.9 H, OH). 
13C NMR (62.9 MHz, CDCl3): G = 56.6 (C-CH3), 115.7 (C-6’), 119.9 (C-4’), 120.2 
(C-3, C-5’), 126.1 (C-4), 130.1 (C-1), 130.4 (C-6), 132.6 (C-5), 136.3 (C-1’), 137.7 
(C-2), 143.9 (C-3’), 149.0 (C-2’).  
EI-MS: m/z = 525 [M]+, 242.1 [M – C4F9O2S]
+.
Anal. calcd for C17H12F9N303S: C, 38.87; H, 2.30; N, 8.00; S, 6.10. Found: C, 38.95; 
H, 2.33; N, 7.92; S, 6.07. 
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Nonafluoro-N-{2-[(E)-2-(1-hydroxy-2-naphthyl)diazenyl]phenyl}-1-butane-
sulfonamide (19) 
Synthesised from 1-naphthol (7i). Reaction time: 4 h. Dark red solid; yield 1.18 g 
(86%); mp 161.6í161.9 °C (petroleum ether/toluene). 
IR (KBr):ҏ Q = 3441 (NH, OH), 1354, 1186 (SO2), 1236, 1135 cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 205 (40400), 245 (29900), 293 (20200), 524 
nm (26800). 
1H NMR (600 MHz, acetone-d6): G =7.04 (d, 1 H, J3’-4’ = 9.3 Hz, H-3’), 7.22–7.27 (m, 
2 H, H-5, H-4’), 7.32–7,39 (m, 2 H, H-4, H-6’), 7.44 (d, 1 H, J3-4 = 7.9 Hz, H-3), 7.52–
8.53 (ddd, 1 H, J7’-5’ = 1.0, J7’-6’ = 6.9, J7’-8’ = 7.9 Hz, H-7’), 7.55 (d, 1 H, J5’-6’ = 6.7 Hz, 
H-5’), 7.84 (dd, 1 H, J6-4 = 1.5, J6-5 = 8.4 Hz, H-6), 8.20 (d, 1 H, J8’-7’ = 7.9 Hz, H-8’), 
10.56 (s, 1 H, NH), 14.54 (s, 1 H, OH). 
13C NMR (62.9 MHz, aceton-d6): G = 118.2 (C-6), 122.7 (C-3’), 126.4 (C-4’), 126.8 
(C-8’), 127.0 (C-1), 127.5 (C-6’), 128.8 (C-5), 128.8 (C-5’), 129.5 (C-3), 129.6 
(C-10’), 130.6 (C-4), 132.9 (C-7’), 134.7 (C-2’), 137.9 (C-9’), 143.2 (C-2), 169.5 
(C-1’).  
EI-MS: m/z = 545 [M]+, 262.1 [M – C4F9O2S]
+.
HRMS calcd for C20H12F9N303S: M = 545.04551. Found: m/z 545. 05190. 
Nonafluoro-N-{2-[(E)-2-(2-hydroxy-1-naphthyl)diazenyl]phenyl}-1-butane-
sulfonamide (20a) 
Synthesised from 2-naphthol (7j). Reaction time: 2 h. This product was 
recrystallyzed from petroleum ether/toluene (5:1) without previous chromatography. 
Red solid; yield: 1.28 g (94%); mp 174.0–174.7 °C (petroleum ether/toluene). 
IR (KBr):ҏ Q = 3417 (NH, OH), 1354, 1192 (SO2), 1297, 1235,1142 cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 212 (22600), 226 (21400), 235 (14600), 250 
(8200), 277 (11100), 321 (3700), 518 nm (19000). 
1H NMR (600 MHz, acetone-d6): G = 6.94 (d, 1 H, J3’-4’ = 9.3 Hz, H-3’), 7.44–7,51 (m, 
2 H, H-5, H-6’), 7.59–7.66 (m, 3 H, H-3, H-4, H-7’), 7.77 (d, 1 H, J5’-6’ = 7.8 Hz, H-5’), 
4 Experimental part 
81 
7.95 (d, 1 H, J4’-3’ = 9.3 Hz, H-4’), 8.18 (dd, 1 H, J6-4 = 1.1, J6-5 = 8.2 Hz, H-6), 8.63 
(d, 1 H, J8’-7’ = 8.2 Hz, H-8’), 10.78 (s, 1 H, NH),ҏ 15.58 (s, 1 H, OH). 
13C NMR (151 MHz, aceton-d6):ҏ G = 118.7 (C-6), 122.6 (C-8’), 124.2 (C-3’), 126.9 
(C-6’), 127.1 (C-1), 129.1 (C-5), 129.4 (C-9’), 129.7 (C-5’), 129.9 (C-7’), 129.9 (C-4), 
130.9 (C-3), 131.4 (C-10’), 134.1 (C-1’), 140.9 (C-4’), 144.4 (C-2), 168.1 (C-2’). 
EI-MS: m/z = 545 [M]+, 262.1 [M – C4F9O2S]
+.
Anal. calcd for C20H12F9N3O3S: C, 44.0; H, 2.22; N, 7.70; S, 5.88. Found: C, 43.86; 
H, 2.19; N, 7.60; S, 5.89. 
Trifluoro-N-{2-[(E)-2-(2-hydroxy-1-naphthyl)diazenyl]phenyl}-1-methane-
sulfonamide (20b) 
Synthesised from 2-naphthol (7j) and 1-trifluoromethanesulfonyl-1H-benzotriazole 
(6b;[130] 0.63 g, 2.5 mmol). Reaction time: 2 h. This product was recrystallised from 
toluene and not chromatographied. Red solid; yield: 0.95 g (90%); mp 209.4–
210.1 °C (toluene). 
IR (KBr):ҏ Q = 3422 (NH, OH), 1373, 1207 (SO2), 1294, 1233, 1151 cm-1 (CF).
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 227 (31700), 312 (6600), 486 nm (13100). 
1H NMR (250 MHz, DMSO-d6): G = 6.88 (d, 1 H, J3’-4’ = 9.6, H-3’), 7.27–7.49 (m, 4 H, 
H-3, H-4, H-5, H-6’), 7.53–7.62 (m, 1 H, H-7’), 7.74 (d, 1 H, J4’-3’ = 7.6 Hz, H-5’), 7.93 
(d, 1 H, J5’-6’ = 9.6 Hz, H-4’), 8.05 (d, 1 H, J6-5 = 7.4 Hz, H-6), 8.5 (d, 1 H, J8’-7’ = 
8.1 Hz, H-8’), 12.39 (s, 1.5 H, NH, OH). 
13C NMR (62.9 MHz, DMSO-d6):ҏҏ G = 171.2 (C-2’), 141.5 (C-2), 141.2 (C-4’), 133.2 
(C-1’), 130.4 (C-10’), 129.7 (C-7’), 129.4 (C-5’), 129.3 (C-3), 128.6 (C-4), 128.4 
(C-1), 128.4 (C-7’), 128.2 (C-5), 126.6 (C-6’), 124.88 (C-3’), 121.92 (C-8’) 117.2 
(C-6). 
EI-MS: m/z = 395.1 [M]+, 262.1 [M – CF3O2S]
+.
Anal. calcd for C17H12F3N3O3S: C, 51.64; H, 3.06; N, 10.64; S, 8.11. Found: 
C, 51.35; H, 3.07; N, 10.47; S, 8.10. 
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4.2.3 Related to Chapter 2.2.5 
9,10,16,17,23,24-[Hexakis-3,5-bis(tert-butylphenoxy)]-2,3-[d]{1-[(trifluoro-
methane)sulfonyl]-1H-1,2,3-triazole}phthalocyaninato zinc (6e) 
Method 1 
To a stirred solution of (5b;[188] 100 mg, 54 µmol) in anhydrous CH2Cl2 (3 ml) was 
added pyridine (20 µL, 240 µmol). The reaction mixture was cooled to 0 °C. After 15 
minutes, trifluoromethanesulfonic anhydride (20 µL, 240 µmol) was added dropwise. 
The reaction mixture was stirred at room temperature for ca. 2 h, while the progress 
of the reaction was monitored by TLC. After removal of the solvent, the crude 
product was purified by chromatography on silica gel under protection from light 
[eluent: CHCl3] to give 6e; green solid; yield: 102 mg (88%). Product·2Py = 
2135.07 g/mol. 
Method 2 
To a stirred solution of (5b;[188] 50 mg, 27 µmol) in anhydrous CH2Cl2 (2 mL) was 
added K2CO3 (41 mg, 30 µmol). The reaction mixture was cooled to 0 °C. After 15 
minutes, trifluoromethanesulfonic anhydride (20 µL, 240 µmol) was added dropwise. 
The reaction mixture was stirred at room temperature for ca. 2 h, while the progress 
of the reaction was monitored by TLC. After removal of the solvent, the crude 
product was purified by chromatography on silica gel under protection from light 
[eluent: CHCl3] to give 6e; green solid; yield: 50 mg (93%).  
IR (KBr): 539 vw, 580 w, 617 m, 691 vw, 707m, 720 w, 748 m, 807 vw, 824 vw, 
842vw, 878 m, 902 m, 961 s, 1003 w, 1035 m, 1049 w, 1088 s, 1120 m, 1134 m, 
1200 s, 1229 m, 1244 m, 1269 s, 1297 vs, 1317 m, 1364 m, 1402 vs, 1422 vs, 
1440 s, 1586 vs, 1608 m, 2360 vw, 2869 m, 2906 m, 2964 vs, 3072 cm–1 w. 
UV/Vis (CH2Cl2): (c = 4.77·10
–6) O [log (Hmolí1dm3cmí1] = 291 (4.68), 352 (4.88), 
620 (4.57), 683 (5.23), 697 nm (5.23). 
1H NMR (250 MHz, THF-d8): G= 1.36 s, 1.37 s (72 H, H-10), 1.41 (s, 18 H, H-10’’), 
1.44 (s, 18 H, H-10’), 7.18–7.31 (m, 16 H, H-6, H-6’, H-6’’, H-8),  
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7.39 (t, 1 H, J8’’-6’’ = 1.8 Hz, H-8’’), 7.44 (t, 1 H, J8’-6’ = 1.8 Hz, H-8’), 9.00 s, 9.02 s, 
9.03 s (6 H, H-3), 9.43 (s, 1 H, H-J’), 9.86 (s, 1 H, H-J).
13C NMR (62.9 MHz, THF-d8): G = 31.9 [C-10], 35.7, 35.8, [C-9], 104.9 (C-J’), 113.1, 
113.2, 113.4,113.9, 114.4 [C-6] 114.1, 114.25, 115.28, 115.3, 115.5 [C-3], 115.8 
(C-J), 117.7, 117.8, 117.9, 118.3, 118.6 [C-8], 123.2 (C-G’), 124.6 (C-py), 133.1 
(C-E’), 134.9, 135.2, 135.6, 135.75, 135.76, 135.8 [C-2], 137.6 (C-py), 138.0 (C-E),
141.4 (C-D’), 147.4 (C-D), 147.6 (C-Py), 150.5 (C-G), 150.3, 150.9, 151.4, 151.5, 
152.0, 152.3 [C-4] 153.29, 153.30, 153.33, 153.35, 153.5, 153.7 [C-7], 153.2, 153.7, 
154.6, 154.7, 154.8, 155.0 [C-1], 157.5, 158.1, 158.5, 158.6, 158.7 [C-5]. 
MS MALDI-TOF: m/z = 2136 [M + 2Py + H]+, 1970 [M + 2Py – N2 + H]
+,
1879 [M + 2Py – N2 – CF3 + H]
+,1843 [M + 2Py – SO2CF3 + H]
+.
Anal. calcd for C117H134F3N11O8SZn: C, 71.09; H, 6.83; N, 7.79; S, 1.62. Found: 
C, 70.88; H, 6.77; N, 7.47; S, 0.00. 
9,10,16,17,23,24-[Hexakis-3,5-bis(tert-butylphenoxy)]-2-(trifluormethane-
sulfonamide)-3-(2 hydroxynaphthalin-1-ylazo)phthalocyaninato zinc (20c) 
NaH (3 mg, 75 µmol, 60 % suspension in oil) was added to a stirred solution of 
2Naphthol (7j; 11 mg, 75 µmol) in anhydrous toluene (3 mL) at room temperature. 
After 15 minutes compound 6e was added and the mixture was stirred for 10 
minutes while controlling the progress of the reaction by TLC. At the end of this 
period AcOH (0.5 mL) was added. The organic phase was evaporated, and the 
crude product was purified by chromatography over silica gel [eluent: CHCl3
containing 1% AcOH] to afford 20c; green solid; yield: 46 mg (86 %). 
IR (KBr): 459 vw, 507 vw, 597 w, 706 m, 719 w, 748 m, 866 m, 902 m, 961 s, 
1002 vw, 1037 s, 1087 s, 1119 m, 1139 m, 1198 vs, 1226 m, 1247 m, 1269 s, 
2361 vw, 1297 vs, 1364 m, 1402 vs, 1422 vs, 1450 vs, 1479 vs, 1586 s, 1608 s, 
2868 m, 2906 m, 2963 vs, 3071 cm–1 vw. 
UV/Vis (THF): (c = 2.70·10–6) O [log (Hmolí1dm3cmí1] = 287 (4.72), 356 (4.94), 569 
(4.44), 628 (4.67), 691 (5.27), 711 nm (5.13). 
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UV/Vis (CH2Cl2): (c = 5.82·10
–6) O [log (Hmolí1dm3cmí1] = 290 (4.59), 352 (4.77), 
520 (4.16), 565 (4.09), 689 (4.89), 728 nm (4.78). 
1H NMR (250 MHz, THF-d8):G= 1.34 s,1.35 s, 1.36 s, 1.40 s (90 H, H 10), 1.45 (s, 
18 H, H-10’), 6.77 (d, 1 H, Jc-d = 9.6 Hz, H-c), 7.17–7.30 (m, 17 H, H-6, H-6’, H-8), 
7.46 (t, 1 H, J8’-6’ = 1.8 Hz, H-8’), 7.53 (dd, 1 H, Jf-g = 6.9, Jf-e = 7.7 Hz, H-f), 7.67 (dd, 
1 H, Jg-f = 6.9, Jg-h= 7.7 Hz, H-g), 7.73 (d, 1 H, Je-f = 7.7 Hz, H-e), 7.96 (d, 1 H, J = 
9.55 Hz, H-d), 8.94 (d, 1 H, Jh-g = 7.7 Hz, H-h), 9.10 (s, 5 H, H-3), 9.31 (s, 1 H, H-3’), 
9.48 (s, 1 H, H-J’), 9.92 (s, 1 H, H-J), 16.98 (s, 1.4 H, OH, NH). 
1H NMR (250 MHz, THF-d8 + Et3N):G= 1.34 s, 1.35 s, 1.36 s, 1.37 s (90 H, H 10), 
1.45 (s, 18 H, H-10’), 7.05 (d, 1 H, Jc-d = 9.6 Hz, H-c,), 7.17–7.30 (m, 17 H, H-6, H-6’, 
H-8), 7.35 (t, 1 H, J8’-6’ = 1.2 Hz, H-8’), 7.44 (dd, 1 H, Jh-g = 7.8 Hz, Jh-f = 7.2 Hz, H-f), 
7.61 (m, 1 H, H-d, H-g), 7.79 (d, 1 H, Je-f = 9.6 Hz, H-e), 8.87 (d, 1 H, Jh-g = 7.8 Hz, 
H-h), 9.08s, 9.11s, 9.14s (5 H, H-3), 9.34 (s, 1 H, H-3’), 9.57 (s, 1 H, H-J’), 9.87 (s, 
1 H, H-J), 16.98 (s, 1 H, NH). 
13C NMR (62.9 MHz, THF-d8 + Et3N):G= 31.7, 31.9, 31.9 [C-10], 35.73, 35.78, 
[C-9], 109.7 (C-J), 113.05, 113.08, 113.1, 113.2, 113.5 [C-6], 114.1,114.2, 114.7, 
114.9, 115.0 [C-3], 115.4 (C-3’), 117.4, 117.6, 117.7 [C-8], 118.1 (C-J’, C-8), 123.1 
(C-h), 123.2 (q, CF3 , J = 327 Hz), 127.7 (C-c), 129.1 (C-i), 129.6 (C-d), 130.2 (C-g), 
131.8 (C-j), 134.1 (C-E’), 135.2 (C-a), 135.8, 135.83, 135.85, 135.9, 136.2, [C-4], 
138.2 (C-E),139.4 (C-G’), 141.3 (C-G), 141.6 (C-e), 150.5, 150.6, 150.9, 151.0, 151.1, 
151.27 [C-4], 153.3, 153.4, [C-7], 153.50, 153.55, 154.3, 154.4 [C 1], 156.0 (C-D’),
156.2 (C-D), 158.2, 158.5, 158.61, 158.67, 158,72, 158.74 [C-5], 178.7 (C-b). 
MS-MALDI-TOF: m/z = 2121 [M]+, 1964 [M – C10H7N2O]
+.
Anal. calcd for C127H142F3N11O9SZn
2+: C, 71.92; H, 6.75; N, 7.26; S 0.00. Found: 
C, 72.17; H, 6.81; N, 6.97; S, 0.03. 
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4.2.4 Related to Chapter 2.2.6 
Preparation of Phosphonium Salts 
The phosphonium salts (21’) were prepared according to the literature,[200,201]
heating a toluene solution of Ph3P and the corresponding equivalent amounts of 
benzyl halides (21) overnight at reflux. The precipitated phosphonium salts were 
collected by filtration washed repeatedly with Et2O and used subsequently without 
further purification. 
General Method for the Synthesis of Triphenylphosphoranylidenes 
NaH (0.12 g, 60% suspension in oil) was added to a stirred solution of phosphonium 
salt (2.3 mmol) in anhydrous THF (10 ml) at room temperature under argon. The 
mixture was stirred for 4 h. At the end of this period, 1-nonafluorobutanesulfonyl-1H-
benzotriazole (6a; 1.00 g, 2.5 mmol) was added and stirred for 30 minutes. EtOAc 
(50 ml) and H2O (50 ml) were added and the aqueous phase was extracted with 
EtOAc (2 u 25 ml). The organic phase was dried (Na2SO4), filtered, and the solvent 
was evaporated. The crude product was purified by chromatography over silica gel 
(eluent: EtOAc). 
{[2-(2-{[Nonafluorobutanesulfonyl]amino}phenyl)diazenyl](phenyl)methyl}-
(triphenyl)phosphonium chloride (22a) 
Synthesised from benzyl chloride (21a) according to literature procedure;[200] The 
product was dissolved in EtOAc (10 ml) and HCl gas was introduced. The solvent 
was evaporated to give 22a; white solid; yield: 1.64 g (90%); mp 213.4í214.7 °C 
(dec.; EtOAc). 
IR (KBr): Q ҏ = 3437 (NH), 1349, 1192 (SO2), 1439 (CP), 1266, 1033 cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 328 nm (8540).
1H NMR (250 MHz, CDCl3): G = 6.86í6.97 (m, 2 H, H-4, H-6), 7.00í7.07 (m, 1 H, 
H-5), 7.12í7.16 (m, 2 H, H-3’, H-5’), 7.29 (dd, 1 H, J3-4 = 1.5, J3-5 = 7.6 Hz, H-3), 
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7.33í7.42 (m, 3 H, H-2’, H-4’, H-6’), 7.47í7.65 (m, 12 H, H-2’’, H-3’’, H-5’’, H-6’’), 
7.76í7.84 (m, 3 H, H-4’’), 10.72 (s, 1 H, NH). 
13C NMR (62.9 MHz, CDCl3): G = 116.5 (C-6), 118.7 (d, J1’’-P = 89.6 Hz, C-1’’), 122.9 
(C-1), 124.0 (C-4), 125.7 (d, JCP-P = 130 Hz, C-CP), 127.4 (d, J1’-P = 20.3 Hz, C-1’), 
128.3 (C-5), 129.9 (C-4’), 130.1 (C-3’, C-5’), 130.1 (d, J2’’-P/6’’-P = 12.2 Hz, C-2’’, 
C-6’’), 130.2 (C-3), 131.4 (d, J2’-P/6’-P = 1.74 Hz, C-2’, C-6’), 134.4 (d, J3’’-P/5’’-P = 
9.6 Hz, C-3’’, C-5’’), 135.1 (d, J4’’-P = 3.5 Hz, C-4’’), 138.5 (C-2). 
FAB-MS: m/z = 754.14 [M + H]+.
FAB(–)-MS: m/z = 752 [M í H]í, 788 [M + Cl]í.
Anal. calcd for C35H26ClF9N3O2PS: C, 53.21; H, 3.32; N, 5.32; S, 4.06. Found: 
C, 53.10; H 3.29; N, 5.45; S, 3.98. 
Nonafluorobutane-N-{2-[2-[(3-chlorophenyl)(triphenylphosphoranylidene)-
methyl]diazenyl]phenyl}-1-sulfonamide (22b) 
Synthesised from 3-chlorobenzyl bromide (21b) according to literature procedure;[200]
yellow solid; yield: 1.23 g (68%); mp 199.2í200.3 °C (dec.; EtOAc). 
IR (KBr): Q = 3425 (NH), 1350, 1192 (SO2), 1439 (CP), 1265, 1130, 1030 cm-1 (CF).
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 379 nm (5410). 
1H NMR (250 MHz, CDCl3): G = 6.63í6.68 (m, 1 H, H-5), 6.75í6.89 (m, 3 H, H-4, 
H-6, H-2’), 7.09í7.11 (m, 1 H, H-6’), 7.35í7.37 (m, 2 H, H-4’, H-5’), 7.48í7.67 (m, 
13 H, H-3, H-1’’, H-2’’, H-3’’, H-4’’), 7.78í7.84 (m, 3H, H-4’’), 10.6 (s, 1 H, NH). 
13C NMR (62.9 MHz, CDCl3): G = 112.4 (C-6), 117.5 (d, JCP-P = 137 Hz, C-CP), 119.1 
(d, J1’’-P = 90.5 Hz, C-1’’), 120.5 (C 5), 123.7 (C-3), 124.6 (C-4), 127.9 (d, J6’-P = 
4.2 Hz, C-6’), 129.3 (d, J1’’-P = 21.7 Hz, C-1’), 129.6 (d, J2’-P = 2.8 Hz, C-2’), 130.1 (d, 
J2’’-P/6’’-P = 12.9 Hz, C-2’’, C-6’’), 131.2 (d, J5’-P = 1.4 Hz, C-5’), 131.8 (C-4’), 133.8 
(C-1), 134.25 (d, J3’’-P/5’’-P = 10.2 Hz, C-3’’, C-5’’), 135.1 (d, J4’’-P/ = 3.2 Hz, C-4’’), 
136.0 (C-3’), 136.2 (d, J2’-P = 1 Hz, C-2). 
FAB-MS: m/z = 788.0 [M + H]+.
Anal. calcd for C35H24ClF9N3O2PS: C, 53.34; H, 3.07; N, 5.33; S, 4.07. Found: 
C, 53.57; H, 3.19; N, 5.29 S, 3.87. 
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Nonafluorobutane-N-{2-[2-((4-chlorophenyl)(triphenylphosphoranylidene)-
methyl)diazenyl]phenyl}-1-sulfonamide (22c) 
Synthesised from 4-chlorobebzyl (21c) chloride according to literature procedure;[200]
yellow solid; yield: 1.25 g (69%); mp 200.3í203.5 °C (dec.; EtOAc). 
IR (KBr): Q = 3442 (NH), 1350, 1190 (SO2), 1439 (CP), 1267, 1029 cmí1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 379 nm (5480). 
1H NMR (250 MHz, CDCl3): G = 6.62í6.69 (m, 1 H, H-5), 6.77í6.88 (m, 2 H, H-4, 
H-6), 6.95 (d, 2 H, J2’-3’/6’-5’ = 8.3 Hz, H-2’, H-6’), 7.30 (d, 2 H, J3’-2’/5’-6’ = 8.3 Hz, H-3’, 
H-5’), 7.45í7.66 (m, 13 H, H-3, H-2’’, H-3’’, H-4’’, H-6’’), 7.77í7.84 (m, 3 H, H-4’’), 
10.49 (s, 1 H, NH). 
13C NMR (62.9 MHz, CDCl3): G = 112.5 (C-6), 118.1 (d, JCP-P = 137 Hz, C-CP), 119.2 
(d, J1’’-P = 89.8 Hz, C-1’’), 120.6 (C-5), 123.9 (C-3), 124.4 (C-4), 126.0 (d, J1’-P = 
21.7 Hz, C-1’), 130.1 (d, J2’’-P/6’’-P = 12.9 Hz, C-2’’, C-6’’), 130.7 (C-3’, C-5’), 130.9 (d, 
J2’-P/6’-P = 3.7 Hz, C-2’, C-6’,), 133.9 (C-1), 134.3 (d, J3’’-P/5’’-P = 10.2 Hz, C-3’’, C-5’’), 
135.1 (d, J4’’-P = 2.8 Hz, C-4’’), 135.8 (C-4’), 137.3 (d, J2’-P/ = 1.9 Hz, C-2’). 
FAB-MS: m/z = 788.0 [M + H]+.
Anal. calcd for C35H24ClF9N3O2PS: C, 53.34; H, 3.07; N, 5.33; S, 4.07. Found: 
C, 53.20; H, 3.07; N, 5.16; S, 3.93. 
{(4-Nitrophenyl)[2-(2-{[nonafluorobutanesulfonyl]amino}phenyl)diazenyl]-
methyl}(triphenyl)phosphonium chloride (22d) 
Synthesised from 4-nitrobenzyl chloride (21d) according to literature procedure;[200]
The product was dissolved in EtOAc (10 ml) and HCl gas was introduced. The 
solvent was evaporated to give 22d; orange solid; yield: 1.21 g (63%); mp 
205.9í207.6 °C (dec.; EtOAc). 
IR (KBr): Q = 3425 (NH), 1192 (SO2), 1439 (CP), 1348 (NO2), 1268, 1131, 1032 cm-1
(CF).
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 317 nm (16100). 
1H NMR (250 MHz, CDCl3): G = 6.64í6.71 (m, 1 H, H-5), 6.80í6.87 (m, 2 H, H-4, 
H-6), 7.20í7.24 (m, 2 H, H-2’, H-6’), 7.38í7.42 (m, 1 H, H-3), 7.51í7.68 (m, 12 H, 
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H-2’’, H-3’’, H-5’’, H-6’’), 7.77í7.85 (m, 3 H, H-4’’), 8.09í8.12 (m, 2 H, H-3’, H-5’), 
10.62 (s, 1 H, NH). 
13C NMR (62.9 MHz, CDCl3): G = 112.7 (C-6), 116.9 (d, JCP-P = 137.6 Hz, C-CP), 
118.8 (d, J1’’-P = 90.5 Hz, C-1’’), 120.9 (C-5), 123.9 (C-3), 124.9 (C-4), 125.3 (C-3’, 
C-5’), 130.3 (d, J2’’-P/6’’-P = 12.9 Hz, C-2’’, C-6’’), 130.9 (d, J2’-P/6’-P = 3.2 Hz, C-2’, 
C-6’), 133.7 (C-1), 134.3 (d, J3’’-P/5’’-P = 9.7 Hz, C-3’’, C-5’’), 134.4 (d, J1’-P = 21.7 Hz, 
C-1’), 135.3 (d, J4’’-P = 3.23 Hz, C-4’’), 135.9 (C-2). 
FAB-MS: m/z = 799.1 [M + H]+.
Anal. calcd for C35H25F9N4OP4S: C, 50.34; H, 3.02; N, 6.71; S, 3.84. Found: C, 
50.44; H, 3.00; N, 6.78; S, 3.52. 
Nonafluorobutane-N-{2-[2-((4-methoxyphenyl)(triphenylphosphoranylidene)-
methyl)diazenyl]phenyl}-1-sulfonamide (22e) 
Synthesised from 4-methoxybenzyl chloride (21e) according to literature 
procedure;[201] yellow solid; yield: 1.48 g (82%); mp 208.2í209.0 °C (dec.; EtOAc). 
IR (KBr): Q = 3445 (NH), 1192 (SO2), 1440 (CP), 2843 (OMe), 1264, 1133, 1033 cm-1 
(CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 374 nm (7690). 
1H NMR (250 MHz, CDCl3): G = 3.74 (s, 3 H, H-CH3), 6.61í6.68 (m, 1 H, H-5), 
6.77í6.94 (m, 6 H, H-4, H-6, H-2’, H-3’, H-5’, H-6’), 7.45í7.64 (m, 13 H, H-3, H-2’’, 
H-3’’, H-5’’, H-6’’), 7.74í7.82 (m, 3 H, H-4’’), 12.45 (s, 1 H, NH). 
13C NMR (62.9 MHz, CDCl3): G = 55.3 (C-CH3), 112.4 (C-6), 115.9 (C-3’, C-5’), 119.2 
(d, J1’-P = 21.7 Hz, C-1’), 119.5 (d, J1’’-P = 89.6 Hz, C-1’’), 119.9 (d, JCP-P = 134 Hz, 
C-CP), 123.8 (C-3), 123.9 (C-4), 130.0 (d, J2’’-P/6’’-P = 12.5 Hz, C-2’’, C-6’’), 131.1 (d, 
J = 3.7 Hz, C-2’, C-6’), 134.3 (d, J3’’-P/5’’-P = 9.7 Hz, C-3’’, C-5’’), 134.3 (C-1), 134.9 (d, 
J4’’-P = 2.8 Hz, C-4’’), 135.3 (C-2), 161.4 (C-4’). 
FAB-MS: m/z = 784.0 [M + H]+.
Anal. calcd for C36H27FN3O3PS: C, 5.18; H, 3.47; N, 5.36; S, 4.09. Found: C, 54.23; 
H, 3.50; N, 5.42; S, 3.93. 
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Ethyl 2-{(E)-2-[2-({nonafluorobutanesulfonyl}amino)phenyl]diazenyl}-2-
(triphenylphosphoranylidene)acetate (24a) 
Synthesised from (carbethoxymethyl)triphenylphosphonium bromide (23a; 0.99 g, 
2.3 mmol); yellow solid; yield: 1.46 g (83%); mp 193.5í196.5 °C (dec.; EtOAc). 
IR (KBr): Q = 3442 (NH), 1349, 1191 (SO2), 1688 (CO), 1440 (CP), 1264, 1130, 1029 
cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 410 nm (13400). 
1H NMR(250 MHz, CDCl3): G = 1.09 (t, 3 H, J1’’-2’’ = 7.1 Hz, H-CH3), 4.29 (q, 2 H, 
J2’’-1’’ = 7.1 Hz, H-CH2) 6.55í6.58 (m, 2 H, H-3, H-4), 6.92í6.99 (m, 1 H, H-5), 
6.55í6.58 (m, 2 H, H-3, H-4), 7.58í7.70 (m, 13 H, H-6, H-2’, H-3’, H-5’, H-6’), 
7.76í7.84 (m, 3 H, H-4’), 13.89 (s, 1H, NH). 
13C NMR(62.9 MHz, CDCl3): G = 13.9 (C2’’-CH3), 62.9 (C1’’-CH2), 104.5 (d, JCP-P = 
145 Hz, C-CP), 113.4 (C-3), 119.7 (d, J1’-P = 93.26, C-1’), 120.0 (C-4), 122.7 (C-6), 
127.5 (C-5), 129.8 (d, J2’-P/6’-P = 12.9 Hz, C-2’, C-6’), 133.0 (C-2), 134.1 (d, J3’-P/5’-P = 
10.2 Hz, C-3’, C-5’), 134.6 (d, J4’-P = 2.8 Hz, C-4’), 138.7 (C-1), 161.6 (d, JCO-P = 
27.2 Hz, C-CO). 
FAB-MS: m/z = 749.9 [M + H]+.
Anal. calcd for C32N25F9N3O4PS: C, 51.27; H, 3.36; N, 5.61; S, 4.28. Found: 
C, 51.27; H, 3.55; N, 5.62; S, 4.13. 
Nonafluoro-N-{2-[2-({2-[2-({nonafluorobutanesulfonyl}amino)phenyl]diazenyl}-
(triphenylphosphoranylidene)methyl)diazenyl]phenyl}-1-butanesulfonamide 
(24b)
BuLi in n-hexane (0.50 ml, 1.35 mmol) was added to a stirred solution of 
methyltriphenylphosphonium bromide (23b; 0.45 g, 1.26 mmol) in anhydrous THF 
(10 ml) at room temperature under argon. The mixture was stirred for 4 h. At the end 
of this period, 1-nonafluorobutanesulfonyl-1H-benzotriazole (6a; 1.00 g, 2.5 mmol) 
was added and stirred for 30 minutes EtOAc (50 ml) and H2O (50 ml) were added 
and the aqueous phase was extracted with EtOAc (2 u 25 ml). The organic phase 
was dried (Na2SO4), filtered, and the solvent was evaporated. The crude product 
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was purified by chromatography over silica gel [eluent: petroleum ether/EtOAc (1:3)]; 
brown solid; yield: 0.58 g (44%); mp 189.7í192.5 °C (petroleum ether/EtOAc). 
IR (KBr): Q = 3442 (NH, OH), 1350, 1191 (SO2), 1440 (CP), 1134, 1035 cm-1 (CF). 
UV/Vis (CH3CN): O (H molí1dm3cmí1) = 534 nm (12800). 
1H NMR (250 MHz, CDCl3): G = 6.89í6.95 (m, 2 H, H-4, H-4’), 7.02í7.06 (m, 2 H, 
H-3, H-3’), 7.09í7.16 (m, 2 H, H-5, H-5’), 7.45í7.48 (m, 2H, H-6, H-6’), 7.59í7.67 
(m, 12 H, H-2’’, H-3’’, H-5’’, H-6’’), 7.71í7.81 (m, 3 H, H-4’’), 16.5 (s, 2H, NH). 
13C NMR (62.9 MHz, CDCl3): G = 115.8 (C-3, C-3’), 119.1 (d, J1´´-P = 92.3 Hz, C-1’’), 
125.1 (C-4, C-4’), 126.6 (C-6, C-6’), 128.0 (d, JCP-P = 174 Hz, C-CP), 130.0 (d, 
J2’’-P/6’’-P = 12.9 Hz, C-2’’, C-6’’), 130.5 (C-5, C-5’), 134.2 (d, J3’’-P/5’’-P = 10.2 Hz, C-3’’, 
C-5’’), 134.9 (C-2, C-2’), 135.1 (d, J4’’-P = 3.2 Hz, C-4’’), 140.8 (C-1, C-1’). 
FAB-MS: m/z = 1078.9 [M + H]+.
Anal. calcd for C39H25F18N6O4PS2: C, 43.42; H, 2.34; N, 7.79; S, 5.95. Found: 
C, 44.09; H, 2.46; N, 7.85; S, 5.47. 
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4.2.5 Related to Chapter 2.2.7 
Reactions with 1-(Toluene-4-sulfonyl)-1H-1,2,3-benzotriazole (6c) 
Method 1 
NaH (80 mg, 2 mmol, 60% suspension in oil) was added to a stirred solution of 
2,3,4,6-tetra-O-benzyl-D-D-glucopyranose (1;[116] 1 g, 1.9 mmol), and 1-(toluene-4-
sulfonyl)-1H-1,2,3-benzotriazole (6c;[138] 0.57 g, 2 mmol) in dry THF (10 ml) at room 
temperature under argon. The mixture was stirred 6 hours. At the end of this period, 
the mixture was poured into brine (100 ml) and Et2O (20 ml). The aqueous layer was 
extracted with Et2O (3 u 20 ml). The organic layer was washed with H2O (3u 20 ml). 
After drying (Na2SO4), filtration and removal of the solvent, the crude product was 
purified by chromatography on silica gel [eluent: toluene/acetone, 30:1]; yield: 41 mg 
26D + 419 26E + 215 mg 25D [55%; 25D26D:26E:, (5:1:10)]. 
Method 2 
2,3,4,6-Tetra-O-benzyl-D-D-glucopyranose (1;[116]1 g, 1.9 mmol) in dry THF (10 ml) 
was added dropwise to a stirred solution of NaH (80 mg, 2 mmol, 60% suspension in 
oil) and 1-(toluene-4-sulfonyl)-1H-1,2,3-benzotriazole (6c;[138] 0.57 g, 2 mmol) in dry 
THF (10 ml) at room temperature under argon. The mixture was stirred 6 hours. At 
the end of this period, the mixture was poured into brine (100 ml) and Et2O (20 ml). 
The aqueous layer was extracted with Et2O (3 u 20 ml). The organic layer was 
washed with H2O (3 u 20 ml). After drying (Na2SO4), filtration and removal of the 
solvent, the crude product was purified by chromatography on silica gel [eluent: 
toluene/acetone, 30:1]; yield: 420 mg 25E+ 410 26E + 39 mg 25D [74%; 
25D:25E:26E, (1:10:10)]. 
Reaction with 1-trifluoromethanesulfonyl-1H-1,2,3-benzotriazole (6b) 
Synthesised from 1-trifluoromethanesulfonyl-1H-benzotriazole (6b;[130] 0.50 g, 2 
mmol) as in method 2; yield: 90 mg 26D + 350 mg 26E+ 350 mg 25D [66%; 
25D:26D:26E, (3:1:3)]. 
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Reaction with 1-nonafluorobutanesulfonyl-1H-1,2,3-benzotriazole (6a) 
Synthesised from 1-nonafluorobutanesulfonyl-1H-benzotriazole (6a; 0.80 g, 2 mmol) 
as in method 1 at 70°; yield: 110 mg 26E + 155 mg 25E [21%; 25E:26E, (3:2)] 
1H-1,2,3-Benzotriazole-2,3,4,6-tetra-O-benzyl-D-D-glucopyranoside (25D)
White solid; mp 117–118 °C (n-heptane/EtOAc); > @ q20
D
D +21.7° (c = 1, CHCl3)
1H NMR (250 MHz, CDCl3): G= 3.40–3.44 (dd, 1 H, J6a-5 = 1.5, J6a-6b = 10.8 Hz, 
H-6a), 3.65–3.70 (dd, 1 H, J6b-5 = 2.7, J6b-6a = 10.8 Hz, H-6b), 3.85–3.95 (m, 2 H, 
H-4, H-5), 4.15–4.21 (dd, 1 H, J2-1 = 5.9, J2-3 = 9.3 Hz, H-6), 4.36 (d, 1 H, J = 12 Hz, 
H-CH2), 4.45–4.52 (m, 2 H, H-CH2), 4.57 (d, 1 H, J = 11 Hz, H-CH2), 4.75 (d, 1 H, 
J = 12.3 Hz, H-CH2), 4.89–5.13 (m, 4 H, H-3, H-CH2), 6.05 (d, 1 H, J1-2 = 5.9 Hz, 
H-1), 6.97–7.01 (m, 2 H, H-2Ar), 7.10–7.40 (m, 21 H, H-4’, H-5’, H-6’, H-2Ar, H-3Ar, 
H-4Ar), 8.12 (d, 1 H, J7’-6’ = 8.4, H-7’). 
13C NMR (62.9 MHz, CDCl3): G= 68.0 (C-6), 73.2 (C-5), 73.5, 74.3, 74.9, 75.8 
[C-CH2], 77.5 (C-4), 79.2 (C-2), 81.3 (C-1), 82.7 (C-3), 109.5 (C-4’), 120.1 (C-7’), 
124.2 (C-5’), 127,60, 127.65, 127.70, 127.75, 127.9, 128.0, 128.1, 128.3, 128.4, 
128.5 [C-6’, C-2Ar, C-3Ar, C-4Ar], 134.0 (C-7’a), 137.6, 137.8, 138.4, 138.8 [C-1Ar], 
142.2 (C-3’a). 
MS-MALDI-TOF: m/z = 664.0 [M + Na]+.
Anal. calcd for C40H39N3O5: C, 74.86; H, 6.13; N, 6.55. Found: C, 74.81; H, 6.29; 
N, 6.63. 
1H-1,2,3-Benzotriazole-2,3,4,6-tetra-O-benzyl-E-D-glucopyranoside (25E)[213]
Colourless oil; > @ q20
D
D –21.8° (c = 0.5, CHCl3), (Lit.[213] > @ q20DD  –22.8°, (c = 1, CHCl3)).
1H NMR (400 MHz, CDCl3): G= 3.73–3.98 (m, 6 H, H-3, H-4, H-5, H-6, H-CH2), 
4.29–4.34 (m, 2 H, H-2, H-CH2), 4.47 (d, 1 H, J = 12.1 Hz, H-CH2), 4.54 (d, 1 H, J = 
12.1 Hz, H-CH2), 4.67 (d, 1 H, J = 10.6 Hz, H-CH2), 4.89–4.97 (m, 2 H, H-CH2),  
5.96 (d, 1 H, J1-2 = 9.1 Hz, H-1), 6.74 (d, 2 H, J = 7.3 Hz, H-2Ar), 7.01–7.07 (m, 3 H, 
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H-3Ar, H-4Ar), 7.21–7.44 (m, 17 H, H-5’, H-6’, H-2Ar, H-3Ar, H-4Ar), 7.61 (d, 1 H, J = 
8.1 Hz, H-4’), 8.07 (d, 1 H, J = 7.8 Hz, H-7’). 
13C NMR (100 MHz, CDCl3): G= 68.3 (C-6), 73.4, 74.7, 75.2, 75.8 [C-CH2], 77.2 
(C-5), 77.9 (C-4), 79.4 (C-2), 85.5 (C-3), 87.2 (C-1), 110.7 (C-4’), 120.2 (C-7’), 124.3 
(C-5’), 127.56, 127.59, 127.69, 127.74, 127.91, 127.97, 127.99, 128.1, 128.3, 128.6 
[C-6’, C-2Ar,C-3Ar, C-4Ar], 132.3 (C-7’a), 136.6, 137.7, 137.9, 138.1 [C-1Ar], 146.3 
(C-3’a). 
FAB-MS: m/z = 642.1 [M + H]+.
2H-1,2,3-Benzotriazole-2,3,4,6-tetra-O-benzyl-D-D-glucopyranoside (26D)[213]
Colourless oil; > @ q20
D
D +92.4° (c = 0.5, CHCl3), (Lit.[213] > @ q20DD  +93°, (c = 0.5, CHCl3)). 
1H NMR (250 MHz, CDCl3): G= 3.52–8.58 (dd, 1 H, J6a-5 = 1.9, J6a-6b = 11 Hz, H-6a), 
3.72–3.78 (dd, 1 H, J6b-5 = 2.9, J6b-6a = 11 Hz, H-6b), 3.87–3.95 (dd, 1 H, J4-3 = 9.4, 
J4-5 = 9.8 Hz, H-4), 4.09–4.16 (dd, 1 H, J2-1 = 6.0, J2-3 = 9.6 Hz, H-2), 4.41–4.66 (m, 
6 H, H-5, H-CH2), 4.90–5.07 (m, 4 H, H-3, H-CH2), 6.58 (d, 1 H, J1-2 = 6.0 Hz, H-1), 
7.11–7.45 (m, 22 H, H-5’, H-6’, H-2Ar, H-3Ar, H-4Ar), 7.88–7.93 (dd, 2 H, J4’-6’/7’-5’ = 
2.9, J4’-5’/7’-6’ = 6.6 Hz, H-4’, H-7’). 
13C NMR (62.9 MHz, CDCl3): G= 68.1 (C-6), 73.4, 73.6 [C-CH2], 74.3 (C-5), 75.4, 
75.6 [C-CH2], 77.4 (C-4), 78.4 (C-2), 81.5 (C-3), 88.8 (C-1), 118.7 (C-4’, C-7’), 126.8 
(C-5’, C-6’), 127.6 , 127.7, 127.82, 127.89, 127.9, 128.0, 128.1, 128.4, 128.4 [C-2Ar, 
C-3Ar, C-4Ar], 137.2, 137.8, 138.2, 138.8 [C-1Ar], 144.2 (C-3’a, C-7’a). 
FAB-MS: m/z = 642.1 [M + H]+.
2H-1,2,3-Benzotriazole-2,3,4,6-tetra-O-benzyl-E-D-glucopyranoside (26E)[213]
White solid; > @ q20
D
D –33.8° (c = 0.5, CHCl3), (Lit.[213] > @ q20DD  –34.6°, (c = 1, CHCl3)). 
1H NMR (250 MHz, CDCl3): G= 3.74–3.95 (m, 5 H, H-3, H-4, H-5, H-6), 4.06 (d, 1 H, 
J = 10.8 Hz, H-CH2), 4.44–4.57 (m, 4 H, H-2, H-CH2), 4.63 (d, 1 H, J = 10.8, H-CH2),
4.86–5.00 (m, 3 H, H-CH2), 5.93 (d, 1 H, J1-2 = 9.1 Hz, H-1), 6.73–6.77 (m, 2 H, 
H-2Ar), 6.97–7.09 (m, 3 H, H-3Ar, H-4Ar), 7.16–7.34 (m, 15 H, H-2Ar, H-3Ar, H-4Ar), 
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7.38–7.43 (dd, 2 H, J5’-7’/6’-4’ = 2.9, J5’-4’/6’-7’ = 6.6 Hz, H-5’, H-6’), 7.87–7.91 (dd, 2 H, 
J4’-6’/7’-5’ = 2.9, J4’-5’/7’-6’ = 6.6 Hz, H-4’, H-7’). 
13C NMR (62.9 MHz, CDCl3): G= 68.6 (C-6), 73.5, 74.8, 75.2, 75.7 [C-CH2], 77.4 
(C-5), 78.3 (C-4), 80.9 (C-2), 85.7 (C-3), 92.2 (C-1), 118.7 (C-4’, C-7’), 127.2 (C-5’, 
C-6’), 127.6, 127.7, 127.9, 128.0, 128.3, 128.4 [C-2Ar, C-3Ar, C-4Ar], 137.3, 137.8, 
137.9, 138.2 [C-4Ar], 144.5 (C-3’a, C-7’a). 
FAB-MS: m/z = 642.1 [M + H]+.
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4.2.6 Related to Chapter 2.2.8 
Nonafluorobutane1-sulfone acid 1H-1,2,3-benzotriazol-4-yl ester (28b) 
A 1.6 M solution of BuLi in n-hexane (6.25 ml, 10 mmol) was added slowly to a
stirred solution of 1-hydroxy-1H-1,2,3-benzotriazole (27; 1.35 g, 10 mmol) in 
anhydrous THF (50 ml) at 0 °C under argon. After 1 h, nonafluorobutanesulfonyl 
fluoride (2.15 ml, 12 mmol) was added dropwise. The reaction mixture was stirred 
under reflux for ca. 12 h, while the progress of the reaction monitored by TLC. After 
completion of the reaction, the mixture was cooled to room temperature, and diluted 
with Et2O (100 ml). The organic layer was washed with aq sat. NH4Cl solution (2 u
50 ml), and H2O (1 u 50 ml). After drying (Na2SO4), filtration and removal of the 
solvent, the crude product was purified by chromatography on silica gel [eluent: 
petroleum ether/EtOAc, 1:1] and recrystallised from toluene to give 28b; colourless 
needles; yield 1.40 g (33%); mp 202.5–203.5 °C (toluene). 
IR (KBr): 521 w, 571 w, 585 w, 635 w, 652 w, 738 m, 752 m, 788 m, 806 m, 836 w, 
890 m, 992 w, 1006 s, 1035 m, 1061 m, 1128 m, 1145 s, 1195 vs, 1241 s, 1295 w, 
1356 m, 1406 m, 1426 vs, 1448 w, 1592 w, 1637 w, 2898 w, 2960 w, 3020 w, 
3106 m, 3442 cm–1 w. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 211 (10900), 254 (6800), 272 nm (5100). 
1H NMR (250 MHz, DMSO-d6): G= 7.51 (d, 1 H, J5-6 = 7.9 Hz, H-5), 7.60–7.68 (dd, 
1 H, J6-5 = 7.9, J6-7 = 8.1 Hz, H-6), 7.98 (d, 1 H, J7-6 = 8.1 Hz, H-7), 16.35 (s, 1 H, 
H-1) 
13C NMR (62.9 MHz, DMSO-d6): G= 113 (bs, C-7), 115.6 (bs, C-5), 127.4 (bs, C-6). 
MS-EI: m/z = 416.9 [M]+, 389.0 [M – N2]
+, 134.0 [M – C4F9O2S]
+, 106.1 [M – 
C4F9N2O2S]
+.
Anal. calcd for C10H4F9N3O3S: C, 28,79; H, 0,97; N, 10,07; S, 7,69. Found: C, 28.95; 
H, 0.92; N, 10.03; S, 7.70. 
4 Experimental part 
96 
Trifluoromethane-1-sulfone acid 1H-1,2,3-benzotriazol-4-yl ester (29a) 
Method 1 
Pyridine (0.35 ml, 4.3 mmol) was added to a stirred solution of 1-Hydroxy-1H-1,2,3-
benzotriazole (27; 0.5 g, 3.7 mmol) in anhydrous CH2Cl2 (20 ml) at 0 °C under argon. 
After 30 minutes trifluoromethanesulfonyl anhydride (2b; 0.93 ml, 4.3 mmol) was 
added dropwise. The reaction mixture was stirred at 0°C for ca. 30 minutes, while 
the progress of the reaction monitored by TLC. After completion of the reaction, the 
mixture was diluted with CH2Cl2 (100 ml). The organic layer was washed with H2O (2 
u 50 ml). After drying (Na2SO4), filtration and removal of the solvent, the crude 
product was purified by chromatography on silica gel [eluent: petroleum 
ether/EtOAc, 1:1] and recrystallised from petroleum ether/EtOAc to give 29a; yield 
0.41 g (41%). 
Method 2 
Na2CO3 (0.41 ml, 3.8 mmol) was added to a stirred solution of 1-Hydroxy-1H-1,2,3-
benzotriazole (27; 0.5 g, 3.7 mmol) in anhydrous CH2Cl2 (20 ml) at 0 °C under argon. 
After 30 minutes trifluoromethanesulfonyl anhydride (2b; 0.93 ml, 4.3 mmol) was 
added dropwise. The reaction mixture was stirred at 0°C for ca. 30 minutes, while 
the progress of the reaction monitored by TLC. After completion of the reaction, the 
mixture was diluted with CH2Cl2 (100 ml). The organic layer was washed with H2O (2 
u 50 ml). After drying (Na2SO4), filtration and removal of the solvent, the crude 
product was purified by chromatography on silica gel [eluent: petroleum 
ether/EtOAc, 1:1] and recrystallised from petroleum ether/EtOAc to give 29a; yield 
0.49 g (49%). 
Colourless needles; mp 200.5–201.5 °C (Dec.; petroleum ether/EtOAc). 
IR (KBr): 520 vw, 561 vw, 590 w, 691 vw, 755 w, 766 , 804 w, 825 s, 883 m, 906 vw, 
992 w, 1006 w, 1041 vw, 1062 w, 1140 vs, 1205 vs, 1272 w, 1311 vw, 1384 w, 
1404 w, 1426 vs, 1448 w, 1592 w, 1635 w, 1360 vw, 1843 w, 2896 w, 2959 w, 
3017w , 3105 m, 3423 cm–1 w. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 210 (8800), 254 (6200), 272 nm (4400). 
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1H NMR (400 MHz, DMSO-d6): G= 7.48 (d, 1 H, J5-6 = 7.8 Hz, H-5), 7.60–7.68 (dd, 
1 H, J6-5 = 7.8, J6-7 = 8.0 Hz, H-6), 7.94 (d, 1 H, J7-6 = 8.0 Hz, H-7), 15.09 (s, 0.7 H, 
H-1). 
13C NMR (62.9 MHz, DMSO-d6): G= 112.0 (bs, C-7), 116.0 (bs, C-5), 118.8 (d, JC-F = 
320 Hz, CF3), 128.0 (bs, C-6). 
MS-EI: m/z = 267.1 [M]+, 239.1 [M – N2]
+, 134.2 [M – CF3O2S]
+, 106.2 [M – 
CF3N2O2S]
+.
Anal. calcd for C7H4F3N3O3S: C, 31,47; H, 1,51; N, 15,73 ; S, 12,00. Found: 
C, 31.34; H, 1.43; N, 15.65; S, 11.84. 
General procedure for the synthesis of 1-hydroxy-1H-benzotriazoles 
A o-chloronitrobenzene derivative (0.1 mol) and hydrazine hydrate (15 g, 0.3 mol) 
were dissolved in 50 ml EtOH. The reaction mixture was stirred under reflux for 24 h. 
After completion of the reaction, the mixture was cooled to room temperature, and 
diluted with H20 (200 ml). Concentrated HCl was then added until pH 1. The formed 
solid was filtered and recrystallised with EtOH/H2O (1:1) Containging 5% of toluene 
to give the corresponding 1-hydroxy-1H-benzotriazole. 
1-Hydroxy-5-methyl-1H-1,2,3-benzotriazole (31a)[232]
Prepared from 3-chloro-4-nitrotoluene (30a, 5 ml, 30 mmol). Colourless needles; 
yield: 3.56 g (82%); mp 183–184 °C (dec.; EtOH/H2O/toluene); (Lit.
[232] mp 191 °C, 
(EtOH)). 
IR (KBr): 620 m, 635 m, 699 s, 768 vs, 793 vs, 825 s, 871 vw, 929 s, 1037 m, 
1098 s, 1144 vs, 1171 s, 1219 m, 1279 s, 1347 vs, 1377 vs, 1455 m, 1621 s, 1850 s, 
2493 s, 2924 w, 2956 w, 3068 w, 3103 w, 3434 cm–1 vw. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 211 (19500), 259 (5500), 292 nm (4100). 
1H NMR (250 MHz, MeOD-d4): G= 2.38 (s, 3 H, H-CH3), 7.28 (d, 1 H, J6-7 = 6.9 Hz, 
H-6), 7.36 (s, 1 H, H-4), 7.45 (d, 1 H, J7-6 = 6.9 Hz, H-7). 
13C NMR (62.9 MHz, MeOD-d4): G= 21.6 (C-CH3), 126.7 (C-7a), 127.1 (C-7), 130.5 
(C-5), 132.3 (C-4), 132.9 (C-6), 141.6 (C-3a). 
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MS-EI: m/z = 149.1 [M]+.
Anal. calcd for C7H7N3O: C, 56.37; H, 4.73; N, 28.17. Found: C, 56.51; H, 4.72; 
N, 28.05. 
1-Hydroxy-6-methyl-1H-1,2,3-benzotriazole (31b)[233]
Prepared from 4-chloro-3-nitrotoluene (30b). Colourless needles; yield: 11.7 g 
(79%); mp 181–182 °C (dec.; EtOH/H2O/toluene); (Lit.
[233] mp 188–189 °C, (H2O)). 
IR (KBr): 623 vw, 710 w, 782 m, 809 vs, 936 s, 995 w, 1039 w, 1092 s, 1140 w, 
1174 s, 1229 w, 1241 m, 1267 s, 1347 m, 1388 s, 1457 m, 1618 s, 2598 s, 2925 w, 
3071 w, 3415 cm–1 s. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 212 (18500), 268 nm (5800). 
1H NMR (400 MHz, DMSO-d6): G= 2.39 (s, 3 H, H-CH3), 7.14 (d, 1 H, J5-6 = 8.3 Hz, 
H-5), 7.40 (s, 1 H, H-7), 7.45 (d, 1 H, J4-5 = 8.3 Hz, H-4) 
13C NMR (100 MHz, DMSO-d6): G= 22.2 (C-CH3), 109.2 (C-7), 119.6 (C-5), 127.7 
(C-4), 129.1 (C-7a), 138.6 (C-6), 142.4 (C-3a) 
MS-EI: m/z = 149.1 [M]+.
Anal. calcd for C7H7N3O: C, 56.37; H, 4.73; N, 28.17. Found: C, 56.19; H, 4.76; 
N, 28.15. 
4-Chloro-1-hydroxy-1H-1,2,3-benzotriazole (31c)[222]
Prepared from 2,3-dichloronitrobenzene (30c). Colourless needles; yield: 15.5 g 
(92%); mp 171–172 °C (dec.; EtOH/H2O/toluene), (Lit.
[222] mp 170–172 °C, (EtOH)). 
IR (KBr): 556 w, 735 s, 769 s, 786 s, 864 s, 894 vw, 926 w, 965 w, 1140 w, 1158 m, 
1169 m, 1201 m, 1230 w, 1255 vw, 1288 s, 1365 vs, 1390 vs, 1434 m, 1476 w, 
1492 w, 1522 w, 1605 w, 1617 w, 1871m, 2434 m, 2693 m, 3093 m, 3314 cm–1 s.
UV/Vis (THF): O (Hmolí1dm3cmí1) = 211 (18100), 262 (5500), 270 (4600), 288 nm 
(4600).
1H NMR (400 MHz, DMSO-d6): G= 7.36–7.42 (m, 1 H, H-5, H-6), 7.54–7.60 (dd, 1 H, 
J7-5 = 3.6, J7-6 = 5.6 Hz, H-7), 13.92 (s, 1 H, OH). 
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13C NMR (100 MHz, DMSO-d6): G= 109.4 (C-7), 123.8 (C-4), 124.6 (C-6), 128.6 
(C-5), 129.8 (C-7a), 140.6 (C-3a). 
MS-EI: m/z = 169.1 [M]+.
Anal. calcd for C6H4ClN3O: C, 42.50; H, 2.38; N, 24.78. Found: C, 42.62; H, 2.51; 
N, 25.23. 
6-Chloro-1-hydroxy-1H-1,2,3-benzotriazole (31d)[234]
Prepared from 2,5-dichloronitrobenzene (30d). Colourless needles; Yield: 14.4 g 
(86%); mp 197–198 °C (dec.; EtOH/H2O/toluene); (Lit.
[234] mp 195 °C, (H2O/EtOH)). 
IR (KBr): 604 w, 639 w, 670 m, 753 vs, 775 m, 813 vs, 856 m, 912 vs, 961 vw, 
1038 m, 1134 w, 1152 w, 1177 s, 1211 vs, 1241 m, 1295 vs, 1346 vs, 1388 vs, 
1437 vs, 1475 s, 1609 m, 1710 s, 2515 s, 3104 m, 3158 vw, 3418 cm–1 w. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 214 (26300), 271 nm (6300). 
1H NMR (250 MHz, DMSO-d6): G= 7.37–7.41 (dd, 1 H, J5-7 = 1.9, J5-4 = 8.8 Hz, H-5), 
7.82–7.85 (dd, 1 H, J7-4 = 1, J7-5 = 1.9 Hz, H-7), 7.97–8.02  (dd, 1 H, J7-5 = 1, J7-6 = 
8.8 Hz, H-4), 13.76 (s, 1 H, OH) 
13C NMR (62.9 MHz, DMSO-d6): G= 109.6 (C-7), 121.4 (C-4), 125.8 (C-5), 128.8 
(C-6), 132.9 (C-7a), 142.0 (C-3a) 
MS-EI: m/z = 169.1 [M]+.
Anal. calcd for C6H4ClN3O: C, 42.50; H, 2.38; N, 24.78. Found: C, 42.95; H, 2.47; 
N, 24.65. 
1-Hydroxy-6-trifluoromethyl-1H-1,2,3-benzotriazole (31e)[232]
Prepared from 4-chloro-3-nitro-benzotrifluoride (30e). Colourless needles; Yield: 
17.87 g (88%); mp 145–146 °C (dec.; toluene); (Lit.[232] mp 148–149 °C, (H2O)). 
IR (KBr): 547 w, 596 w, 617 w, 645 vw, 670 vw, 736 s, 765 s, 806 m, 822 m, 895 s, 
921 s, 1036 m, 1145 vs, 1166 vs, 1218 m, 1250 s, 1316 vs, 1361 vs, 1406 m, 
1445 m, 1631 m, 1780 w, 2362 m, 2547 m, 3106 w, 3432 cm–1 vw. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 211 (22100), 243 (6100), 292 nm (3800). 
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1H NMR (400 MHz, DMSO-d6): G= 7.62 (d, 1 H, J5-4 = 8.9 Hz, H-5), 8.12 (s, 1 H, 
H-7), 8.17 (d, 1 H, J4-5 = 8.9 Hz, H-4), 13.69 (s, 0.5 H, OH) 
13C NMR (62.9 MHz, DMSO-d6): G= 108.8 (q, J7-F = 4.4 Hz, C-7), 121.1 (q, J5-F = 
3.5 Hz, C-5), 121.4 (C-4), 124.4 (q, J7-F = 272 Hz, C-CF3), 127.5 (C-7a), 128.2 (q, 
J6-F = 32 Hz, C-6), 144.5 (C-3a). 
MS-EI: m/z = 203.1 [M]+.
Anal. calcd for C7H4F3N3O: C, 41.39; H, 1.98; N, 20.69. Found: C, 41.39; H, 1.90; 
N, 20.41. 
5,7-Dichloro-1-hydroxy-1H-1,2,3-benzotriazole (31f) 
Prepared from 1,3,5-trichloro-2-nitrobenzene (30f, 2.25 g, 0.01 mmol) in MeOH. 
Colourless needles; Yield: 1.31 g (64%); mp 184–185 °C (dec.; toluene). 
IR (KBr): 641 vw, 685 w, 746 w, 805 w, 831 m, 849 vs, 867 w, 877 m, 1003 s, 
1076 m, 1120 vs, 1167 vs, 1210 w, 1226 m, 1262 w, 1273 vw, 1353 vs, 1379 m, 
1402 vs, 1475 m, 1521 m, 1588 s, 2342 m, 2361 vw, 3081 vw, 3094 , 3453 cm–1 m. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 217 (28200), 262 (5300), 271 (4600), 303 nm 
(4300).
1H NMR (250 MHz, DMSO-d6): G= 7.73 (s, 1 H, H-6), 8.13 (s, 1 H, H-4), 14.09 (s, 
1 H, OH) 
13C NMR (62.9 MHz, DMSO-d6): G= 116.6 (C-7), 118.5 (C-4), 124.5 (C-5), 128.5 
(C-6), 129.6 (C-7a), 145.0 (C-3a) 
MS-EI: m/z = 203.0 [M]+.
Anal. calcd for C6H3Cl2N3O: C, 35.32; H, 1.48; N, 20.60. Found: C, 35.54; H, 1.46; 
N, 20.54. 
General procedure for the synthesis of substituted 1H-1,2,3-benzotriazoles 
Na2CO3 (1 mmol) was added to a stirred solution of a 1-Hydroxy-1H-1,2,3-
benzotriazole derivative (1 mmol) in anhydrous CH2Cl2 (20 ml) at –78 °C under 
argon. Trifluoromethanesulfonyl anhydride (1.2 mmol) was added dropwise. The 
reaction mixture was heated till room temterature and stirred for the given time 
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(see below), while the progress of the reaction monitored by TLC. Without workup 
the crude product was purified by chromatography on silica gel [eluent: petroleum 
ether/EtOAc, 1:1] and recrystallised from petroleum ether/EtOAc. 
Reaction with 1-Hydroxy-1H-1,2,3-benzotriazole (27) 
Amount: 500 mg (3.7 mmol) of 27. Reaction time: 12 h. 2 Products isolated as a 
mixture. White solid; Yield: 920 mg [93%; 29a/29b, 66:33 (NMR)] 
Trifluoromethane-1-sulfone acid 1H-1,2,3-benzotriazol-6-yl ester (29b) 
1H NMR (250 MHz, DMSO-d6): G= 7.58 (dd, 1 H, J6-4 = 2.2, J6-7 = 9.0 Hz, H-6), 7.60–
7.68 (m, 2 H, H-4, H-7). 
13C NMR (62.9 MHz, DMSO-d6): G= 108.6 (bs, C-4), 116.6 (bs, C-7), 118.6 (d, JC-F = 
320 Hz, CF3), 119.7 (bs, C-6). 
MS-EI: m/z = 267.1 [M]+, 239.1 [M – N2]
+, 134.2 [M – CF3O2S]
+, 106.2 [M – 
CF3N2O2S]
+.
Reaction with 1-Hydroxy-5-methyl-1H-1,2,3-benzotriazole (29a) 
Amount: 100 mg (0.67 mmol) of 31a.[232] Reaction time: 12 h. 2 Products isolated as 
a mixture. White solid; Yield: 170 mg [90%; 31a/32b, 55:45 (NMR)]. 
Trifluoromethane-1-sulfone acid 6-methyl-1H-1,2,3-benzotriazol-4-yl ester (32a) 
1H NMR (250 MHz, Acetone-d6): G= 2.56 (s, 3 H, CH3), 7.31 (s, 1 H, H-5), 7.69 (s, 
1 H, H-7), 14.93 (bs, 0.5 H, H-1). 
13C NMR (62.9 MHz, Acetone-d6): G= 20.7 (C-CH3), 110.8 (bs, C-7), 117.8 (bs, C-5), 
118.8 (d, JC-F = 320 Hz, CF3).
MS-FAB: m/z = 281.9 [M + H]+.
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Trifluoromethane-1-sulfone acid 5-methyl-1H-1,2,3-benzotriazol-4-yl ester (32b) 
1H NMR (250 MHz, Acetone-d6): G= 2.53 (s, 3 H, H-CH3), 7.58 (d, 1 H, J6-7 = 8.5 Hz, 
H-6), 7.90 (d, 1 H, J7-6 = 8.5 Hz, H-7), 14.98 (bs, 0.75 H, H-1). 
13C NMR (62.9 MHz, Acetone-d6): G= 14.9 (C-CH3), 111.2 (bs, C-7), 118.7 (d, JC-F = 
320 Hz, CF3), 131.1 (bs, C-6). 
MS-FAB: m/z = 281.9 [M + H]+.
Reaction with 1-Hydroxy-6-methyl-1H-1,2,3-benzotriazole (32b) 
Amount: 500 mg (3.3 mmol) of 31b.[233] Reaction time: 12 h. 2 Products isolated as a 
mixture. White solid; Yield: 820 mg [88%; 32b/32c, 70:30 (NMR)]. 
Trifluoromethane-1-sulfone acid 5-methyl-1H-1,2,3-benzotriazol-6-yl ester (32c) 
1H NMR (600 MHz, Acetone-d6): G=2.53 (s, 3 H, CH3), 8.01 (s, 1 H, H-4), 7.90 (s, 
1 H, H-7). 
13C NMR (62.9 MHz, Acetone-d6): G= 16.4 (C-CH3), 108.8 (bs, C-7), 116.1 (bs, C-4), 
118.7 (d, JC-F = 320 Hz, CF3). 
MS-FAB: m/z = 281.9 [M + H]+.
Reaction with 4-chloro-1-Hydroxy-1H-1,2,3-benzotriazole (31c) 
Amount: 500 mg (2.95 mmol) of 31c.[222] Reaction time: 24 h. 2 Products. Yield: 470 
mg 33a + 310 mg 33b [88%; 33a:33b, 60:40]. 
1.Fraction 
Trifluoromethane-1-sulfone acid 7-chloro-1H-1,2,3-benzotriazol-4-yl ester (33a) 
Colourless solid; mp 94.5–96 °C (petroleum ether/EtOAc). 
IR (KBr): 573 m, 593 s, 630 s, 666 m, 707 m, 770 m, 828 vs, 847 vs, 951 m, 970 m, 
1013 s, 1057 s, 1090 m, 1135 vs, 1216 vs, 1251 vs, 1286 s, 1381 m, 1433 vs, 
1514 vs, 1580 vw, 1630 w, 2847 s, 2935 s, 2997 s, 3088 s, 3416 cm–1 m. 
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UV/Vis (THF): O (Hmolí1dm3cmí1) = 211 (23500), 257 (8300), 264 (8100), 282 nm 
(8200). 
1H NMR (250 MHz, Acetone-d6): G= 7.57 (d, 1 H, J6-7 8.2 Hz, H-6), 7.70 (d, 1 H, 
J7-6 = 8.2 Hz, H-7). 
13C NMR (62.9 MHz, Acetone-d6): G= 118.2 (bs, C-7), 118.8 (q, JC-F = 320 Hz, 
C-CF3), 126.6 (bs, C-7). 
MS-FAB: m/z = 301.9 [M + H]+.
Anal. calcd for C7H3ClF3N3O3S: C, 27,87; H, 1,00; N, 13,93; S, 10,63. Found: 
C, 28.01; H, 1.03; N, 13.67; S, 10.60. 
2.Fraction 
Trifluoromethane-1-sulfone acid 7-chloro-1H-1,2,3-benzotriazol-6-yl ester (33b) 
Colourless solid; mp 173–174 °C (dec.; petroleum ether/EtOAc). 
IR (KBr): 547 vw, 576 vw, 605 s, 632 m, 658 vw, 679 w, 739 m, 768 vw, 815 m, 
846 s, 952 s, 1005 m, 1035 w, 1099 w, 1131 vs, 1211 vs, 1307 vw, 1372 vw, 
1390 w, 1424 vs, 1460 w, 1508 vw, 1592 vw, 1618 w, 2803 m, 2936 w, 2987 w, 
3030 w, 3074 w, 3416 cm–1 w. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 212 (25700), 255 (8200), 261 (7600), 282 nm 
(5500). 
1H NMR (250 MHz, Acetone-d6): G= 7.66 (d, 1 H, J5-4 = 9.0 Hz, H-5), 8.06 (d, 1 H, 
J4-5 = 9.0 Hz, H-4), 15.38 (bs, 0.2 H, H-1). 
13C NMR (62.9 MHz, Acetone-d6): G= 118.7 (d, JC-F = 320 Hz, C-CF3), 121.3 (bs, 
C-4, C-5). 
MS-FAB: m/z = 301.9 [M + H]+.
Anal. calcd for C7H3ClF3N3O3S: C, 27,87; H, 1,00; N, 13,93; S, 10,63. Found: 
C, 28.15; H, 0.98; N, 13.68; S, 10.64. 
Reaction with 6-chloro-1-Hydroxy-1H-1,2,3-benzotriazole (31d) 
Amount: 500 mg (2.95 mmol) of 31d.[234] Reaction time: 24 h. 2 Products. Yield: 310 
mg 34a + 470 mg 34b [75%; 34a:34b, 40:60]. 
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1. Fraction 
Trifluoromethane-1-sulfone acid 5-chloro-1H-1,2,3-benzotriazol-6-yl ester (34a) 
Colourless solid; mp 194–195.5 °C (dec.; petroleum ether/EtOAc). 
IR (KBr): 518 w, 568 w, 583 m, 613 vs, 667 m, 708 w, 747 s, 776 w, 812 m, 893 vs, 
983 m, 1007 vs, 1100 m, 1134 vs, 1210 vs, 1248 vs, 1272 m, 1299 s, 1361 w, 
1404 s, 1429 vs, 1455 m, 1493 w, 1586 vw, 1629 w, 1737 vw, 2784 s, 2850 s, 
2941 s, 3023 m, 3104 s, 3423 cm–1 w. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 212 (38100), 251 (8100), 285 nm (6200). 
1H NMR (250 MHz, Acetone-d6): G= 8.25 (s, 1 H, H-4), 8.31 (s, 1 H, H-7). 
13C NMR (62.9 MHz, Acetone-d6): G= 110.6 (bs, C-7), 116.7 (bs, C-4), 118.7 (d, 
JC-F = 320 Hz, CF3).
MS-FAB: m/z = 301.9 [M + H]+.
Anal. calcd for C7H3ClF3N3O3S: C, 27,87; H, 1,00; N, 13,93; S, 10,63. Found: 
C, 28.30; H, 0.94; N, 13.82; S, 10.64. 
2.Fraction 
Trifluoromethane-1-sulfone acid 5-chloro-1H-1,2,3-benzotriazol-4-yl ester (34b) 
Colourless solid; mp 215.1– 215.4 °C (dec.; petroleum ether/EtOAc). 
IR (KBr): 514 vw, 530 vw, 568 w, 603 m, 641 s, 686 vw, 728 w, 765 vw, 824 m, 
840 vs, 916 s, 1010 m, 1071 m, 1138 vs, 1211 vs, 1237 s, 1268 vw, 1310 vw, 
1372 m, 1387 m, 1428 vs, 1445 m, 1499 vw, 1586 w, 1619 w, 2940 w, 3109 m, 
3416 cm–1 m. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 211 (24300), 254 (6700), 285 nm (4600). 
1H NMR (250 MHz, Acetone-d6): G= 7.74 (d, 1 H, J6-7 = 8.9 Hz, H-6), 8.01 (d, 1 H, 
J7-6 = 8.9 Hz, H-7). 
13C NMR (62.9 MHz, Acetone-d6): G= 114.2 (C-7), 118.7 (d, JC-F = 320 Hz, C-CF3), 
128.8 (C-7). 
MS-FAB: m/z = 301.9 [M + H]+.
Anal. calcd for C7H3ClF3N3O3S: C, 27,87; H, 1,00; N, 13,93; S, 10,63. Found: 
C, 28.28; H, 1.15; N, 13.67; S, 10.58. 
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Reaction with 1-Hydroxy-6-trifluoromethyl-1H-1,2,3-benzotriazole (31e) 
Amount: 500 mg (2.17 mmol) of 31e.[233] Reaction time: 36 h. 3 Products isolated as 
a mixture. Yield: 650 mg [89%; 35a/35b/35c (20:40:40); (HPLC)]. For analytical 
purpose 100 mg were separated by preparative HPLC. 
1. Fraction 
Trifluoromethane-1-sulfone acid 5-trifluromethyl-1H-1,2,3-benzotriazol-7-yl 
ester (35a) 
Colourless solid; mp 164–165 °C (dec.; petroleum ether/EtOAc). 
IR (KBr): 508 vw, 543 vw, 570 vw, 588 w, 606 w, 648 vw,663 vw, 681 vw, 703 w, 
764 w, 794 w, 820 m, 888 m, 927 m, 985, w, 1005 w, 1067 w, 1092 m, 1122 m, 
1132 s, 1147 vs, 1193 m, 1221 vs, 1248 vs, 1352 s, 1386 w, 1420 s, 1443 s, 1524w, 
1600 vw, 1646 vw, 3095 w, 3454 cm–1 m. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 211 (22200), 242 (8100), 277 nm (4300). 
1H NMR (250 MHz, Acetone-d6): G= 7.87 (s, 1 H, H-6), 8.49 (s, 1 H, H-4). 
13C NMR (62.9 MHz, Acetone-d6): G= 113.0 (bs, C-4), 114.0 (bs, C-6), 118.8 (q, 
JC-F = 320 Hz, C-CF3). 
MS-FAB: m/z = 335.9 [M + H]+.
Anal. calcd for C8H3F6N3O3S: C, 28,67; H, 0,90; N, 12,54; S, 9,57. Found: C, 29.13; 
H, 0.80; N, 11.76; S, 9.02. 
2. Fraction 
Trifluoromethane-1-sulfone acid 5-trifluromethyl-1H-1,2,3-benzotriazol-6-yl 
ester (35b) 
Colourless solid; mp 167–168.5 °C (dec.; petroleum ether /EtOAc). 
IR (KBr): 518 vw, 571 vw, 587 vw, 645 m, 664 vw, 724 w, 748 vw, 769 w, 817 w, 
871 s, 884 s, 915 m, 1008 m, 1133 vs, 1169 s, 1213 vs, 1241 vs, 1259 s, 1288 w, 
1336 m, 1379 w, 1408 vs, 1497 w, 1605 w, 1641 w, 2798 w, 2857 w, 2957 w, 
3073 w, 3417 cm–1 w. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 211 (28700), 246 (7100), 275 nm (4600). 
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1H NMR (250 MHz, Acetone-d6): G= 8.27 (s, 1 H, H-7), 8.62 (s, 1 H, H-4). 
13C NMR (62.9 MHz, Acetone-d6): G= 109.2 (C-7), 117.8 (bs, C-4), 118.5 (d, JC-F = 
320 Hz, C-CF3), 122.6 (d, JC-F = 272 Hz, C-CF3).
MS-FAB: m/z = 335.9 [M + H]+.
Anal. calcd for C8H3F6N3O3S: C, 28,67; H, 0,90; N, 12,54; S, 9,57. Found: C, 28.66; 
H, 0.82; N, 11.87; S, 9.13. 
3.Fraction 
Trifluoromethane-1-sulfone acid 5-trifluromethyl-1H-1,2,3-benzotriazol-4-yl 
ester (35c) 
Colourless solid; mp 168–169.5 °C (dec.; petroleum ether /EtOAc) 
IR (KBr): 520 vw, 579 w, 633 m, 651 vw, 685 w, 694 w, 760 m, 832 s, 916 s, 989 vw, 
1008 w, 1072 m, 1090 w, 1113 m, 1132 s, 1148 s, 1177 m, 1190 s, 1212 vs, 1235 s, 
1332 vs, 1375 m, 1416 s, 1430 s, 1514 w, 1569 vw, 1594 w, 1638 m, 3133 m, 
3415 cm–1 w. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 211 (24400), 245 nm (8100). 
1H NMR (250 MHz, Acetone-d6): G= 7.92 (d, 1 H, J6-7 = 8.6 Hz, H-6), 8.62 (s, 1 H, 
J7-6 = 8.6 Hz, H-7). 
13C NMR (62.9 MHz, Acetone-d6): G= 113.6 (C-7), 118.7 (d, JC-F = 318 Hz, C-CF3), 
124.5 (bs, C-4). 
MS-FAB: m/z = 335.9 [M + H]+.
Anal. calcd for C8H3F6N3O3S: C, 28,67; H, 0,90; N, 12,54; S, 9,57. Found: C, 29.13; 
H, 0.98; N, 12.29; S, 9.06. 
Reaction with 5,7-dichloro-1-hydroxy-1H-1,2,3-benzotriazole (31f) 
Amount: 500 mg (2.45 mmol) of 31f. Reaction time: 12 h. Yield: 620 mg (73%).  
4 Experimental part 
107 
Trifluoromethane-1-sulfone acid 4,6-dichloro-1H-1,2,3-benzotriazol-7-yl ester 
(36)
Colourless solid; mp 75–76 °C (petroleum ether/EtOAc). 
IR (KBr): 509 w, 540 vw, 568 vw, 603 s, 627 m, 650 m, 706 w, 768 w, 810 m, 835 vs, 
881 vw, 973 m, 1011 m, 1078 m, 1135 s, 1213 vs, 1293 w, 1368 vw, 1433 vs, 
1499 s, 1587 w, 1618 w, 1637 w, 2857 m, 2924 m, 3089 m, 3415 m, 3476 m, 
3551 cm–1 w. 
UV/Vis (THF): O (Hmolí1dm3cmí1) = 212 (32900), 260 (7800), 269 (7700), 290 nm 
(6300). 
1H NMR (250 MHz, Acetone-d6): G= 7.88 (s, 1 H, H-5). 
13C NMR (62.9 MHz, Acetone -d6): G= 118.6 (q, JC-F = 320 Hz, C-CF3), 127.7 (bs, 
C-5). 
MS-FAB: m/z = 335.8 [M + H]+.
Anal. calcd for C7H2Cl2F3N3O3S: C, 25,02; H, 0,60; N, 12,50; S, 9,54. Found: 
C, 25.52; H, 0.65; N, 12.26; S, 9.45. 
Reaction with 1-Hydroxy-7-aza-1H-1,2,3-benzotriazole 
Amount: 100 mg (0.73 mmol) of 31g. Reaction time: 48 h. The isolation of the active 
ester was not possible. 
Nonafluorobutane-1-sulfonic acid 1-(nonafluorobutane-1-sulfonyl)-1H-1,2,3-
benzotriazol-4-yl ester (37) 
A 2.5 M solution of BuLi in n-hexane (0.5 ml, 1.3 mmol) was added slowly to a stirred 
solution of nonafluorobutane-1-sufonic acid-1H-1,2,3-benzotriazol-4-yl ester (28b;
1.8 g, 15 mmol) in anhydrous dimethoxymethane (10 ml) at 0 °C under argon. After 
1 h, nonafluorobutanesulfonyl fluoride (2a; 0.4 ml, 2.2 mmol) was added dropwise. 
The reaction mixture was stirred under reflux for ca. 3 h, while the progress of the 
reaction monitored by TLC. After completion of the reaction, the mixture was cooled 
to room temperature, and diluted with Et2O (20 ml). The organic layer was washed 
with aq sat. NH4Cl solution (2 u 10 ml), and H2O (1 u 10 ml). After drying (Na2SO4),
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filtration and removal of the solvent, the crude product was purified by 
chromatography on silica gel under protection from light [eluent: petroleum 
ether/EtOAc, 4:1] to give 37; yelowish solid; yield: 0.26 g (31%); mp 83–84 °C 
(petroleum ether/EtOAc). 
IR (KBr): 515 w, 532 vw, 550 vw, 586 w, 622 w, 653 w, 663 m, 678 vw, 741 w, 
754 vw, 789 w, 804 m, 835 vw, 895 vw, 915 vw, 948 vw, 1009 m, 1037 w, 1112 w, 
1142 vs, 1202 vs, 1231 s, 1261 m, 1300 w, 1329 w, 1355 m, 1415 vs, 1445 s, 
1495 w, 1593 vw, 1620 vw, 2924 m, 3418 m.  
1H NMR (250 MHz, CDCl3): G= 7.48 (d, 1 H, J5-6 = 7.9 Hz, H-5), 7.72–7.80 (dd, 1 H, 
J6-5 = 7.9, J6-7 = 8.4  Hz, H-6), 7.91 (d, 1 H, J7-6 = 8.4 Hz, H-7). 
13C NMR (62.9 MHz, CDCl3): G= 111.3 (C-7),119.0 (C-5), 132.1 (C-6), 133.6 (C-7a), 
137.5 (C-4), 139.6 (C-3a). 
MS-EI: m/z = 698.8 [M]+, 479.9 [M – C4F9]
+.
Nonafluoro-butane-1-sulfonic acid 2-(2-hydroxy-phenylazo)-3-(nonafluoro-
butane-1-sulfonylamino)-phenyl ester (38) 
NaH (20 mg, 60% suspension in oil) was added to a stirred solution of phenol (7a,
45 mg, 0.48 mmol) and nonafluorobutane-1-sulfonic acid 1-(nonafluorobutane-1-
sulfonyl)-1H-1,2,3-benzotriazol-4-yl ester (37; 150 mg, 0.21 mmol) in anhydrous 
toluene (10 ml) at room temperature under argon. The mixture was stirred for 7 h. 
while controlling the progress of the reaction by TLC. At the end of this period, 
EtOAc (20 ml) and H2O (10 ml) were added and the suspension was treated with 
conc. HCl, till the colour of the organic phase changed from red to orange-red. The 
aqueous phase must remain colourless during this time. The organic phase was 
separated, dried (Na2SO4), filtered, and the solvent was evaporated. The crude 
product was purified by chromatography over silica gel [eluent: petroleum 
ether/EtOAc (30:1) containing 1% AcOH] to give 38; orange solid; yield: 0.1 g (60%); 
mp 118–120 °C (petroleum ether/EtOAc). 
IR (KBr): 507 w, 532 vw , 548 vw, 571 w, 585 m, 616 vw, 652 vw, 696 m, 730 m, 
771 m, 799 m, 839 vw, 858 vw, 847 vw, 916 vw, 936 w, 1037 s, 1125 m, 1148 vs, 
4 Experimental part 
109 
1200 vs, 1238 vs, 1353 s, 1428 vs, 1469 vs, 1572 m, 1617 m, 1958 vw, 2360 vw, 
2854 vw, 2925 vw, 2963 vw, 3443 cmí1 w. 
UV/Vis (): O (Hmolí1dm3cmí1) = 247 (10200), 327 (11200), 398 nm (8400). 
1H NMR (250 MHz, CDCl3): G= 710–7.20 (m, 2 H, H-3’, H-5’), 7.35 (d, 1 H, J4-5 = 8.6 
Hz, H-4), 7.45–7.59 (m, 2 H, H-5, H-4’), 7.74–780 (dd, 1 H, J6’-4’ = 1.7, J6’-5’ = 8.6 Hz, 
H-6’), 7.92 (d, 1 H, J4-5 = 8.6 Hz, H-6), 11.21 (bs, 1 H, H-NH), 12.86 (s, 1 H, OH).) 
13C NMR (62.9 MHz, CDCl3): G= 118.8 (C-4), 119.5 (C-3’), 119.8 (C-6), 121.4 (C-5’), 
130.1 (C-3), 131.4 (C-1’), 132.5 (C-6’), 132.9 (C-5), 136.4 (C-2), 136.5 (C-4’), 147.2 
(C-1), 153.0 (C-2’). 
MS-EI: m/z = 793.0 [M]+, 510.1 [M – SO2C4F9]
+, 227.2 [M – S2O4C8F18]
+.
HRMS: calcd for C20H9F18N3O6S2: M = 792.96769. Found: m/z = 792.96443. 
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4.2.7 Related to Chapter 2.3.2 
3,4-Dicyanophenyl-2,3,4,6-tetra-O-benzyl-D/E-D-glucopyranoside (38D/38E)
Method 1 
NaH (280 mg, 7 mmol, 60% suspension in oil) was added to a stirred solution of 
2,3,4,6-tetra-O-benzyl-D/E-D-glucopyranose (1;[116] 3.80 g, 7.0 mmol) and 4-nitro-
phthalonitrile (40; 1.33 g, 7.7 mmol) in dry DMF (25 ml) under argon. The mixture 
was stirred for 2 h. At the end of this period, the reaction was poured into H2O (200 
ml) and CH2Cl2 (100 ml). The aqueous layer was extracted with CH2Cl2 (3 u 50 ml). 
The combined organic layers were washed with H2O (3 u 50 ml). After drying 
(Na2SO4), filtration and removal of the solvent, the crude product was purified by 
chromatography on silica gel [eluent: toluene/acetone, 10:1] to give (38D/38E); yield: 
4.63 g [99%; D/E, 95:5 (HPLC)]. 
Method 2
NaH (9 mg, 0.22 mmol, 60% suspension in oil) was added to a stirred solution of 
2,3,4,6-tetra-O-benzyl-D/E-D-glucopyranose (1;[116] 100 mg, 0.18 mmol) and 4-nitro-
phthalonitrile (40; 38 mg, 0.22 mmol) in dry THF (5 ml) under argon. The mixture 
was stirred for 2 h. At the end of this period, the reaction was poured into H2O
(15 ml) and Et2O (25 ml). The mixture was cooled to room temperature, and diluted 
with Et2O (25 ml). The organic layer was washed with aq sat. NH4Cl solution (2 u
15 ml), and H2O (1 u 15 ml). After drying (Na2SO4), filtration and removal of the 
solvent, the crude product was purified by chromatography on silica gel [eluent: 
toluene/acetone, 10:1] to give (41D/41E); yield: 117 g [98%; D/E, 1:2 (HPLC)]. 
D-Isomer (41D)
Colorless oil; > @ q20
D
D  +132.7 (c = 1.0, CHCl3).  
1H NMR (250 MHz, CDCl3): G= 3.51–3.59 (m, 1 H, H-6a), 3.64–3.83 (m, 5 H, H-2, 
H-3, H-4, H-5, H-6b), 4.08–4.18 (dd,1 H, J3-4 = 8.6, J3-2 = 9.4 Hz, H-3), 4.38–4.65 (m, 
4 H, H-CH2), 4.81–4.93 (m, 3 H, H-CH2), 5.03 (d, 1 H, J = 10.8 Hz, H-CH2), 5.37 (d, 
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1 H, J1-2 = 3.4 Hz, H-1), 7.11–7.17 (m, 2 H, H-Ar), 7.23–7.44 (m, 20 H, H-Ar, H-2’, 
H-6’), 7.66 (d, 1 H, J5’-6’ = 8.6 Hz, H-5’).  
13C NMR (62.9 MHz, CDCl3): G= 67.9 (C-6), 71.9 (C-5), 73.5, 74.0, 75.3, 75.9 
[C-CH2], 76.9 (C-2), 79.5 (C-4), 81.6 (C-3), 96.3 (C-1), 108.9 (C-4’), 115.0 (C-3’CN), 
115.4 (C-4’CN), 117.5 (C-3’), 121.4 (C-2’, C-6’), 127.81, 127.87, 127.91, 127.95, 
128.0, 128.2, 128.46, 128.48, 128.5, 128.6 [C-2Ar, C-3Ar, C-4Ar], 135.2 (C-5’), 
137.5, 137.7, 137.8, 138.5 [C-1Ar], 159.7 (C-1’). 
MS-MALDI-TOF: m/z = 689.4 [M + Na]+.
Anal. calcd for C42H38N2O6: C, 75.66; H, 5.74; N, 4.20. Found: C, 75.95; H, 5.76; 
N, 4.30. 
E-Isomer (41E)
1H NMR (250 MHz, CDCl3): G= 3.58–3.78 (m, 6 H, H-2, H-3, H-4, H-5, H-6), 4.42–
4.59 (m, 3 H, H-CH2), 3.78–4.95 (m, 5 H, H-CH2), 5.01 (d, 1 H, J1-2 = 7.8 Hz, H-1), 
7.13–7.43 (m, 22 H, H-Ar, H-2’, H 6’), 7.59 (d, 1 H, J5’-6’ = 8.6 Hz, H-5’).  
13C NMR (62.9 MHz, CDCl3): G= 68.4 (C-6), 73.5, 75.1, 75.3 [C-CH2], 75.5 (C-5), 
75.8 (C-CH2), 77.3 (C-2), 81.7 (C-4), 84.5 (C-3), 100.7 (C-1), 109.1 (C-4’), 115.0 
(C-3’CN), 115.4 (C-4’CN), 117.4 (C-3’), 121.1 (C-2’), 121.7 (C-6’), 127.5, 127.7, 
127.8, 127.9, 128.0, 128.44, 128.47, 128.5, 128.8, 128.9 [C-2Ar, C-3Ar, C-4Ar], 
135.2 (C-5’), 137.7, 137.8, 138.1 [C-1Ar], 159.9 (C-1’). 
MS-MALDI-TOF: m/z = 689.4 [M + Na]+.
General method for the synthesis of substituted dicyanophenyl compounds: 
K2CO3 (6 mmol) was added to a stirred solution of 1-OH/1-SH unprotected 
carbohydrate (1 mmol) and 4-nitrophthalonitrile (40; 1.2 mmol) in dry DMF (10 ml). 
The mixture was stirred overnight. At the end of this period, the mixture was poured 
into H2O (100 ml) and CH2Cl2 (20 ml). The aqueous layer was extracted with CH2Cl2
(3 u 20 ml). The organic layer was washed with H2O (3 u 20 ml). After drying 
(Na2SO4), filtration and removal of the solvent, the crude product was purified by 
chromatography on silica gel [eluent: toluene/acetone, 10:1]. For analytical purposes 
the D/E-mixtures were separated by preparative HPLC. 
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3,4-Dicyano-phenyl-2,3,4,6-tetra-O-benzoyl-D/E-D-glucopyranoside (42D/42E)
Synthesised from 2,3,4,6-tetra-O-benzoyl-D/E-D-glucopyranose (36b;[265] 4.00 g, 
6.7 mmol); yield: 4.80 g [99%; D/E, 95:5 (HPLC)]. 
D-Isomer (42D)
Amorphous white solid; > @ q20
D
D  +98.4 (c = 1.0, CHCl3).  
1H NMR (250 MHz, CDCl3): G= 7.38–4.58 (m, 3 H, H-5, H-6), 5.44–5.52 (d, 2 H, 
J2-1 = 3.7, J2-3 = 10.1 Hz, H-2), 5.71–5.76 (dd,1 H, J4-5 = 9.6, J4-3 = 9.9 Hz, H-4), 
 6.14 (d, 1 H, J1-2 = 3.4 Hz, H-1), 6.27–6.39 (dd, 1 H, J3-4 = 9.9, J3-2 = 10.1 Hz, H-3), 
 7.27–7.65 (m, 15 H, H-2Ar H-4Ar, H-2’, H-5’, H-6’), 7.83–7.98 (m, 8 H, H-3Ar).  
13C NMR (62.9 MHz, CDCl3): G= 62.6 (C-6), 68.9 (C-4), 69.7 (C-5), 69.72 (C-3), 71.1 
(C-2), 94.4 (C-1), 109.7 (C-4’), 114.6 (C-3’CN), 115.0 (C-4’CN), 117.7 (C-3’), 120.9 
(C-2’), 121.7 (C-6’), 128.2, 128.3, 128.4, 128.54, 128.59, 128.6, 128.7, 129.1 [C-1Ar, 
C-3Ar], 129.5, 129.7, 129.9 [C-2Ar], 133.5, 133.7, 133.8, 133.9 [C-4Ar], 135.3 (C-5’), 
158.6 (C-1’), 165.3, 165.6, 165.75, 165.76 [C-CO].  
FAB-MS: m/z = 723.1 [M + H]+.
Anal. calcd for C42H30N2O10: C, 69.80; H, 4.18; N, 3.88. Found: C, 69.90; H, 4.20; 
N, 3.79. 
E-Isomer (42E)
1H NMR (250 MHz, CDCl3): G= 4.39–4.57 (m, 2 H, H-5, H-6a), 4.64–4.71 (dd, 1 H, 
J6b-5 = 2.5, J6b-6a = 11.8 Hz, H-6b), 5.56 (d, 1 H, J1-2 = 7.2 Hz, H-1), 5.69–5.82 (m, 
2 H, H-2, H-4), 5.94–6.03 (t, 1 H, J3-2/3-4 = 9.1 Hz, H-3), 7.20–7.64 (m, 15 H, H-2’, 
H-5’, H-6’, H-3Ar, H-4Ar), 8.82–8.99 (m, 8 H, H-2Ar).  
13C NMR (62.9 MHz, CDCl3): G= 62.7 (C-6), 68.9 (C-4), 71.3 (C-2), 72.2 (C-3), 73.3 
(C-5), 98.2(C-1), 109.9 (C-4’), 114.7 (C-3’CN), 115.1 (C-4’CN), 117.6 (C-3’), 121.2 
(C-2’), 121.6 (C-6’), 128.4, 128.6, 128.7 [C-3Ar], 129.1 (C-1Ar), 129.6, 129.7, 129.8, 
129.9 [C-2Ar], 133.5, 133.6, 133.8 [C-4Ar], 135.1 (C-5’), 159.1 (C-1’), 164.9, 165.2, 
165.6, 165.8 [C-CO].  
FAB-MS: m/z = 723.1 [M + 1]+.
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3,4-Dicyanophenyl-2,3,4,6-tetra-O-acetyl-D/E-D-glucopyranosid (43D/43E)
Synthesised from 2,3,4,6-tetra-O-acetyl-D/E-D-glucopyranose (39c;[266] 6 g, 17 
mmol). Yield: 8.06 g [Quantitative; D/E, 95:5 (HPLC)] 
D-Isomer (43D)
Amorphous white solid; > @ q20
D
D  +202.0° (c = 1, CHCl3). 
1H NMR (250 MHz, CDCl3): G= 2.01 s, 2.02 s, 2.03 s, 2.04 s [12 H, H-CH3], 3.91–
4.06 (m, 2 H, H-5, H-6a), 4.15–4.24 (dd, 1 H, J6b-5 = 4.9, J6b-6a = 12.3 Hz, H-6b), 
5.02–5.07 (dd, 1 H, J2-1 = 3.5, J2-3 = 10.1 Hz, H-2), 5.08–5.18 (dd, 1 H, J4-3 = 9.6, J4-5
= 10.1 Hz, H-4), 5.57–5.67 (dd, 1 H, J3-4 = 9.6, J3-2 = 10.1 Hz, H-3), 5.81 (d, 1 H, J1-2
= 3.5 Hz, H-1), 7.38–7.45 (dd, 1 H, J6’-2’ = 2.5, J6’-5’ = 8.6 Hz, H-6’), 7.53 (d, 1 H, 
J2’-6’ = 2.5 Hz, H-2’), 7.75 (d, 1 H, J5’-6’ = 2.5  8.6 Hz, H-5’). 
13C NMR (62.9 MHz, CDCl3): G= 20.4 (C-CH3), 61.4 (C-6), 67.8 (C-4), 69.1 (C-5), 
69.4 (C-3), 69.9 (C-2), 94.6 (C-1), 109.9 (C-4’), 114.7 (C-3’CN), 115.1 (C-4’CN), 
117.8 (C-3’), 121.1 (C-6’), 121.5 (C-2’), 135.4 (C-5’), 158.9 (C-1’), 169.4, 169.9, 
170.0, 170.3 [C-CO]. 
MS-MALDI-TOF: m/z = 497.23 [M + Na]+.
Anal. calcd for C22H22N2O10: C, 55.70; H, 4.67; N 5.90. Found: C, 55.50; H, 4.63; 
N, 5.57. 
E-Isomer (43E)
1H NMR (250 MHz, CDCl3): G= 2.02 s, 2.05 s, 2.09 s (12 H, H-CH3), 3.89–3.97 (m, 
1 H, H-5), 2.17–2.24 (m, 2 H, H-6), 5.02–5.31 (m, 4 H, H-1, H-2, H-3, H-4), 7.25–
7.30 (dd, 1 H, J6’-2’ = 2.5, J6’-5’ = 8.6 Hz, H-6’), 7.38 (d, 1 H, J2’-6’ = 2.5 Hz, H-2’), 7.72 
(d, 1 H, J5’-6’ = 8.6 Hz, H-5’). 
13C NMR (62.9 MHz, CDCl3): G= 20.52 (C-CH3), 61.87 (C-6), 67.90 (C-2), 70.79 
(C-4), 72.25 (C-3), 72.76 (C-5), 97.98 (C-1), 110.08 (C-4’), 114.90 (C-3’CN), 115.06 
(C-4’CN), 117.70 (C-3’), 121.09 (C-2’), 121.77 (C-6’), 135.21 (C-5’), 159.26 (C-1’), 
169.06, 169.31, 170.03, 170.37 [C-CO]. 
MS-MALDI-TOF: m/z = 497.23 [M + Na]+.
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3,4-Dicyanophenyl-3,4,6-tri-O-acetyl-2-desoxy-2-phthalimido-E-D-gluco-
pyranoside (44E)
Synthesised from 3,4,6-tri-O-acetyl-2-desoxy-2-phthalimido-D/E-D-glucopyranose 
(39d;[265b,267] 6.50 g, 15 mmol); amorphous white pouder; yield: 4.25 g (50%);  
> @ q20
D
D  +74.9 (c = 1, CHCl3). 
1H NMR (250 MHz, CDCl3): G= 1.87 s, 2.05 s, 2.12 s [H-CH3], 4.03–4.15 (m, 1 H, 
H-5), 2.16–4.31 (m, 2 H, H-6), 4.56–4.65 (dd, 1 H, J2-1 = 8.8, J2-3 = 10.6 Hz, H-2), 
5.15–5.25 (dd, 1 H, J4-3 = 9.1, J4-5 = 10.1 Hz, H-4), 5.78–5.88 (dd, 1 H, J3-4 = 9.1, 
J3-2 = 10.6 Hz, H-3), 6.11 (d, 1 H, J1-2 = 8.8 Hz, H-1), 4.18–4.24 (dd, 1 H, J6’-2’ = 2, 
J6’-5’ = 8.8 Hz, H-6’), 7.33 (d, 1 H, J2’-6’ = 2 Hz, H-2’), 7.65 (d, 1 H, J5’-6’ = 8.8 Hz, 
H-5’), 7.72–7.79 (m, 2 H, H-3Ar, H-4Ar), 7.80–7.88 (m, 2 H, H-2Ar, H-6Ar). 
13C NMR (62.9 MHz, CDCl3): G= 20.3, 20.6, 20.7 [C-CH3], 54.1 (C-2), 61.9 (C-6), 
68.4 (C-4), 70.3 (C-3), 72.8 (C-5), 95.3 (C-1), 110.0 (C-4’), 114.9 (C-3’CN), 115.1 
(C-4’CN), 117.6 (C-3’), 121.4 (C-2’), 121.7 (C-6’), 123.9 (C-2Ar, C-5Ar), 131.1 
(C-1Ar, C-6Ar), 134.7 (C-3Ar, C-4Ar), 135.1 (C-5’), 159.1 (C-1’), 169.37, 170.02, 
170.43 [C-CO]. 
MS-MALDI-TOF: m/z = 584.32 [M + Na]+.
Anal. calcd for C28H23N3O10: C, 59.89; H, 4.13; N 7.48. Found: C, 59.95; H, 4.18; 
N, 7.28. 
3,4-Dicyanophenyl-2,3,4,6-tetra-O-acetyl-1-thio-E-D-glucopyranoside (45E)
Synthesised from 2,3,4,6-Tetra-O-acetyl-1-thio-E-D-glucopyranose (39e;[266a,268]
4.00 g, 11 mmol); amorphous white pouder; yield: 5.48 g (Quantitative); > @ q20
D
D  –51.0 
(c = 0.5, CHCl3).  
1H NMR (250 MHz, CDCl3): G= 1.98 s, 2.02 s, 2.06 s, 2.12 s [12 H, H-CH3], 3.78–
3.86 (m, 1 H, H-5), 4.18–4.23 (m, 2 H, H-6), 4.82 (d, 1 H, J1-2 = 10 Hz, H-1), 4.92–
5.08 (m, 2 H, H-2, H-4), 5.20–5.30 (dd, 1 H, J3-4 = 9.1, J3-4 = 9.3 Hz, H-3), 7.67–7.71 
(dd, 1 H, J5’-2’ = 1, J5’-6’ = 8.4 Hz, H-5’), 7.71–7.76 (dd, 1 H, J6’-2’ = 2, J6’-5’ = 8.4 Hz, 
H-6’), 7.86–7.88 (dd, 1 H, J2’-5’ = 1, J2’-6’ = 2 Hz, H-2’). 
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13C NMR (62.9 MHz, CDCl3): G= 20.5, 20.7, 20.8 [C-CH3], 61.9 (C-6), 67. 8 (C-4), 
69.4 (C-2), 73.4 (C-3), 76.4 (C-5), 83.9 (C-1), 114.3 (C-4’), 114.9 (C-3’CN), 115.0 
(C-4’CN), 116.5 (C-3’), 133.3 (C-5’), 134.9 (C-2’), 135.0 (C-6’), 140.88 (C-1’),169.1, 
169.3, 169.9, 170.5 [C-CO]. 
MS-MALDI-TOF: m/z = 513.24 [M + Na]+.
Anal. calcd for C22H22N2O9S: C, 53.87; H, 4.52; N, 5.71; S, 6.54. Found: C, 53.86; 
H, 4.73; N, 5.33; S, 6.24. 
2,3,6,2’,3’,4’,6’-Hepta-O-benzoyl-1-thio-E-lactose (36f) 
Lactose (6.50 g, 19 mmol) in Pyridin (60 ml) was heated at 80 °C for 30 minutes and 
on cooling benzoyl chloride (30 ml, 258 mmol) was added dropwise. The reaction 
mixture was heated for 2 h at 0 °C. To the cooled solution was added H2O (10 ml) 
and after 10 minutes the mixture was poured into ice water (500 ml). The aqueous 
phase was extracted with CH2Cl2 (3 u 100 ml). The organic phase was washed with 
2M HCl (3 u 50 ml), sat. solution of NaHCO3 (1 u 50 ml) and H2O (1 u 50 ml), dried 
(Na2SO4), filtrated and the solvent was removed in vacuo. The product was not 
isolated and used immediately.  
A solution of 1,2,3,6,2’,3’,4’,6’-octa-O-benzoyl-D/E-lactose (19 mmol) in CH2Cl2 (50 
ml) was treated with 33% HBr in AcOH (20 ml) at r.t. for 2 h. The solution was cooled 
in an ice-bath, diluted with CH2Cl2 (100 ml), washed sequentially with ice-cold H2O
(50 ml), ice-cold, sat. solution of NaHCO3 (2 u 50 ml) and ice cold H2O (50 ml), dried 
(Na2SO4), and filtrated and the solvent was removed in vacuo. The product was not 
isolated and used immediately. 
A solution of 2,3,6,2’,3’,4’,6’-hepta-O-benzoyl-D-lactosyl bromide and thiourea 
(1.90 g, 25 mmol) in anhydrous acetone (200 ml) was boiled under reflux for 7 h, 
cooled and aceton was evaporated in vacuo. The residue was stierred with CH2Cl2
(100 ml) and one aqueous solution  of K2S207 (5.60 g, 25 mmol) at reflux over night. 
After cooling, the organic layer was separeted and washed with water (25 ml). After 
drying (Na2SO4), filtration and removal of the solvent, the crude product was purified 
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by chromatography on silica gel [eluent: toluene/acetone, 10:1] to give 36f;
amorphous white solid; yield: 12.47 g (60 %); > @ q20
D
D  –69.8 (c = 0.5, CHCl3).
1H NMR (250 MHz, CDCl3): G ҏ= 3.68–3.76 (m, 2 H, H-6’), 3.80–3.91 (m, 2 H, H-5, 
H-5’), 4.20–4.30 (dd, 1 H, J4-3 = 9.4, J4-5 = 9.8 Hz, H-4), 4.47–4.60 (m, 2 H, H-6), 
4.68–4.77 (dd, 1 H, J1-2 = 9.6, J1-SH = 9.8 Hz, H-1), 4.86 (d, 1 H, J1-2 = 7.9 Hz, H-1’), 
5.31–5.45 (m, 2 H, H-2, H-3’), 5.65–5.81 (m, 3 H, H-3, H-2’, H-4’), 7.09–7.60 (m, 
21 H, H-3Ar, H-4Ar), 7.84–8.02 (m, 14 H, H-2Ar). 
13C NMR (62.9 MHz, CDCl3): G = 61.0 (C-6’), 62.5 (C-6), 67.5 (C-4’), 69.9 (C-2’), 
71.4 (C-5’), 71.8 (C-3’), 73.7 (C-3), 74.1 (C-2), 75.7 (C-4), 77.5 (C-5), 78.9 (C-1), 
100.9 (C-1’), 128.2, 128.4, 128.51, 128.55, 128.6 [C-3Ar], 129.5, 129.64,129.67, 
129.7, 129.9, 129.9 [C-1Ar, C-2Ar], 133.2, 133.4, 133.5 [C-4Ar], 164.8, 165.2, 165.3, 
165.5, 165.9 [C-CO]. 
MALDI-TOF: m/z = 1109.65 [M + Na]+.
Anal. calcd for C61H50O17S: C, 67.39; H, 4.64; S, 3.65. Found: C, 68.05; H, 4.29; 
S, 2.55. 
3,4-Dicyanophenyl-2,3,6,2’,3’,4’,6’-hepta-O-benzoyl-1-thio-E-lactoside (46E)
Synthesised from 2,3,6,2’,3’,4’,6’-Hepta-O-benzoyl-1-thio-E-lactose (39f; 10.00 g, 
9.2 mmol); amorphous white solid; yield: 11.00 g (Quantitative); > @ q20
D
D  +20.6 (c = 0.5, 
CHCl3).
1H NMR (250 MHz, CDCl3):ҏ G = 3.64–3.84 (m, 2 H, H-6’), 3.92–4.03 (m, 2 H, H-5, 
H-5’), 4.12–4.21 (dd, 1 H, J4-3 = 9.4, J4-5 = 9.6 Hz, H-4), 4.45–4.54 (dd, 1 H, J6a-5 = 
4.9, J6a-6b = 12.3 Hz, H-6a), 4.63–4.71 (dd, 1 H, J6b-5 = 1.7, J6b-6a = 12.3 Hz, H-6b), 
4.90 (d, 1 H, J1’-2’ = 7.9 Hz, H-1’), 4.99 (d, 1 H, J1-2 = 9.9 Hz, H-1), 4.34–4.45 (m, 2 H, 
H-2, H-3’), 4.67–4.76 (m, 2 H, H-2’, H-4’), 4.80–4.89 (t, 1 H, JH-2/H-5 = 9.4 Hz, H-3), 
7.09–7.60 (m, 24 H, H-3Ar, H-4Ar, H-2’’, H-5’’, H-6’’), 7.84–8.02 (m, 14 H, H-2Ar). 
13C NMR (62.9 MHz, CDCl3): G = 60.9 (C-6’), 62.1 (C-6), 67.5 (C-4’), 69.9 (C-2’), 
70.0 (C-2), 71.5 (C-5’), 71.7 (C-3’), 73.5 (C-3), 75. 8 (C-4), 77.6 (C-5), 83.9 (C-1), 
101.1 (C-1’), 114.2 (C-4’’), 114.6 (C-3’’CN), 114.9 (C-4’’CN), 116.2 (C-3’’), 128.3, 
128.4, 128.5, 128.6, 128.7 [C-3Ar], 128.8, 129.2, 129.4 [C-1Ar], 128.5, 129.6, 129.7, 
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129.92, 129.98 [C-2Ar], 133.2, 133.3, 133.4, 133.5, 133.6, 133.7, 133.8 [C-5’’, 
C-4Ar], 135.3 (C-6’’), 135.4 (C-2’’), 140.4 (C-1’’), 164.8, 165.1, 165.19, 165.22, 
165.4, 165.6 [C-CO]. 
MS-MALDI-TOF: m/z = 1235.92 [M + Na]+.
Anal. calcd for C69H52N2O17S: C, 68.31; H, 4.32; N 2.31; S, 2.64. Found: C, 68.02; 
H, 4.29; N, 2.23; S, 2.56. 
General method for the synthesis of monosubstituted phenyl glycosides: 
NaH (88 mg, 2.2 mmol, 60% suspension in oil) was added to a stirred solution of 
2,3,4,6-tetra-O-benzyl-D/E-D-glucopyranose (1;[116] 1 g, 1.85 mmol) and nitrobenzene 
derivatives (2.2 mmol) in dry DMF (10 ml) at room temperature under argon. The 
mixture was stirred 15 minutes At the end of this period, the mixture was poured into 
H2O (100 ml) and CH2Cl2 (20 ml). The aqueous layer was extracted with CH2Cl2 (3 u
20 ml). The organic layer was washed with H2O (3 u 20 ml). After drying (Na2SO4),
filtration and removal of the solvent, the crude product was purified by 
chromatography on silica gel [eluent: toluene/acetone, 20:1]. For analytical purposes 
the D/E-mixtures were separated, when possible, by preparative HPLC. 
2-Nitrophenyl-2,3,4,6-tetra-O-benzyl-D/E-D-glucopyranoside (50D/50E)
Synthesised from 2,3,4,6-tetra-O-benzyl-D/E-D-glucopyranose (1)[116] and 
o-dinitrobenzene (48); yield: 1.22 g [94%; D/E, 3:1 (HPLC)]. 
D-Isomer (50D)
Colourless oil; > @ q20
D
D  +120.1° (c = 1, CHCl3). 
1H NMR (250 MHz, CDCl3): G= 3.52–3.58 (dd, 1 H, J6a-5 = 2, J6a-6b = 11 Hz, H-6a), 
3.67–3.78 (m, 3 H, H-2, H-4, H-6b), 3.89–3.95 (m, 1 H, H-5), 4.17–4.27 (dd, 1H, 
J3-2 = 9.1, J3-4 = 9.3 Hz, H-3), 4.4 (d, 1 H, J = 12 Hz, H-CH2), 4.47–4.64 (m, 3 H, 
H-CH2), 4.77–4.91 (m, 3 H, H-CH2), 5.00 (d, 1 H, J = 11 Hz, H-CH2), 5.46 (d, 1 H, 
J1-2 = 3.5 Hz, H-1), 7.02–7.11 (ddd, 1 H, J4’-6’ = 1.2, J4’-5’ = 7.4, J4’-3’ = 8.4 Hz, H-4’), 
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7.13–7.37 (m, 21 H, H-6’, H-2Ar, H-3Ar, H-4Ar), 7.38–7.45 (ddd, 1 H, J5’-3’ = 1.7, 
J5’-4’ = 7.4, J5’-6’ = 9.1 Hz, H-5’), 7.80–7.84 (dd, 1 H, J3’-5’ = 1.7, J3’-4’ = 8.4 Hz, H-3’). 
13C NMR (62.9 MHz, CDCl3): G= 68.2 (C-6), 71.9 (C-5), 73.4, 73.5, 74.9, 75.9 
[C-CH2], 77.1 (C-4), 79.8 (C-2), 81.5 (C-3), 96.9 (C-1), 117.1 (C-6’), 121.8 (C-4’), 
125.4 (C-3’), 127.6, 127.7, 127.8, 128.9, 128.1, 128.3, 128.4, 128.5 [C-2Ar, C-3Ar, 
C-4Ar], 133.8 (C-5’), 137.7, 138.2, 138.3, 138.7 [C-1Ar], 140.8 (C-2’), 149.9 (C-1’). 
MS-MALDI-TOF: m/z = 684.6 [M + Na]+.
Anal. calcd for C40H39NO8: C, 72.60; H, 5.94; N, 2.12. Found: C, 72.98; H, 5.84; 
N, 2.09. 
E-Isomer (50E)
1H NMR (250 MHz, CDCl3): G= 3.55–3.87 (m, 6 H, H-2, H-3, H-4, H-5, H-6), 4.45–
4.58 (m, 3 H, H-CH2), 4.77–4.85 (m, 3 H, H-CH2), 4.97 (d, 1H, J = 11 Hz, H-CH2), 
5.04 (d, 1H, J = 11 Hz, H-CH2), 5.11 (d, 1 H, J1-2 = 7 Hz, H-1), 7.15–7.50 (m, 23 H, 
H-4’, H-5’, H-6’, H-2 Ar, H-3 Ar, H-4Ar), 7.83 (d, 1 H, J3’-4’ = 7.9 Hz, H-3’). 
13C NMR (62.9 MHz, CDCl3): G= 68.9 (C-6), 73.5 (C-5), 75.1, 75.2, 75.5, 75.8 
[C-CH2], 77.5 (C-2), 81.6 (C-4), 84.6 (C-3), 100.9 (C-1), 117.1 (C-6’), 122.0 (C-4’), 
125.4 (C-3’), 127.7, 127.8, 127.9, 128.0, 128.3, 128.4, 128.5 [C-2Ar, C-3 Ar, C-4 Ar], 
133.9, 137.8, 137.9, 138.4 [C-1Ar], 140.5 (C-2’), 150.1 (C-1’). 
MS-MALDI-TOF: m/z = 684.6 [M + Na]+.
2-Nitrophenyl-2,3,4,6-tetra-O-benzyl-D/E-D-galactopyranoside (51D/51E)
Synthesised from 2,3,4,6-tetra-O-benzyl-D/E-D-galactopyranose (47b;[269] 0.5 g, 
0.92 mmol) and o-dinitrobenzene (48); yield: 0.55 g [92%; D/E, 3:1 (HPLC)]. 
D-Isomer (51D)
Colourless oil; > @ q20
D
D  +129° (c = 0.75, CHCl3). 
1H NMR (250 MHz, CDCl3): G= 3.42–3.54 (m, 2 H, H-6), 3.99 (bs, 1 H, H-4), 4.07–
4.15 (dd, 1 H, J5-6a = 6.4, J5-6b = 6.9 Hz, H-5), 4.17–4.25 (m, 2 H, H-2, H-3), 4.27–
4.39 (m, 2 H, H-CH2), 4.30 (d, 1 H, J = 11.6 Hz, H-CH2), 4.37 (d, 1 H, J = 11.8 Hz, 
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H-CH2), 4.56 (d, 1 H, J = 11.3 Hz, H-CH2), 4.63 (d, 1 H, J = 12.3 Hz, H-CH2), 4.78 (d, 
1 H, J = 11.6 Hz, H-CH2), 4.82–4.92 (m, 2 H, H-CH2), 4.96 (d, 1 H, J = 11.3 Hz, 
H-CH2), 5.56 (d, 1 H, J1-2 = 2.2 Hz, H-1), 7.00–7.07 (ddd, 1 H, J4’-6’ = 0.9, J4’-5’ = 7.2, 
J4’-3’ = 8.1 Hz, H-4’), 7.12–7.43 (m, 22 H, H-2Ar, H-3Ar, H-4Ar), 7.78–7.84 (dd, 1 H, 
J3’-5’ = 1.7, J3’-4’ = 8.1 Hz, H-3’). 
13C NMR (62.9 MHz, CDCl3): G= 68.6 (C-6), 71.2 (C-5), 73.2, 73.5, 73.6, 74.9 
[C-CH2], 75.2 (C-4), 76.1 (C-2), 78.6 (C-3), 97.2 (C-1), 117.0 (C-6’), 121.5 (C-4’), 
125.4 (C-3’), 127.55, 127.58, 127.61, 127.63, 127.73, 127.74, 128.21, 128.26, 
128.29, 128.31, 128.39 [C-2Ar, C-3Ar, C-4Ar], 133.8 (C-5’), 137.8, 138.51, 138.54, 
138.6 [C-1Ar], 140.7 (C-2’), 150.1 (C-1’). 
MS-MALDI-TOF: m/z = 684.0 [M + Na]+.
Anal. calcd for C40H39NO8: C, 72.60; H, 5.94; N, 2.12. Found: C, 73.05; H, 5.97; 
N, 2.10. 
E-Isomer (51E)
1H NMR (250 MHz, CDCl3): G= 3.53–3.70 (m, 2 H, H-6), 3.76–3.78 (m, 1 H, H-5), 
4.10–4.15 (dd, 1 H, J3-4 = 3.9, J3-2 = 7.6 Hz, H-3), 4.29–4.61 (m, 9 H, H-2, H-2, 
H-CH2), 4.69 (d, 1 H, J = 11.8 Hz, H-CH2), 5.66 (1 H, J1-2 = 1.2 Hz, H-1), 7.04–7.11 
(ddd, 1 H, J4’-6’ = 1, J4’-5’ = 7.1, J4’-3’ = 8.1 Hz, H-4’), 7.12–7.43 (m, 22 H, H-2Ar, 
H-3Ar, H-4Ar), 7.78–7.82 (dd, 1 H, J3’-5’ = 1.7, J3’-4’ = 8.1 Hz, H-3’). 
13C NMR (62.9 MHz, CDCl3): G= 70.5 (C-6), 72.2, 72.5, 73.4, 75.5 (x2) [C-CH2]
(C-5), 82.1 (C-4), 82.3 (C-3), 88.5 (C-2), 106.4 (C-1), 119.4 (C-6’), 122.2 (C-4’), 
125.5 (C-3’), 127.5, 127.6, 127.7, 127.8, 127.9, 128.0, 128.1, 128.33, 128.37, 
128.36, 128.39, 128.4 [C-2Ar, C-3Ar, C-4Ar], 133.7 (C-5’), 137.3, 137.6, 138.1, 
138.2 [C-1Ar], 141.3 (C-2’), 149.8 (C-1’).  
MS-MALDI-TOF: m/z = 684.0 [M + Na]+.
4 Experimental part 
120 
2-Nitrophenyl -2,3,4,6-tetra-O-benzyl-D-D-manopyranoside (52D)
Synthesised from 2,3,4,6-tetra-O-benzyl-D/E-D-manopyranose (47c;[270] 0.5 g, 
0.92 mmol) and o-dinitrobenzene (48); colourless oil; yield: 0.53 g (89%); 
> @ q20
D
D  +59.7° (c = 1, CHCl3). 
1H NMR (250 MHz, CDCl3): G= 3.66–3.71 (dd, 1 H, J6a-5 = 2.2, J6a-5 = 10.8 Hz, 
H-6a), 3.73–3.80 (dd, 1 H, J6b-5 = 4.9, J6b-5 = 11.1 Hz, H-6b), 3.89–4.13 (m, 4 H, H-2, 
H-3, H-4, H-5), 4.46 (d, 1 H, J = 11.8 Hz, H-CH2), 4.52 (d, 1 H, J = 11.1 Hz, H-CH2), 
4.60 (d, 1 H, J = 11.8 Hz, H-CH2), 3.67–4.75 (m, 3 H, H-CH2),  
4.81 (d, 1 H, J = 12.1 Hz, H-CH2), 4.89 (d, 1 H, J = 11.1 Hz, H-CH2), 5.57 (d, 1 H, 
J1-2 = 2.0 Hz, H-1), 7.04–7.12 (ddd, 1 H, J4’-6’ = 1.7, J4’-5’ = 6.7, J4’-3’ = 8.1 Hz, H-4’), 
7.16–7.45 (m, 22 H, H-2Ar, H-3Ar, H-4Ar), 7.78–7.83 (dd, 1 H, J3’-5’ = 1.4, J3’-4’ = 
8.1 Hz, H-3’). 
13C NMR (62.9 MHz, CDCl3): G= 69.1 (C-6), 72.7, 73.2 [C-CH2], 73.3 (C-5, C-CH2), 
74.4 (C-4), 74.8 (C-2), 75.0 (C-CH2), 79.6 (C-3), 98.3 (C-1), 118.7 (C-6’), 122.3 
(C-4’), 125.4 (C-3’), 127.5, 127.6, 127.7, 127.8, 127.9, 128.1, 128.2, 128.3, 128.4, 
128.5 [C-2Ar, C-3Ar, C-4Ar], 134.1 (C-5’), 138.1, 138.2 (x 2), 138.4 [C-1Ar], 140.7 
(C-2’), 149.7 (C-1’). 
MS-MALDI-TOF: m/z = 684.0 [M + Na]+.
Anal. calcd for C40H39NO8: C, 72.60; H, 5.94; N, 2.12. Found: C, 73.02; H, 5.96; 
N, 2.11. 
4-Cyanophenyl-2,3,4,6-tetra-O-benzyl-D/E-D-glucopyranoside (53D/53E)
Synthesised from 2,3,4,6-tetra-O-benzyl-D/E-D-glucopyranose (1)[116] and 
p-nitrobenzonitrile (49); slighly yellow oil; yield: 0.95 g [82%; D/E, 3:1 (NMR)]. 
Representativ signals in 13C NMR for D and E isomers. 
D-Isomer (53D)
13C NMR (62.9 MHz, CDCl3): G= 68.1 (C-6), 71.3 (C-5), 77.1 (C-4), 79.6 (C-2), 81.8 
(C-3), 95.4 (C-1), 105.6 (C-4’), 117.2 (C-2’, C-6’), 133.9 (C-3’, C-5’), 159.9 (C-1’). 
4 Experimental part 
121 
E-Isomer (53E)
13C NMR (62.9 MHz, CDCl3): G= 68.7 (C-6), 75.3 (C-5), 77.5 (C-2), 81.8 (C-4), 84.6 
(C-3), 100.7 (C-1), 105.9 (C-4’), 117.2 (C-2’, C-6’), 133.9 (C-3’, C-5’), 160.3 (C-1’). 
MS-MALDI-TOF: m/z = 663.9 [M + Na]+.
4-Cyanophenyl-2,3,4,6-tetra-O-benzyl-D/E-D-galactopyranoside (54D/54E)
Synthesised from 2,3,4,6-tetra-O-benzyl-D/E-D-galactopyranose[269] (47b) and 
p-nitrobenzonitrile (49); slighly yellow oil; yield: 0.97 g [84 %; D/E, 6:1 (NMR)]. 
Representativ signals in 13C NMR for D and E isomers 
D-Isomer (54E)
13C NMR (62.9 MHz, CDCl3): G= 68.6 (C-6), 70.6 (C-5), 74.7 (C-4), 76.0 (C-2), 78.7 
(C-3), 96.4 (C-1), 105.5 (C-4’), 117.4 (C-2’, C-6’), 133.8 (C-3’, C-5’), 160.3 (C-1’). 
E-Isomer (54E)
13C NMR (62.9 MHz, CDCl3): G= 70.3 (C-6), 75.9 (C-5), 82.3 (C-4), 82.4 (C-3), 88.5 
(C-2), 104.3 (C-1), 105.5 (C-4’), 117.4 (C-2’, C-6’), 133.8 (C-3’, C-5’), 160.3 (C-1’). 
MS-MALDI-TOF: m/z = 663.9 [M+ + Na]. 
4-Cyanophenyl-2,3,4,6-tetra-O-benzyl-D-D-manopyranoside (55D)
Synthesised from 2,3,4,6-tetra-O-benzyl-D/E-D-manopyranose (47c;[270] 0.5 g, 
0.92 mmol) and p-nitrobenzonitrile (49); slighly yellow oil; yield: 0.49 g (84%); > @ q20
D
D
+80.8 (c = 0.75, CHCl3). 
1H NMR (250 MHz, CDCl3): G= 3.59–3.66 (dd, 1 H, J6a-5 = 3.9, J6a-5 = 12.5 Hz, 
H-6a), 3.70–3.80 (m, 2 H, H-5, H-6b), 3.91–3.95 (t, 1 H, J2-1/2-3 = 3.9 Hz, H-2) 4.01–
4.13 (m, 2 H, H-3, H-4), 4.43 (d, 1 H, J = 11.8 Hz, H-CH2), 4.51 (d, 1 H, J = 10.5 Hz, 
H-CH2), 4.59 (d, 1 H, J = 11.8 Hz, H-CH2), 3.67–4.90 (m, 5 H, H-CH2), 5.58 (d, 1 H, 
J1-2 = 2.0 Hz, H-1), 7.05 (d, 2 H, J2’-3’/6’-5’ = 8.9 Hz, H-2’, H-6’), 7.13–7.40 (m, 20 H, 
H-2Ar, H-3Ar, H-4Ar), 7.52 (d, 2 H, J3’-4’/5’-6’ = 8.9 Hz, H-3’, H-5’). 
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13C NMR (62.9 MHz, CDCl3): G= 68.8 (C-6), 72.6 (C-CH2), 72.9 (C-5), 73.1, 73.3 
[C-CH2], 74.4 (C-4), 74.5 (C-2), 75.1 (C-CH2), 79.6 (C-3), 96.5 (C-1), 105.6 (C-4’), 
117.1 (C-2’, C-6’), 127.5, 127.6, 127.71, 127.75, 127.83, 127.87, 127.9, 128.3, 
128.4, 128.5 [C-2Ar, C-3Ar, C-4Ar], 133.9 (C-3’, C-5’), 137.9, 138.1, 138.2 (x 2) 
[C-1Ar], 159.3 (C-1’). 
MS-MALDI-TOF: m/z = 663.9 [M+ + Na]. 
Anal. calcd for C41H39NO6: C, 76.73; H, 6.13; N, 2.18. Found: C, 76.81; H, 6.14; 
N, 2.18. 
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4.2.8 Related to Chapter 2.3.3 
Tetrakis-2(3),9(10),16(17),23(24)-(2,3,4,6-tetrabenzyl-D/E-D-glucopyranosyl)-
phthalocyaninato zinc (56a) 
A mixture of 3,4-Dicyanophenyl-2,3,4,6-tetra-O-benzyl-D/E-D-glucopyranoside 
(41D/41E, 3.5 g, 5.2 mmol) and zinc acetate dihydrate (0.57 g, 2.6 mmol) in pentanol 
(10 ml) was stirred 5 h at 150 °C. After cooling, the mixture was poured into MeOH 
(100 ml) and the solid was filtered. The crude product was purified by 
chromatography over silica gel [eluent: CH2Cl2] to give 56a; green solid; yield 1.9 g 
(58%).
UV-Vis (DMSO): O (In. Rel. %) = 354 (42, B-band), 612 (19, sh), 680 nm (100, 
Q-band).  
1H NMR (250 MHz, DMSO-d6): G= 3.75–5.37 (m, 24 H, H-2’, H-3’, H-4’, H-5’, H-6’), 
6.29 (br, 1 H, H-1’), 7.03–7.55 (br, 80 H, H-Bn), 7.98 (br, 4 H, H-5), 9.25 (s, 4 H, 
H-3), 9.39 (bd, 4 H, H-6). 
13C NMR (62.9 MHz, DMSO-d6): G= 69.9 (C-6’D), 73.1 (C-5’D), 73.7, 74.0, 74.2, 
75.7, 76.3, 76.5 [C-CH2BnD/E], 78.8 (C-4’D), 81.4(C-2’D), 83.2 (C-3’D), 83.5 (C-4’E),
85.9 (C-3’E), 96.9, 97.2 [C-1’D], 102.7 (C-1’E), 110.5 (C-3), 119.0 (C-5), 124.7 (C-6), 
127–129 [C-Bn], 134.0 (C-7), 139–140 [C-Bn], 141.5 (C-2), 154.0 (C-1, C-8), 160 
(C-4).  
MS MALDI-TOF: m/z = 2730 [M + H]+.
Anal. calcd for C168H152N8O24Zn: C, 73.85; H, 5.61; N, 4.10. Found: C, 73.09; 
H, 5.65; N, 4.10. 
Tetra-2(3),9(10),16(17),23(24)-D/E-D-glucopyranosyl-phthalocyaninato zinc (56c) 
Method 1 
A mixture of 3,4-Dicyanophenyl-2,3,4,6-tetra-O-benzoyl-D/E-D-glucopyranoside 
(42D/42E, 2 g, 2.7 mmol) and zinc acetate dihydrate (1.1 g, 5.4 mmol) in DMAE 
(2 ml) was stirred 5 h at 170 °C. After cooling, the mixture was poured into MeOH 
(100 ml) and the solid was filtered. The crude product was purified by 
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chromatography over silica gel [eluent: CH2Cl2] to give 56b. The resulting mixture of 
phthalocyanines was dissolved in dry MeOH containing 20% of dry THF. NaOMe 
(100 Pl) was added and the solution was stirred for 1 h. Dowex 50WX8-400 Ion 
exchanger was added to neutralise the solution and then was filtered off. The solvent 
was evaporated and the solid washed with n-hexane to give 56c as a mixture of 
110 mg from phthalocyanines with different grade of deprotection. 
Method 2 
A mixture of 3,4-dicyanophenyl-2,3,4,6-tetra-O-acetyl-D/E-D-glucopyranoside 
(43D/43E; 1 g, 2 mmol) was suspended in dry MeOH (25 ml). NaOMe (100 Pl) was 
added and the solution was stirred for 1 h. Dowex 50WX8-400 ion exchanger was 
added to neutralise the solution. The ion exchanger was then filtered off and the 
solvent evaporated.  
To the deprotected dinitrile dissolved in a mixture of DMAE (1 ml) zinc acetate 
dihydrate (231 mg, 1 mmol) was added. The reaction mixture was stirred under 
Argon for 8 h at 100°C. After cooling it was dissolved in a minimal amount of water 
and acetone was added. The solid was filtered, dissolved again in a minimal amount 
of water, reprecipitated adding acetone and collected after filtration. The crude 
product was purified by preparative reverse phase HPLC chromatography [eluent: 
H2O/CH3CN] to give 56c; green solid; yield 82 mg (12%). 
Method 3 
A mixture of 3,4-dicyanophenyl-2,3,4,6-tetra-O-acetyl-D/E-D-glucopyranoside 
(43D/43E; 1 g, 2 mmol) was suspended in dry MeOH (25 ml). NaOMe (100 Pl) was 
added and the solution was stirred for 1 h. Dowex 50WX8-400 ion exchanger was 
added to neutralise the solution. The ion exchanger was then filtered off and the 
solvent evaporated.  
To the deprotected dinitrile dissolved in a mixture of DMAE (1 ml) and butanol 
(0.5 ml), zinc acetate (183 mg, 1 mmol) was added. The reaction mixture was stirred 
under Argon for 24 h at 100°C. After cooling it was dissolved in a minimal amount of 
water and acetone was added. The solid was filtered, dissolved again in a minimal 
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amount of water, reprecipitated adding acetone and collected after filtration. The 
crude product was purified by preparative reverse phase HPLC chromatography 
[eluent: H2O/CH3CN] to give 56c; green solid; yield 320 mg (51%). 
UV-Vis (DMSO): O (In. Rel. %) = 354 (41, B-band), 613 (17, sh), 681 nm (100, 
Q-band).  
1H NMR (250 MHz, DMSO-d6): G= 6.05 (br, 4 H, H-1’), 7.95 (br, 4 H, H-6), 9.08 (br, 
4 H, H-3), 9.35 (s, 4 H, H-5). 
13C NMR (62.9 MHz, DMSO-d6): G= 61.3 (C-6’), 70.5 (C-5’), 72.3 (C-4’), 73.8 (C-2’), 
74.8 (C-3’), 98.9 (C-1’), 109.8 (C-3), 120.2 (C-5), 124.2 (C-6), 132.5 (C-7), 140.1 
(C-2), 153 (C-1, C-8), 159 (C-4).  
MS-MALDI-TOF: Anal. calcd for C56H57N8O24Zn [M + H]
+ m/z = 1289.2777. Found: 
m/z = 1289.2690. 
Tetra-2(3),9(10),16(17),23(24)-(1-thio-E-D-glucopyranosyl)-phthalocyaninato 
zinc (56d) 
A mixture of 3,4-dicyanophenyl-2,3,4,6-tetra-O-acetyl-1-thio-E-D-glucopyranoside 
(45E; 1.5 g, 3.1 mmol) was suspended in dry MeOH (25 ml). NaOMe (100 Pl) was 
added and the solution was stirred for 1 h. Dowex 50WX8-400 ion exchanger was 
added to neutralise the solution. The ion exchanger was then filtered off and the 
solvent evaporated.  
To the deprotected dinitrile dissolved in a mixture of DMAE (1 ml) zinc acetate 
dihydrate (335 mg, 1.53 mmol) was added. The reaction mixture was stirred under 
Argon for 12 h at 100°C. After cooling it was dissolved in a minimal amount of water 
and acetone was added. The solid was filtered, dissolved again in a minimal amount 
of water, reprecipitated adding acetone and collected after filtration. The crude 
product was purified by preparative reverse phase HPLC chromatography [eluent: 
H2O/CH3CN] to give 56d; green solid; yield 95 mg (15%). 
UV-Vis (DMSO): O (In. Rel. %) = 362 (33, B-band), 622 (16, sh), 691 nm (100, 
Q-band). 
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1H NMR (250 MHz, DMSO-d6): G= 8.3 (br, 4 H, H-6), 9.3 (br, 4 H, H-5), 9.5 (br, 4 H, 
H-3). 
13C NMR (62.9 MHz, DMSO-d6): G= 61.6 (C-6’), 70.3 (C-4’), 73.1 (C-2’), 78.8 (C-5’), 
81.7 (C-3’), 88.0 (C-1’), 123.0 (C-3), 123.6 (C-6), 130.9 (C-4), 136.5 (C-7), 137.8 
(C-2), 139 (C-4), 153 (C-1, C-8). 
MS-MALDI-TOF: Anal. calcd for C56H57N8O20S4Zn [M + H]
+ m/z = 1353.18634. 
Found: m/z = 1353.14486. 
Tetra-2(3),9(10),16(17),23(24)-(1-thio-E-D-lactosyl) phthalocyaninato zinc (56e) 
A mixture of 3,4-dicyanophenyl-2,3,4,6-tetra-O-benzoyl-1-thio-E-D-lactoside (46E,
3.0 g, 2.5 mmol) was suspended in dry MeOH (200 ml). NaOMe (100 Pl) was added 
and the solution was stirred for 3 h. Dowex 50WX8-400 ion exchanger was added to 
neutralise the solution. The ion exchanger was then filtered off and the solvent 
evaporated.  
To the deprotected dinitrile dissolved in a mixture of DMAE (1 ml) zinc acetate 
dihydrate (271 mg, 1.25 mmol) was added. The reaction mixture was stirred under 
Argon for 12 h at 100°C. After cooling it was dissolved in a minimal amount of water 
and acetone was added. The solid was filtered, dissolved again in a minimal amount 
of water, reprecipitated adding acetone and collected after filtration. The crude 
product was purified by preparative reverse phase HPLC chromatography [eluent: 
H2O/CH3CN] to give 56e: Yield 125 mg (10%). 
UV-Vis (DMSO): O (In. Rel. %) = 363 (55, B-band), 622 (22, sh), 689 nm (100, 
Q-band).  
1H NMR (250 MHz, DMSO-d6): G= 8.3 (br, 4 H, H-6), 9.5 (br, 4 H, H-5), 9.3 (br, 4 H, 
H-3). 
13C NMR (62.9 MHz, DMSO-d6): G= 60.9 (C-6’, C-6’’), 68.6 (C-4’’), 71.0 (C-2’’), 73.2 
(C-2’), 73.7 (C-5’), 76.0 (C-3’), 76.9 (C-3’’), 79.6 (C-5’’), 80.6 (C-4’), 87.6 (C-1’),
104.3 (C-1’’).
MS-MALDI-TOF: Anal. calcd for C80H96N8O40S4Zn+Na [M]
+ m/z = 2013.37958. 
Found: m/z =2023.378. 
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5 Crystal Data 
Figure 3 Molecular structure and atom numbers of compound 8a
Table 21 Crystal data of compound 8a
Crystal description orange needle 
Crystal size [mm]  a 0.75 
  b 0.15 
  c 0.15 
Temperature [K] 213(2) 
Unit cell dimensions  [Å]  a 5.6549(3) 
  b 12.2550(9) 
  c 27.170(6) 
 [°] D 90
E 90.446(8) 
J 90
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Table 21 cont. Crystal data of compound 8a
Volume [Å3] 1882.9(5) 
Crystal system monoclinic 
Space group P21/c
Z 4 
Calculated density [g/cm3] 1.747 
Independent reflexions 3075 
2Ĭmax [°] 129.9 
Reflections observed 2735 
Refined parameter 329 
R1 0.0881 
wR2 0.2521 
Table 22 Atomic coordinates [Å] and isotropic displacement parameter [Å2] for compound 8a
 Atom  X Y Z U (eq) 
C  (1) –0.1490 (2) 0.5696 (6) 0.5696 (6) 0.083 (2) 
C  (2) –0.2543 (2) 0.5049 (7) 0.5049 (7) 0.100 (2) 
C  (3) –0.0820 (1) 0.4394 (4) 0.4394 (4) 0.058 (1) 
C  (4) –0.1952 (9) 0.3632 (4) 0.3632 (4) 0.053 (1) 
C  (11) –0.3124 (8) 0.2696 (4) 0.2696 (4) 0.044 (1) 
C  (12) –0.2734 (1) 0.3617 (4) 0.3617 (4) 0.055 (1) 
C  (13) –0.4322 (1) 0.3923 (4) 0.3923 (4) 0.056 (1) 
C  (14) –0.6318 (1) 0.3313 (4) 0.3313 (4) 0.055 (1) 
C  (15) –0.6711 (9) 0.2372 (4) 0.2372 (4) 0.049 (1) 
C  (16) –0.5146 (8) 0.2053 (3) 0.2053 (3) 0.043 (1) 
C  (21) –0.7440 (9) –0.0772 (4) –0.0772 (4) 0.049 (1) 
C  (22) –0.7995 (1) –0.1683 (4) –0.1683 (4) 0.057 (1) 
C  (23) –0.6516 (1) –0.2051 (4) –0.2051 (4) 0.059 (1) 
C  (24) –0.4399 (1) –0.1506 (5) –0.1506 (5) 0.061 (1) 
C  (25) –0.3810 (9) –0.0605 (4) –0.0605 (4) 0.052 (1) 
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Table 22 cont. Atomic coordinates [Å] and isotropic displacement parameter [Å2] for compound 8a
C  (26) –0.5293 (8) –0.0226 (4) –0.0226 (4) 0.045 (1) 
F  (11) –0.3196 (1) 0.6289 (7) 0.6289 (7) 0.185 (3) 
F  (12) –0.0894 (1) 0.5115 (5) 0.5115 (5) 0.148 (2) 
F  (13) 0.0142 (2) 0.6305 (6) 0.6305 (6) 0.216 (5) 
F  (21) –0.4249 (8) 0.4449 (6) 0.4449 (6) 0.132 (2) 
F  (22) –0.3501 (2) 0.5810 (6) 0.5810 (6) 0.198 (4) 
F  (31) 0.0546 (1) 0.5106 (5) 0.5106 (5) 0.146 (3) 
F  (32) 0.0464 (1) 0.3795 (4) 0.3795 (4) 0.153 (3) 
F  (41) –0.3634 (6) 0.4169 (3) 0.4169 (3) 0.076 (1) 
F  (42) –0.2985 (7) 0.2798 (3) 0.2798 (3) 0.079 (1) 
N  (1) –0.1531 (8) 0.2336 (3) 0.2336 (3) 0.052 (1) 
N  (2) –0.5844 (7) 0.1081 (3) 0.1081 (3) 0.044 (1) 
N  (3) –0.4498 (7) 0.0716 (3) 0.0716 (3) 0.043 (1) 
O  (1) 0.1050 (7) 0.3965 (3) 0.3965 (3) 0.068 (1) 
O  (2) 0.1576 (7) 0.2326 (3) 0.2326 (3) 0.073 (1) 
O  (3) –0.8946 (6) –0.0445 (3) –0.0445 (3) 0.060 (1) 
S  (1) 0.0117 (2) 0.3058 (1) 0.3058 (1) 0.051 (1) 
Table 23 Hydrogen coordinates [Å] and isotropic displacement parameter [Å2] for compound 8a
 Atom  X Y Z U (eq) 
H  (1) –0.4000 (1)  0.4520 (5) –0.0600 (2) 0.066 (2) 
H  (2) –0.8330 (1)  0.1940 (4) –0.0261 (2) 0.057 (1) 
H (3) –0.6940 (1) –0.2660 (5) 0.1700 (2) 0.061 (2) 
H  (4) –0.1300 (1)  0.4020 (5) –0.0040 (2) 0.063 (2) 
H  (5) –0.2260 (1) –0.0140 (6) 0.1440 (2) 0.083 (2) 
H  (6) –0.8670 (1)  0.0210 (6) 0.0400 (2) 0.074 (2) 
H  (7) –0.3640 (9) –0.1690 (4) 0.1860 (2) 0.048 (1) 
H  (8) –0.9230 (1) –0.1950 (5) 0.1020 (2) 0.070 (2) 
H  (9) –0.1800 (1)  0.1690 (5) 0.0740 (2) 0.056 (2) 
H (10) –0.7210 (1)  0.3470 (5) –0.0690 (2) 0.070 (2) 
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Table 24 Bond lengths [Å] for compound 8a
Atom  Length Atom  Length 
O(3)–C(21) 1.346 (6) N(1)–S(1) 1.605 (4) 
C(21)–C(22) 1.385 (7) C(1)–F(13) 1.231 (9) 
C(21)–C(26) 1.410 (7) C(1)–F(12) 1.257 (8) 
C(22)–C(23) 1.372 (8) C(1)–F(11) 1.331 (10) 
C(23)–C(24) 1.397 (8) C(1)–C(2) 1.494 (10) 
C(24)–C(25) 1.368 (8) C(2)–F(21) 1.283 (10) 
C(25)–C(26) 1.400 (7) C(2)–F(22) 1.385 (9) 
C(26)–N(3) 1.404 (6) C(2)–C(3) 1.543 (10) 
N(2)–N(3) 1.269 (5) C(3)–F(31) 1.300 (7) 
N(2)–C(16) 1.416 (6) C(3)–F(32) 1.319 (7) 
C(11)–C(12) 1.382 (7) C(3)–C(4) 1.532 (7) 
C(11)–C(16) 1.413 (6) C(4)–F(42) 1.334 (6) 
C(11)–N(1) 1.422 (6) C(4)–F(41) 1.337 (6) 
C(12)–C(13) 1.377 (8) C(4)–S(1) 1.847 (5) 
C(13)–C(14) 1.375 (8) S(1)–O(1) 1.413 (4) 
C(14)–C(15) 1.376 (7) S(1)–O(2) 1.422 (4) 
C(15)–C(16) 1.392 (7)   
Table 25 Angles [°] for compound 8a
Atom  Angle Atom  Angle 
O(3)–C(21)–C(22) 119.1 (5) F(12)–C(1)–C(2) 112.9 (7) 
O(3)–C(21)–C(26) 122.4 (4) F(11)–C(1)–C(2) 108.4 (8) 
C(22)–C(21)–C(26) 118.5 (5) F(21)–C(2)–F(22) 105.7 (9) 
C(23)–C(22)–C(21) 121.3 (5) F(21)–C(2)–C(1) 113.0 (7) 
C(22)–C(23)–C(24) 120.4 (5) F(22)–C(2)–C(1) 105.6 (7) 
C(25)–C(24)–C(23) 119.3 (5) F(21)–C(2)–C(3) 110.6 (6) 
C(24)–C(25)–C(26) 121.0 (5) F(22)–C(2)–C(3) 103.7 (6) 
C(25)–C(26)–N(3) 115.1 (4) C(1)–C(2)–C(3) 117.0 (8) 
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Table 25 cont. Angles [°] for compound 8a
C(25)–C(26)–C(21) 119.5 (4) F(31)–C(3)–F(32) 108.8 (6) 
N(3)–C(26)–C(21) 125.3 (4) F(31)–C(3)–C(4) 111.0 (4) 
N(3)–N(2)–C(16) 117.5 (4) F(32)–C(3)–C(4) 108.1 (5) 
N(2)–N(3)–C(26) 115.9 (4) F(31)–C(3)–C(2) 106.3 (6) 
C(12)–C(11)–C(16) 118.7 (4) F(32)–C(3)–C(2) 106.2 (5) 
C(12)–C(11)–N(1) 123.0 (4) C(4)–C(3)–C(2) 116.1 (5) 
C(16)–C(11)–N(1) 118.2 (4) F(42)–C(4)–F(41) 107.5 (4) 
C(13)–C(12)–C(11) 120.7 (5) F(42)–C(4)–C(3) 109.5 (4) 
C(14)–C(13)–C(12) 120.7 (5) F(41)–C(4)–C(3) 109.6 (4) 
C(13)–C(14)–C(15) 119.8 (5) F(42)–C(4)–S(1) 107.6 (3) 
C(14)–C(15)–C(16) 120.5 (5) F(41)–C(4)–S(1) 107.5 (3) 
C(15)–C(16)–C(11) 119.5 (4) C(3)–C(4)–S(1) 114.9 (4) 
C(15)–C(16)–N(2) 113.1 (4) O(1)–S(1)–O(2) 122.2 (3) 
C(11)–C(16)–N(2) 127.4 (4) O(1)–S(1)–N(1) 110.9 (2) 
C(11)–N(1)–S(1) 128.4 (3) O(2)–S(1)–N(1) 107.3 (2) 
F(13)–C(1)–F(12) 110.5 (9) O(1)–S(1)–C(4) 105.6 (2) 
F(13)–C(1)–F(11) 108.9 (8) O(2)–S(1)–C(4) 105.1 (2) 
F(12)–C(1)–F(11) 100.1 (7) N(1)–S(1)–C(4) 104.2 (2) 
F(13)–C(1)–C(2) 114.9 (6)   
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Figure 4 Molecular structure and atom numbers of compound 8b
Table 26 Crystal data of compound 8b
Crystal description red needle 
Crystal size [mm] a 0.25 
b 0.10 
  c 0.05 
Temperature [K] 213(2) 
Unit cell dimensions  [Å]  a 5.4635(2) 
   b 10.2660(1) 
   c 17.6448(2) 
[°] D 105.731(6) 
   E 93.187(5) 
   J 97.036(7) 
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Table 26 cont. Crystal data of compound 8b
Volume [Å3] 941.33(2)  
Crystal system triclinic 
Space group P–1 
Z 2 
Calculated density [g/cm3] 1.748 
Independent reflexions 3196 
2Ĭmax [°] 129.86 
Reflections observed 2421 
Refined parameter 329 
R1 0.0707 
wR2 0.1337 
Table 27 Atomic coordinates [Å] and  isotropic displacement parameter [Å2] for compound 8b
 Atom  X Y Z U (eq) 
C (1) 1.4851 (5) 0.7945 (3) –0.0725 (2) 0.035 (1) 
C (2) 1.2909 (6) 0.8661 (3) –0.0493 (2) 0.041 (1) 
C (3) 1.1499 (5) 0.8350 (3) 0.0074 (2) 0.039 (1) 
C (4) 1.1996 (5) 0.7322 (3) 0.0411 (2) 0.034 (1) 
C (5) 1.3954 (5) 0.6608 (3) 0.0174 (2) 0.038 (1) 
C (6) 1.5370 (6) 0.6924 (3) –0.0390 (2) 0.040 (1) 
C (7) 0.9265 (5) 0.5735 (3) 0.1789 (2) 0.036 (1) 
C (8) 0.9642 (6) 0.4531 (3) 0.1970 (2) 0.045 (1) 
C (9) 0.8275 (7) 0.4058 (3) 0.2498 (2) 0.049 (1) 
C (10) 0.6505 (7) 0.4796 (4) 0.2852 (2) 0.052 (1) 
C (11) 0.6102 (7) 0.5995 (4) 0.2696 (2) 0.049 (1) 
C (12) 0.7483 (5) 0.6486 (3) 0.2175 (2) 0.038 (1) 
C (13) 0.7902 (5) 0.9941 (3) 0.3274 (2) 0.039 (1) 
C (14) 0.6765 (6) 1.1047 (3) 0.3864 (2) 0.040 (1) 
C (15) 0.8654 (7) 1.2107 (3) 0.4487 (2) 0.051 (1) 
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Table 27 cont. Atomic coordinates [Å] and  isotropic displacement parameter [Å2] for compound 8b
C (16) 0.7538 (1) 1.3022 (4) 0.5174 (3) 0.072 (1) 
F (1) 0.8669 (4) 0.9063 (2) 0.3639 (1) 0.056 (1) 
F (2) 0.9861 (3) 1.0532 (2) 0.3005 (1) 0.057 (1) 
F (3) 0.5508 (3) 1.1729 (2) 0.3460 (1) 0.053 (1) 
F (4) 0.5162 (4) 1.0436 (2) 0.4247 (1) 0.063 (1) 
F (5) 1.0245 (5) 1.1447 (2) 0.4782 (1) 0.086 (1) 
F (6) 0.9937 (5) 1.2906 (2) 0.4120 (1) 0.078 (1) 
F (7) 0.9274 (6) 1.3975 (3) 0.5605 (2) 0.108 (1) 
F (8) 0.5875 (7) 1.3635 (3) 0.4913 (2) 0.123 (1) 
F (9) 0.6590 (8) 1.2348 (3) 0.5626 (2) 0.140 (1) 
N (1) 1.0437 (4) 0.7068 (2) 0.0986 (1) 0.036 (1) 
N (2) 1.0786 (4) 0.6044 (2) 0.1218 (1) 0.037 (1) 
N (3) 0.7161 (5) 0.7726 (3) 0.1983 (2) 0.042 (1) 
O (1) 1.6355 (4) 0.8213 (2) –0.1269 (1) 0.047 (1) 
O (2) 0.3579 (4) 0.8475 (2) 0.2725 (1) 0.047 (1) 
O (3) 0.5675 (4) 0.9807 (2) 0.1903 (1) 0.052 (1) 
S (1) 0.5742 (1) 0.8942 (1) 0.2407 (1) 0.038 (1) 
Table 28 Hydrogen coordinates [Å] and isotropic displacement parameter [Å2] for compound 8b
 Atom  X Y Z U (eq) 
H (1) 0.8550 (6) 0.3240 (4) 0.2620 (2) 0.049 (9) 
H (2) 1.4350 (6) 0.5940 (3) 0.0400 (2) 0.046 (9) 
H (3) 1.0200 (6) 0.8820 (3) 0.0234 (2) 0.042 (9) 
H (4) 0.5630 (7) 0.4500 (4) 0.3180 (2) 0.067 (1) 
H (5) 0.4860 (6) 0.6500 (3) 0.2930 (2) 0.045 (9) 
H (6) 1.0940 (7) 0.4020 (4) 0.1710 (2) 0.061 (1) 
H (7) 1.2590 (6) 0.9370 (4) –0.0680 (2) 0.058 (1) 
H (8) 1.6640 (6) 0.6420 (3) –0.0570 (2) 0.041 (8) 
H (9) 1.5830 (7) 0.8820 (4) –0.1480 (3) 0.074 (1) 
H (10) 0.8220 (7) 0.7960 (4) 0.1640 (2) 0.071 (1) 
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Table 29 Bond lengths [Å] for compound 8b
Atom  Length Atom  Length 
S(1)–O(3) 1.419 (2) N(3)–C(12) 1.432 (4) 
S(1)–O(2) 1.421 (2) C(1)–C(2) 1.382 (4) 
S(1)–N(3) 1.586 (3) C(1)–C(6) 1.386 (4) 
S(1)–C(13) 1.854 (3) C(2)–C(3) 1.376 (4) 
F(1)–C(13) 1.333 (3) C(3)–C(4) 1.391 (4) 
F(2)–C(13) 1.339 (3) C(4)–C(5) 1.391 (4) 
F(3)–C(14) 1.342 (3) C(5)–C(6) 1.375 (4) 
F(4)–C(14) 1.334 (3) C(7)–C(8) 1.393 (4) 
F(5)–C(15) 1.331 (4) C(7)–C(12) 1.406 (4) 
F(6)–C(15) 1.334 (4) C(8)–C(9) 1.376 (5) 
F(7)–C(16) 1.313 (5) C(9)–C(10) 1.374 (5) 
F(8)–C(16) 1.298 (5) C(10)–C(11) 1.372 (5) 
F(9)–C(16) 1.281 (5) C(11)–C(12) 1.379 (4) 
O(1)–C(1) 1.358 (3) C(13)–C(14) 1.537 (4) 
N(1)–N(2) 1.258 (3) C(14)–C(15) 1.552 (5) 
N(1)–C(4) 1.416 (4) C(15)–C(16) 1.526 (5) 
N(2)–C(7) 1.418 (4)   
Table 30 Angles [°] for compound 8b
Atom  Angle Atom  Angle 
O(3)–S(1)–O(2) 121.79 (14) C(11)–C(12)–N(3) 123.2 (3) 
O(3)–S(1)–N(3) 106.62 (14) C(7)–C(12)–N(3) 117.0 (3) 
O(2)–S(1)–N(3) 112.21 (14) F(1)–C(13)–F(2) 108.5 (2) 
O(3)–S(1)–C(13) 104.93 (14) F(1)–C(13)–C(14) 109.6 (2) 
O(2)–S(1)–C(13) 105.54 (14) F(2)–C(13)–C(14) 109.2 (2) 
N(3)–S(1)–C(13) 104.14 (14) F(1)–C(13)–S(1) 107.6 (2) 
N(2)–N(1)–C(4) 114.9 (2) F(2)–C(13)–S(1) 107.8 (2) 
N(1)–N(2)–C(7) 117.3 (2) C(14)–C(13)–S(1) 114.0 (2) 
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Table 30 cont. Angles [°] for compound 8b
C(12)–N(3)–S(1) 130.3 (2) F(4)–C(14)–F(3) 108.1 (3) 
O(1)–C(1)–C(2) 122.7 (3) F(4)–C(14)–C(13) 108.6 (2) 
O(1)–C(1)–C(6) 117.0 (3) F(3)–C(14)–C(13) 108.8 (2) 
C(2)–C(1)–C(6) 120.2 (3) F(4)–C(14)–C(15) 108.1 (3) 
C(3)–C(2)–C(1) 119.4 (3) F(3)–C(14)–C(15) 107.9 (2) 
C(2)–C(3)–C(4) 120.9 (3) C(13)–C(14)–C(15) 115.1 (3) 
C(5)–C(4)–C(3) 119.3 (3) F(5)–C(15)–F(6) 107.6 (3) 
C(5)–C(4)–N(1) 123.8 (3) F(5)–C(15)–C(16) 108.3 (3) 
C(3)–C(4)–N(1) 116.9 (2) F(6)–C(15)–C(16) 108.2 (3) 
C(6)–C(5)–C(4) 119.8 (3) F(5)–C(15)–C(14) 108.8 (3) 
C(5)–C(6)–C(1) 120.4 (3) F(6)–C(15)–C(14) 108.3 (3) 
C(8)–C(7)–C(12) 118.4 (3) C(16)–C(15)–C(14) 115.5 (3) 
C(8)–C(7)–N(2) 113.7 (3) F(9)–C(16)–F(8) 109.8 (5) 
C(12)–C(7)–N(2) 127.9 (3) F(9)–C(16)–F(7) 107.6 (4) 
C(9)–C(8)–C(7) 121.4 (3) F(8)–C(16)–F(7) 107.2 (4) 
C(10)–C(9)–C(8) 118.9 (3) F(9)–C(16)–C(15) 111.8 (3) 
C(11)–C(10)–C(9) 121.3 (3) F(8)–C(16)–C(15) 110.5 (4) 
C(10)–C(11)–C(12) 120.1 (3) F(7)–C(16)–C(15) 109.7 (4) 
C(11)–C(12)–C(7) 119.8 (3)   
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Figure 5 Molecular structure and atom numbers of compound 9b
Table 31 Crystal data of compound 9b
Crystal description orange needle 
Crystal size [mm]  a 0.5 
  b 0.06 
  c 0.01 
Temperature [K] 220 
Unit cell dimensions  [Å]  a 5.235(1) 
  b 10.503(3) 
  c 17.330(3) 
 [°] D 79.93(3) 
E 87.13(2) 
J 78.96(3) 
Volume [Å3] 920.6 
Crystal system triclinic 
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Table 31 cont. Crystal data of compound 9b
Space group P-1 
Z 2 
Calculated density [g/cm3] 1.722 
Independent reflexions 4090 
2Ĭmax [°] 2.50–28.15 
Refined parameter 307 
R1 0.0751 
wR2 0.1580 
Table 32 Atomic coordinates [Å] and isotropic displacement parameter [Å2] for compound 9b
 Atom  X Y Z U (eq) 
S (1)  1.6912 (3) 0.2162 (2) 0.1320 (1) 0.063 (1) 
S (2) 0.6664 (2) 0.7071 (1) 0.3863 (1) 0.057 (1) 
O (1) 1.8653 (6) 0.2806 (3) 0.1777 (2) 0.056 (1) 
O (2) 1.5042 (7) 0.1617 (4) 0.1809 (2) 0.070 (1) 
O (3) 1.6273 (9) 0.2985 (5) 0.0606 (2) 0.096 (2) 
O (4) 0.7673 (7) 0.6452 (4) 0.4605 (2) 0.070 (1) 
O (5) 0.4118 (6) 0.7027 (4) 0.3632 (2) 0.070 (1) 
N (1) 1.4248 (8) 0.4288 (4) 0.2320 (2) 0.054 (1) 
N (2) 1.2445 (8) 0.5042 (4) 0.2613 (2) 0.054 (1) 
N (3) 0.8776 (9) 0.6677 (5) 0.3214 (3) 0.062 (1) 
C (1) 1.8304 (9) 0.2782 (5) 0.2597 (3) 0.050 (1) 
C (2) 1.6156 (9) 0.3577 (5) 0.2880 (3) 0.050 (1) 
C (3) 1.5990 (1) 0.3622 (6) 0.3676 (3) 0.056 (1) 
C (4) 1.7980 (1) 0.2904 (6) 0.4162 (3) 0.062 (2) 
C (5) 2.0110 (1) 0.2140 (6) 0.3865 (3) 0.061 (2) 
C (6) 2.0290 (1) 0.2069 (5) 0.3079 (3) 0.056 (1) 
C (7) 0.8483 (9) 0.6596 (5) 0.2418 (3) 0.052 (1) 
C (8) 1.0460 (1) 0.5744 (5) 0.2082 (3) 0.053 (1) 
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Table 32 cont. Atomic coordinates [Å] and isotropic displacement parameter [Å2] for compound 9b
C (9) 1.0360 (1) 0.5643 (6) 0.1299 (3) 0.061 (1) 
C (10) 0.8230 (1) 0.6349 (7) 0.0865 (4) 0.072 (2) 
C (11) 0.6320 (1) 0.7159 (6) 0.1195 (3) 0.065 (2) 
C (12) 0.6380 (1) 0.7310 (6) 0.1962 (3) 0.063 (2) 
C (13) 1.9370 (1) 0.0763 (7) 0.1106 (4) 0.076 (2) 
C (14) 0.6710 (1) 0.8813 (6) 0.3838 (4) 0.074 (2) 
F (1) 2.0330 (8) 0.0027 (4) 0.1750 (3) 0.101 (1) 
F (2) 2.1309 (7) 0.1174 (4) 0.0666 (2) 0.094 (1) 
F (3) 1.8197 (9) 0.0077 (5) 0.0714 (3) 0.116 (2) 
F (4) 0.8977 (7) 0.8980 (4) 0.4024 (3) 0.105 (1) 
F (5) 0.4971 (9) 0.9258 (4) 0.4362 (3) 0.104 (1) 
F (6) 0.6010 (9) 0.9500 (4) 0.3158 (2) 0.105 (1) 
Table 33 Hydrogen coordinates [Å] and isotropic displacement parameter [Å2] for compound 9b
 Atom  X Y Z U (eq) 
H (1) 1.040 (1) 0.630 (7) 0.333 (4) 0.110 (20) 
H (2) 1.450 (1) 0.421 (5) 0.391 (3) 0.064 (15) 
H (3) 1.798 (8) 0.290 (4) 0.465 (3) 0.038 (12) 
H (4) 2.152 (9) 0.167 (4) 0.419 (3) 0.045 (12) 
H (5) 2.193 (9) 0.153 (4) 0.281 (3) 0.041 (11) 
H (6) 1.200 (1) 0.507 (6) 0.103 (3) 0.079 (17) 
H (7) 0.830 (9) 0.626 (5) 0.037 (3) 0.053 (14) 
H (8) 0.480 (1) 0.762 (5) 0.091 (3) 0.059 (13) 
H (9) 0.500 (1) 0.791 (6) 0.221 (3) 0.071 (17) 
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Table 34 Bond lengths [Å] for compound 9b
Atom  Length Atom  Length 
S(2)–O(4) 1.414 (3) C(3)–C(4) 1.388 (7) 
S(2)–O(5) 1.421 (3) F(3)–C(13) 1.319 (7) 
S(2)–N(3) 1.588 (5) N(3)–C(7) 1.414 (6) 
S(2)–C(14) 1.828 (7) F(5)–C(14) 1.332 (8) 
S(1)–O(3) 1.395 (4) C(8)–C(9) 1.384 (7) 
S(1)–O(2) 1.402 (4) C(8)–C(7) 1.405 (8) 
S(1)–O(1) 1.553 (4) C(7)–C(12) 1.402 (6) 
S(1)–C(13) 1.836 (8) C(4)–C(5) 1.378 (8) 
O(1)–C(1) 1.420 (6) C(11)–C(10) 1.357 (9) 
N(2)–N(1) 1.257 (6) C(11)–C(12) 1.367 (8) 
N(2)–C(8) 1.427 (5) F(4)–C(14) 1.296 (7) 
N(1)–C(2) 1.433 (5) C(6)–C(5) 1.374 (7) 
C(1)–C(6) 1.382 (6) F(6)–C(14) 1.299 (6) 
C(1)–C(2) 1.389 (7) C(13)–F(1) 1.305 (7) 
F(2)–C(13) 1.332 (7) C(10)–C(9) 1.388 (7) 
C(3)–C(2) 1.387 (7)   
Table 35 Angles [°] for compound 9b
Atom  Angle Atom  Angle 
O(4)–S(2)–O(5) 122.8 (3) C(12)–C(7)–N(3) 123.8 (5) 
O(4)–S(2)–N(3) 108.1 (2) C(8)–C(7)–N(3) 116.5 (4) 
O(5)–S(2)–N(3) 111.2 (2) C(5)–C(4)–C(3) 121.0 (5) 
O(4)–S(2)–C(14) 104.2 (3) C(10)–C(11)–C(12) 122.2 (5) 
O(5)–S(2)–C(14) 105.4 (3) C(3)–C(2)–C(1) 118.4 (4) 
N(3)–S(2)–C(14) 103.0 (3) C(3)–C(2)–N(1) 124.6 (5) 
O(3)–S(1)–O(2) 122.2 (3) C(1)–C(2)–N(1) 117.0 (4) 
O(3)–S(1)–O(1) 108.5 (3) C(5)–C(6)–C(1) 118.8 (5) 
O(2)–S(1)–O(1) 111.9 (2) C(11)–C(12)–C(7) 118.5 (6) 
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Table 35 cont. Angles [°] for compound 9b
O(3)–S(1)–C(13) 106.9 (3) F(1)–C(13)–F(3) 110.0 (6) 
O(2)–S(1)–C(13) 106.0 (3) F(1)–C(13)–F(2) 108.8 (5) 
O(1)–S(1)–C(13) 98.4 (2) F(3)–C(13)–F(2) 109.0 (5) 
C(1)–O(1)–S(1) 121.0 (3) F(1)–C(13)–S(1) 111.1 (4) 
N(1)–N(2)–C(8) 115.2 (4) F(3)–C(13)–S(1) 106.9 (5) 
N(2)–N(1)–C(2) 113.1 (4) F(2)–C(13)–S(1) 111.0 (5) 
C(6)–C(1)–C(2) 122.1 (4) C(11)–C(10)–C(9) 120.7 (5) 
C(6)–C(1)–O(1) 117.8 (4) F(4)–C(14)–F(6) 111.2 (6) 
C(2)–C(1)–O(1) 119.7 (4) F(4)–C(14)–F(5) 108.1 (6) 
C(2)–C(3)–C(4) 119.5 (6) F(6)–C(14)–F(5) 106.9 (5) 
C(7)–N(3)–S(2) 130.5 (4) F(4)–C(14)–S(2) 111.1 (4) 
C(9)–C(8)–C(7) 120.1 (4) F(6)–C(14)–S(2) 111.1 (5) 
C(9)–C(8)–N(2) 125.7 (5) F(5)–C(14)–S(2) 108.4 (5) 
C(7)–C(8)–N(2) 114.2 (4) C(6)–C(5)–C(4) 120.1 (5) 
C(12)–C(7)–C(8) 119.6 (5) C(8)–C(9)–C(10) 118.9 (6) 
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Figure 6 Molecular structure and atom numbers of compound 29a
Table 36 Crystal data of compound 29a
Crystal description white needle 
Crystal size [mm]  a 0.30 
  b 0.10 
  c 0.04 
Temperature [K] 220 
Unit cell dimensions  [Å]  a 9.246(1) 
  b 9.358(1) 
  c 2.3631(3) 
 [°] D 90
E 90
J 90
Volume [Å3] 204.46(4) 
Crystal system orthorhombic 
Space group P b c a (No. 61)
Z 8 
Calculated density [g/cm3] 1.736 
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Table 36 cont. Crystal data of compound 29a
Independent reflexions 2005 
2Ĭmax [°] 2.80–25.99 
Refined parameter 170 
R1 0.0580 
wR2 0.1309 
Table 37 Atomic coordinates [Å] and isotropic displacement parameter [Å2] for compound 29a
 Atom  X Y Z U (eq) 
C (3A) 0.7879 (3) 0.0767 (4) 0.0575 (1) 0.039 (1)
C  (4) 0.8180 (3) –0.0290 (4) 0.0973 (1) 0.043 (1) 
C (5) 0.7069 (4) –0.0932 (4) 0.1258 (2) 0.048 (1) 
C  (6) 0.5643 (4) –0.0508 (4) 0.1153 (2) 0.053 (1) 
C  (7) 0.5286 (4) 0.0513 (4) 0.0762 (2) 0.048 (1) 
C (7A) 0.6453 (3) 0.1140 (4) 0.0477 (1) 0.040 (1) 
C  (8) 1.0824 (7) –0.1251 (8) 0.2018 (2) 0.102 (2) 
F  (1) 0.9632 (5) –0.1463 (7) 0.2241 (2) 0.171 (2) 
F  (2) 1.1728 (5) –0.0691 (7) 0.2383 (2) 0.173 (2) 
F  (3) 1.1384 (6) –0.2398 (5) 0.1825 (2) 0.176 (2) 
N (1) 0.6541 (3) 0.2161 (3) 0.0072 (1) 0.047 (1) 
N  (2) 0.7927 (3) 0.2422 (4) –0.0064 (1) 0.050 (1) 
N  (3) 0.8759 (3) 0.1576 (3) 0.0236 (1) 0.046 (1) 
O (1) 0.9624 (2) –0.0770 (3) 0.1051 (1) 0.050 (1) 
O  (2) 0.9990 (5) 0.1277 (4) 0.1677 (2) 0.121 (2) 
O  (3) 1.2028 (4) 0.0059 (7) 0.1183 (2) 0.137 (2) 
S (1) 1.0683 (1) 0.0073 (1) 0.1440 (1) 0.065 (1) 
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Table 38 Hydrogen coordinates [Å] and isotropic displacement parameter [Å2] for compound 29a
 Atom  X Y Z U (eq) 
H  (1) 0.581 (5) 0.269 (5) –0.007 (2) 0.070 (13)
H  (5) 0.732 (4) –0.168 (4) 0.152 (2) 0.049 (10)
H  (6) 0.484 (5) –0.101 (4) 0.132 (2) 0.061 (11)
H  (7) 0.438 (4) 0.075 (3) 0.067 (1) 0.029 (8) 
Table 39 Bond lengths [Å] for compound 29a
Atom  Length Atom  Length 
S(1)–O(3) 1.383 (4) C(3A)–C(7A) 1.384 (5) 
S(1)–O(2) 1.412 (4) C(3A)–C(4) 1.392 (5) 
S(1)–O(1) 1.557 (3) C(4)–C(5) 1.367 (5) 
S(1)–C(8) 1.849 (7) C(7A)–C(7) 1.400 (5) 
O(1)–C(4) 1.421 (4) C(5)–C(6) 1.399 (5) 
N(3)–N(2) 1.312 (4) C(6)–C(7) 1.370 (5) 
N(1)–N(2) 1.344 (4) F(1)–C(8) 1.237 (7) 
N(3)–C(3A) 1.370 (4) F(2)–C(8) 1.311 (7) 
N(1)–C(7A) 1.353 (4) C(8)–F(3) 1.276 (7) 
Table 40 Angles [°] for compound 29a
Atom  Angle Atom  Angle 
O(3)–S(1)–O(2) 126.1 (3) C(5)–C(4)–O(1) 120.2 (3) 
O(3)–S(1)–O(1) 107.6 (2) C(3A)–C(4)–O(1) 120.0 (3) 
O(2)–S(1)–O(1) 110.66 (18) N(1)–C(7A)–C(3A) 103.9 (3) 
O(3)–S(1)–C(8) 104.7 (3) N(1)–C(7A)–C(7) 133.0 (3) 
O(2)–S(1)–C(8) 105.8 (3) C(3A)–C(7A)–C(7) 123.2 (3) 
O(1)–S(1)–C(8) 98.1 (2) C(4)–C(5)–C(6) 119.7 (4) 
C(4)–O(1)–S(1) 120.5 (2) C(7)–C(6)–C(5) 123.0 (4) 
N(2)–N(3)–C(3A) 107.6 (3) C(6)–C(7)–C(7A) 115.5 (3) 
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Table 40 cont. Angles [°] for compound 29a
N(3)–C(3A)–C(7A) 109.1 (3) F(1)–C(8)–F(3) 112.3 (8) 
N(3)–C(3A)–C(4) 132.0 (3) F(1)–C(8)–F(2) 110.6 (6) 
C(7A)–C(3A)–C(4) 118.9 (3) F(3)–C(8)–F(2) 108.2 (5) 
N(2)–N(1)–C(7A) 110.8 (3) F(1)–C(8)–S(1) 111.1 (4) 
N(3)–N(2)–N(1) 108.6 (3) F(3)–C(8)–S(1) 109.1 (5) 
C(5)–C(4)–C(3A) 119.6 (3) F(2)–C(8)–S(1) 105.3 (6) 
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Figure 7 Molecular structure and atom numbers of compound 38
Table 41 Crystal data of compound 38
Crystal description red needle 
Crystal size [mm]  a 0.5 
   b 0.35 
   c 0.15 
Temperature [K] 220 
Unit cell dimensions [Å]  a 5.9812(11)  
   b 16.572(3) 
   c 17.656(3) 
  [°] D 91.22(2) 
   E 99.38(2) 
   J 92.89(2) 
Volume [Å3] 1723.7(5) 
Crystal system triclinic 
Space group P–1 
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Table 41 cont. Crystal data of compound 38
Z 2 
Calculated density [g/cm3] 1.529 
Independent reflexions 6282 
2Ĭmax [°] 2.34–25.96 
Refined parameter 478 
R1 0.1175 
wR2 0.3093 
Table 42 Atomic coordinates [Å] and isotropic displacement parameter [Å2] for compound 38
 Atom  X Y Z U (eq) 
C  (1) –0.7031 (9) 0.3329 (3) –0.0049 (3) 0.050 (1) 
C  (2) –0.5210 (9) 0.2940 (3) –0.0282 (3) 0.048 (1) 
C  (3) –0.4052 (9) 0.3358 (4) –0.0795 (3) 0.052 (1) 
C  (4) –0.4590 (11) 0.4113 (4) –0.1054 (4) 0.062 (2) 
C  (5) –0.6391 (12) 0.4460 (4) –0.0820 (4) 0.063 (2) 
C  (6) –0.7609 (11) 0.4076 (4) –0.0334 (4) 0.058 (2) 
C  (7) –0.4627 (9) 0.1084 (3) 0.0680 (3) 0.048 (1) 
C  (8) –0.5968 (10) 0.0669 (4) 0.1145 (4) 0.062 (2) 
C  (9) –0.5340 (12) –0.0059 (4) 0.1446 (4) 0.068 (2) 
C (10) –0.3326 (11) –0.0368 (4) 0.1309 (4) 0.060 (2) 
C (11) –0.1965 (10) 0.0025 (4) 0.0866 (4) 0.056 (2) 
C (12) –0.2581 (9) 0.0764 (3) 0.0558 (3) 0.052 (1) 
C (13) –0.6648 (11) 0.3450 (4) 0.1910 (4) 0.063 (2) 
C (14) –0.6944 (16) 0.3858 (5) 0.2673 (5) 0.085 (2) 
C (15) –0.4740 (30) 0.4032 (8) 0.3251 (6) 0.131 (4) 
C (16) –0.4700 (50) 0.4413 (13) 0.3977 (10) 0.177 (7) 
C (17) –0.1370 (14) 0.2984 (5) –0.2407 (4) 0.077 (2) 
C (18) –0.1009 (15) 0.2483 (7) –0.3132 (5) 0.090 (3) 
C (19) –0.0410 (30) 0.2995 (12) –0.3810 (7) 0.148 (5) 
C (20) 0.0210 (30) 0.2583 (14) –0.4456 (10) 0.157 (6) 
5 Crystal data 
148 
Table 42 cont. Atomic coordinates [Å] and isotropic displacement parameter [Å2] for compound 38
F  (1) –0.5125 (7) 0.3895 (3) 0.1600 (2) 0.088 (1) 
F  (2) –0.5843 (7) 0.2719 (3) 0.2032 (3) 0.085 (1) 
F  (3) –0.8268 (13) 0.3356 (5) 0.3007 (3) 0.159 (3) 
F  (4) –0.7874 (15) 0.4549 (4) 0.2530 (3) 0.153 (3) 
F  (5) –0.3232 (14) 0.3564 (8) 0.3216 (5) 0.187 (4) 
F  (6) –0.3670 (30) 0.4721 (11) 0.2903 (6) 0.316 (10)
F  (7) –0.5560 (30) 0.3855 (15) 0.4371 (7) 0.342 (12)
F  (8) –0.6020 (40) 0.4902 (14) 0.3976 (6) 0.440 (20)
F  (9) –0.2900 (30) 0.4519 (8) 0.4409 (6) 0.246 (7) 
F (10) –0.2936 (12) 0.3503 (3) –0.2608 (3) 0.121 (2) 
F (11) 0.0609 (12) 0.3339 (4) –0.2111 (3) 0.142 (3) 
F (12) –0.2792 (15) 0.2042 (6) –0.3363 (4) 0.171 (3) 
F (13) 0.0571 (15) 0.1992 (6) –0.2945 (4) 0.179 (4) 
F (14) –0.2020 (40) 0.3402 (13) –0.4029 (9) 0.415 (17)
F (15) 0.1140 (40) 0.3521 (13) –0.3558 (7) 0.438 (19)
F (16) –0.1250 (40) 0.2138 (15) –0.4707 (9) 0.366 (15)
F (17) 0.0510 (30) 0.3044 (10) –0.5010 (6) 0.279 (7) 
F (18) 0.1820 (40) 0.2335 (19) –0.4347 (9) 0.370 (16)
N  (1) –0.8308 (9) 0.2933 (4) 0.0458 (3) 0.057 (1) 
N  (2) –0.4341 (7) 0.2202 (3) –0.0034 (3) 0.050 (1) 
N  (3) –0.5478 (7) 0.1792 (3) 0.0384 (3) 0.052 (1) 
O (1) –0.2096 (6) 0.3015 (3) –0.0995 (2) 0.060 (1) 
O  (2) –0.9946 (9) 0.4110 (3) 0.1011 (3) 0.084 (2) 
O  (3) –1.0648 (8) 0.2728 (3) 0.1461 (3) 0.080 (1) 
O  (4) –0.4554 (9) 0.2093 (3) –0.1905 (3) 0.083 (2) 
O  (5) –0.0585 (11) 0.1813 (4) –0.1454 (4) 0.105 (2) 
O  (6) –0.1174 (8) 0.1143 (3) 0.0134 (3) 0.069 (1) 
S (1) –0.9235 (3) 0.3322 (1) 0.1178 (1) 0.062 (1) 
S  (2) –0.2308 (3) 0.2356 (1) –0.1667 (1) 0.065 (1) 
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Table 43 Hydrogen coordinates [Å] and isotropic displacement parameter [Å2] for compound 38
 Atom  X Y Z U (eq) 
H  (1) –0.3500 (200) 0.4680 (70) –0.1310 (60) 0.160 (40) 
H  (2) –0.6940 (120) 0.4880 (50) –0.1020 (40) 0.070 (20) 
H  (3) –0.9190 (110) 0.4270 (40) –0.0210 (30) 0.064 (17) 
H  (4) –0.8250 (180) 0.2550 (60) 0.0490 (60) 0.110 (40) 
H  (5) –0.7520 (100) 0.0930 (30) 0.1330 (30) 0.051 (14) 
H  (6) –0.6200 (200) –0.0680 (70) 0.1710 (70) 0.160 (40) 
H  (7) –0.2490 (110) –0.0980 (40) 0.1520 (40) 0.071 (19) 
H  (8) –0.0640 (140) –0.0310 (50) 0.0710 (40) 0.090 (20) 
H  (9) –0.1740 (110) 0.1510 (40) 0.0010 (40) 0.054 (19) 
Table 44 Bond lengths [Å] for compound 38
Atom  Length Atom  Length 
S(1)–O(2) 141.5 (5) F(18)–C(20) 106.1 (18) 
S(1)–O(3) 141.7 (5) O(1)–C(3) 141.7 (7) 
S(1)–N(1) 160.2 (6) O(6)–C(12) 135.5 (7) 
S(1)–C(13) 184.8 (7) N(1)–C(1) 141.9 (8) 
S(2)–O(4) 138.6 (5) N(2)–N(3) 126.8 (6) 
S(2)–O(5) 141.2 (5) N(2)–C(2) 140.4 (7) 
S(2)–O(1) 158.0 (5) N(3)–C(7) 138.2 (7) 
S(2)–C(17) 182.9 (7) C(1)–C(6) 138.5 (8) 
F(1)–C(13) 133.6 (7) C(1)–C(2) 140.6 (8) 
F(2)–C(13) 133.5 (8) C(2)–C(3) 140.1 (7) 
F(3)–C(14) 133.2 (10) C(3)–C(4) 137.6 (8) 
F(4)–C(14) 130.9 (10) C(4)–C(5) 136.3 (10) 
F(5)–C(15) 122.8 (15) C(5)–C(6) 136.1 (9) 
F(6)–C(15) 147.5 (17) C(7)–C(12) 140.3 (8) 
F(7)–C(16) 130.0 (2) C(7)–C(8) 140.5 (8) 
F(8)–C(16) 116.0 (2) C(8)–C(9) 137.4 (9) 
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Table 44 cont. Bond lengths [Å] for compound 38
F(9)–C(16) 122.0 (2) C(9)–C(10) 138.7 (9) 
F(10)–C(17) 131.4 (9) C(10)–C(11) 136.8 (8) 
F(11)–C(17) 131.8 (9) C(11)–C(12) 139.4 (8) 
F(12)–C(18) 126.6 (11) C(13)–C(14) 153.4 (11) 
F(13)–C(18) 128.6 (10) C(14)–C(15) 153.9 (17) 
F(14)–C(19) 122.3 (19) C(15)–C(16) 141.0 (2) 
F(15)–C(19) 125.7 (18) C(17)–C(18) 156.1 (13) 
F(16)–C(20) 114.0 (2) C(18)–C(19) 156.0 (15) 
F(17)–C(20) 128.5 (18) C(19)–C(20) 143.0 (2) 
Table 45 Angles [°] for compound 38
Atom  Angle Atom  Angle 
O(2)–S(1)–O(3) 122.1 (3) C(14)–C(13)–S(1) 115.8 (5) 
O(2)–S(1)–N(1) 110.2 (3) F(4)–C(14)–F(3) 111.3 (8) 
O(3)–S(1)–N(1) 108.2 (3) F(4)–C(14)–C(13) 108.8 (6) 
O(2)–S(1)–C(13) 106.2 (3) F(3)–C(14)–C(13) 107.1 (7) 
O(3)–S(1)–C(13) 105.6 (3) F(4)–C(14)–C(15) 107.5 (8) 
N(1)–S(1)–C(13) 102.7 (3) F(3)–C(14)–C(15) 106.9 (8) 
O(4)–S(2)–O(5) 122.1 (4) C(13)–C(14)–C(15) 115.3 (8) 
O(4)–S(2)–O(1) 110.9 (3) F(5)–C(15)–C(16) 115.3 (14) 
O(5)–S(2)–O(1) 107.0 (3) F(5)–C(15)–F(6) 96.5 (16) 
O(4)–S(2)–C(17) 109.0 (4) C(16)–C(15)–F(6) 96.3 (13) 
O(5)–S(2)–C(17) 106.3 (4) F(5)–C(15)–C(14) 115.8 (10) 
O(1)–S(2)–C(17) 99.1 (3) C(16)–C(15)–C(14) 122.7 (16) 
C(3)–O(1)–S(2) 120.8 (4) F(6)–C(15)–C(14) 101.9 (9) 
C(1)–N(1)–S(1) 127.7 (5) F(8)–C(16)–F(9) 118.0 (2) 
N(3)–N(2)–C(2) 116.3 (4) F(8)–C(16)–F(7) 101.0 (3) 
N(2)–N(3)–C(7) 118.5 (4) F(9)–C(16)–F(7) 96.4 (13) 
C(6)–C(1)–C(2) 120.1 (5) F(8)–C(16)–C(15) 113.7 (16) 
C(6)–C(1)–N(1) 120.8 (5) F(9)–C(16)–C(15) 119.0 (2) 
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C(2)–C(1)–N(1) 119.1 (5) F(7)–C(16)–C(15) 103.6 (19) 
C(3)–C(2)–N(2) 116.0 (5) F(10)–C(17)–F(11) 112.8 (8) 
C(3)–C(2)–C(1) 116.1 (5) F(10)–C(17)–C(18) 109.2 (6) 
N(2)–C(2)–C(1) 127.8 (5) F(11)–C(17)–C(18) 107.1 (7) 
C(4)–C(3)–C(2) 123.3 (6) F(10)–C(17)–S(2) 107.5 (5) 
C(4)–C(3)–O(1) 118.7 (5) F(11)–C(17)–S(2) 107.4 (5) 
C(2)–C(3)–O(1) 117.7 (5) C(18)–C(17)–S(2) 112.9 (6) 
C(5)–C(4)–C(3) 118.3 (6) F(12)–C(18)–F(13) 105.6 (11) 
C(6)–C(5)–C(4) 121.0 (6) F(12)–C(18)–C(19) 109.3 (9) 
C(5)–C(6)–C(1) 121.0 (6) F(13)–C(18)–C(19) 108.4 (9) 
N(3)–C(7)–C(12) 125.8 (5) F(12)–C(18)–C(17) 108.4 (7) 
N(3)–C(7)–C(8) 115.2 (5) F(13)–C(18)–C(17) 109.7 (7) 
C(12)–C(7)–C(8) 119.1 (5) C(19)–C(18)–C(17) 115.0 (10) 
C(9)–C(8)–C(7) 120.4 (6) F(14)–C(19)–F(15) 103.0 (2) 
C(8)–C(9)–C(10) 119.4 (6) F(14)–C(19)–C(20) 108.9 (14) 
C(11)–C(10)–C(9) 121.7 (5) F(15)–C(19)–C(20) 108.7 (16) 
C(10)–C(11)–C(12) 119.4 (6) F(14)–C(19)–C(18) 107.5 (12) 
O(6)–C(12)–C(11) 117.9 (5) F(15)–C(19)–C(18) 109.5 (11) 
O(6)–C(12)–C(7) 122.2 (5) C(20)–C(19)–C(18) 118.3 (16) 
C(11)–C(12)–C(7) 119.9 (5) F(18)–C(20)–F(16) 115.0 (3) 
F(2)–C(13)–F(1) 107.6 (5) F(18)–C(20)–F(17) 99.3 (19) 
F(2)–C(13)–C(14) 110.3 (5) F(16)–C(20)–F(17) 105.2 (19) 
F(1)–C(13)–C(14) 108.6 (6) F(18)–C(20)–C(19) 114.0 (2) 
F(2)–C(13)–S(1) 107.2 (5) F(16)–C(20)–C(19) 108.6 (18) 
F(1)–C(13)–S(1) 106.9 (4) F(17)–C(20)–C(19) 114.1 (19) 
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1 2,3,4,6-Tetra-O-benzyl-(D/E)-D-glucopyranose 
2a Nonafluorobutanesulfonyl fluoride 
2b Trifluoromethanesulfonyl anhydride 
3D Methyl 2,3,4,6-tetra-O-benzyl-D-D-glucopyranoside 
3E Methyl 2,3,4,6-tetra-O-benzyl-E-D-glucopyranoside 
4a 2,2’,3,3’,4,4’,6,6’-Octa-O-benzyl-DD-trehalose 
4b 2,2’,3,3’,4,4’,6,6’-Octa-O-benzyl-DE-trehalose 
4c 2,2’,3,3’,4,4’,6,6’-Octa-O-benzyl-EE-trehalose
5a 1H-1,2,3-benzotriazole 
5b 9,10,16,17,23,24-[Hexakis-3,5-bis(tert-butylphenoxy)]-2,3-[d]{1H-1,2,3-
triazole}phthalocyaninato zinc 
6a 1-Nonafluorobutanesulfonyl-1H-1,2,3-benzotriazole 
6b 1-Trifluoromethanesulfonyl-1H-1,2,3-benzotriazole 
6c 1-(p-Toluenesulfonyl)-1H-1,2,3-benzotriazole 
6d 1-Methanesulfonyl-1H-1,2,3-benzotriazole 
6e 9,10,16,17,23,24-[Hexakis-3,5-bis(tert-butylphenoxy)]-2,3-[d]{1-[(trifluoro-
methane)sulfonyl]-1H-1,2,3-triazole}phthalocyaninato zinc 
7a Phenol 
7b 2-Methylphenol 
7c 3-Methylphenol 
7d 4-Methylphenol 
7e 2,6-Dimethylphenol 
7f 2-tert-Butylphenol 
7g 4-Chlorophenol 
7h 2-Methoxyphenol 
7i 1-Naphthol 
7j 2-Naphthol 
7k 4-Nitrophenol 
7l 3,4-Dicianophenol 
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8a Nonafluoro-N-{2-[(E)-2-(2-hydroxyphenyl)diazenyl]phenyl}-1-butane-
sulfonamide 
8a Nonafluoro-N-{2-[(E)-2-(4-hydroxyphenyl)diazenyl]phenyl}-1-butane-
sulfonamide 
9a Trifluoro-N-{2-[(E)-2-(2-hydroxyphenyl)diazenyl]phenyl}-1-methane-
sulfonamide 
9b Trifluoromethanesulfonic acid 2-[(2-trifluoromethanesufonylaminophenyl)-
diazenyl]phenyl ester 
10 Toluone-4-sulfonic acid phenyl ester 
11 Methanesulfonic acid phenyl ester 
12 Nonafluoro-N-{2-[(E)-2-(2-hydroxy-3-methylphenyl)diazenyl]phenyl}-1-butane-
sulfonamide 
13 Nonafluoro-N-{2-[(E)-2-(2-hydroxy-4-methylphenyl)diazenyl]phenyl}-1-
butanesulfonamide 
14 Nonafluoro-N-{2-[(E)-2-(2-hydroxy-5-methylphenyl)diazenyl]phenyl}-1-butane-
sulfonamide 
15 Nonafluoro-N-{2-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)diazenyl]phenyl}-1-
butanesulfonamide 
16 Nonafluoro-N-{2-[(E)-2-(3-tert-butyl-2-hydroxyphenyl)diazenyl]phenyl}-1-
butanesulfonamide 
17 Nonafluoro-N-{2-[(E)-2-(5-chloro-2-hydroxyphenyl)diazenyl]phenyl}-1-
butanesulfonamide 
18 Nonafluoro-N-{2-[(E)-2-(2-hydroxy-3-methoxyphenyl)diazenyl]phenyl}-1-
butanesulfonamide 
19 Nonafluoro-N-{2-[(E)-2-(1-hydroxy-2-naphthyl)diazenyl]phenyl}-1-butane-
sulfonamide 
20a Nonafluoro-N-{2-[(E)-2-(2-hydroxy-1-naphthyl)diazenyl]phenyl}-1-butane-
sulfonamide 
20b Trifluoro-N-{2-[(E)-2-(2-hydroxy-1-naphthyl)diazenyl]phenyl}-1-methane-
sulfonamide 
20c 9,10,16,17,23,24-[Hexakis-(3,5-bis(tert-butylphenoxy)]-2-[(trifluormethane)-
sulfonamide]-3-(2 hydroxynaphthalin-1-ylazo)phthalocyaninato zinc 
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20d 1-Phenylazo-naphthalen-2-ol 
21a Benzyl chloride 
21b 3-Chlorobenzyl bromide 
21c 4-Chlorobenzyl chloride 
21d 4-Nitrobenzyl chloride 
21e 4-Methoxybenzyl chloride 
21’a Benzyltriphenylphosphonium chloride 
21’b 3-Chlorobenzylphosphonium bromide 
21’c 4-Chlorobenzylphosphonium chloride 
21’d 4-Nitrobenzylphosphonium chloride
21’e 4-Methoxybenzylphosphonium chloride 
22a {[2-(2-{[Nonafluorobutanesulfonyl]amino}phenyl)diazenyl](phenyl)methyl}  
(triphenyl)phosphonium chloride 
22’a Nonafluorobutane-N-{2-[2-[(phenyl)(triphenylphosphoranylidene)methyl]-
diazenyl]phenyl}-1-sulfonamide 
22b Nonafluorobutane-N-{2-[2-[(3-chlorophenyl)(triphenylphosphoranylidene)-
methyl]diazenyl]phenyl}-1-sulfonamide 
22c Nonafluorobutane-N-{2-[2-((4-chlorophenyl)(triphenylphosphoranylidene)-
methyl)diazenyl]phenyl}-1-sulfonamide 
22d {(4-Nitrophenyl)[2-(2-{[nonafluorobutanesulfonyl]amino}phenyl)diazenyl]-
methyl}(triphenyl)phosphonium chloride 
22’d Nonafluorobutane-N-{2-[2-[(4-Nitrophenyl)(triphenylphosphoranylidene)-
methyl]diazenyl]phenyl}-1-sulfonamide 
22e Nonafluorobutane-N-{2-[2-((4-methoxyphenyl)(triphenylphosphoranylidene)-
methyl)diazenyl]phenyl}-1-sulfonamide 
23a (Carbethoxymethyl)triphenylphosphonium bromide  
23b Methyltriphenylphosphonium bromide  
23c Ethyltriphenylphosphonium bromide 
23d Isopropyltriphenylphosphonium iodide 
24a Ethyl 2-{(E)-2-[2-({nonafluorobutanesulfonyl}amino)phenyl]diazenyl}-2-
(triphenylphosphoranylidene)acetate 
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24b Nonafluoro-N-{2-[2-({2-[2-({nonafluorobutanesulfonyl}amino)phenyl]diazenyl}-
(triphenylphosphoranylidene)methyl)diazenyl]phenyl}-1-butanesulfonamide 
25D 1H-1,2,3-Benzotriazole-2,3,4,6-tetra-O-benzyl-D-D-glucopyranoside 
25E 1H-1,2,3-Benzotriazole-2,3,4,6-tetra-O-benzyl-E-D-glucopyranoside 
26D 2H-1,2,3-Benzotriazole-2,3,4,6-tetra-O-benzyl-D-D-glucopyranoside 
26E 2H-1,2,3-Benzotriazole-2,3,4,6-tetra-O-benzyl-E-D-glucopyranoside 
27 1-Hydroxy-1H-1,2,3-benzotriazole 
28a Nonafluorobutane-1-sulfone acid-1H-1,2,3-benzotriazol-1-yl ester 
28b Nonafluorobutane-1-sulfone acid-1H-1,2,3-benzotriazol-4-yl ester 
29a Trifluoromethane-1-sulfone acid-1H-1,2,3-benzotriazol-4-yl ester 
29b Trifluoromethane-1-sulfone acid-1H-1,2,3-benzotriazol-5-yl ester 
30a 3-chloro-4-nitrotoluene 
30b 4-chloro-3-nitrotoluene 
30c 2,3-Dichloronitrobenzene 
30d 2,5-Dichloronitrobenzene 
30e 4-Chloro-3-nitro-benzotrifluoride 
30f 1,3,5-Trichloro-2-nitrobenzene 
31a 1-Hydroxy-5-methyl-1H-1,2,3-benzotriazole 
31b 1-Hydroxy-6-methyl-1H-1,2,3-benzotriazole 
31c 4-Chloro-1-hydroxy-1H-1,2,3-benzotriazole 
31d 6-Chloro-1-hydroxy-1H-1,2,3-benzotriazole 
31e 1-Hydroxy-6-trifluoromethyl-1H-1,2,3-benzotriazole 
31f 5,7-Dichloro-1-hydroxy-1H-1,2,3-benzotriazole 
32a Trifluoromethane-1-sulfone acid 6-methyl-1H-1,2,3-benzotriazol-4-yl ester 
32b Trifluoromethane-1-sulfone acid 5-methyl-1H-1,2,3-benzotriazol-4-yl ester 
32c Trifluoromethane-1-sulfone acid 5-methyl-1H-1,2,3-benzotriazol-6-yl ester 
33a Trifluoromethane-1-sulfone acid 7-chloro-1H-1,2,3-benzotriazol-4-yl ester 
33b Trifluoromethane-1-sulfone acid 7-chloro-1H-1,2,3-benzotriazol-6-yl ester 
34a Trifluoromethane-1-sulfone acid 5-chloro-1H-1,2,3-benzotriazol-6-yl ester 
34b Trifluoromethane-1-sulfone acid 5-chloro-1H-1,2,3-benzotriazol-4-yl ester 
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35a Trifluoromethane-1-sulfone acid 5-trifluromethyl-1H-1,2,3-benzotriazol-7-yl 
ester  
35b Trifluoromethane-1-sulfone acid 5-trifluromethyl-1H-1,2,3-benzotriazol-6-yl 
ester 
35c Trifluoromethane-1-sulfone acid 5-trifluromethyl-1H-1,2,3-benzotriazol-4-yl 
ester 
36 Trifluoromethane-1-sulfone acid 4,6-dichloro-1H-1,2,3-benzotriazol-7-yl ester 
37 Nonafluorobutane-1-sulfonic acid 1-(nonafluorobutane-1-sulfonyl)-1H-1,2,3-
benzotriazol-4-yl ester 
38 Nonafluorobutane-1-sulfonic acid 2-(2-hydroxy-phenylazo)-3-
(nonafluorobutane-1-sulfonylamino)-phenyl ester 
39b 2,3,4,6-Tetra-O-benzoyl-D/E-D-glucopyranose 
39c 2,3,4,6-Tetra-O-acetyl-D/E-D-glucopyranose 
39d 3,4,6-Tri-O-acetyl-2-desoxy-2-phthalimido-D/E-D-glucopyranose 
39e 2,3,4,6-Tetra-O-acetyl-1-thio-E-D-glucopyranose 
39f 2,3,6,2’,3’,4’,6’-Hepta-O-benzoyl-1-thio-E-lactose
40 4-Nitrophthalonitrile 
41D 3,4-Dicyanophenyl-2,3,4,6-tetra-O-benzyl-D-D-glucopyranoside 
41E 3,4-Dicyanophenyl-2,3,4,6-tetra-O-benzyl-E-D-glucopyranoside 
42D 3,4-Dicyanophenyl-2,3,4,6-tetra-O-benzoyl-D-D-glucopyranoside 
42E 3,4-Dicyanophenyl-2,3,4,6-tetra-O-benzoyl-E-D-glucopyranoside 
43D 3,4-Dicyanophenyl-2,3,4,6-tetra-O-acetyl-D-D-glucopyranoside 
43E 3,4-Dicyanophenyl-2,3,4,6-tetra-O-acetyl-E-D-glucopyranoside 
44E 3,4-Dicyanophenyl-3,4,6-tri-O-acetyl-2-desoxy-2-phthalimido-E-D-
glucopyranoside 
45E 3,4-Dicyanophenyl-2,3,4,6-tetra-O-acetyl-1-thio-E-D-glucopyranoside 
46E 3,4-Dicyanophenyl-2,3,6,2’,3’,4’,6’-hepta-O-benzoyl-1-thio-E-lactoside 
47b 2,3,4,6-tetra-O-benzyl-D/E-D-galactopyranose 
47c 2,3,4,6-tetra-O-benzyl-D/E-D-manopyranose 
48 1,2-dinitrobenzene 
49 4-nitrobenzonitrile 
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50D 2-Nitrophenyl-2,3,4,6-tetra-O-benzyl-D-D-glucopyranoside 
50E 2-Nitrophenyl-2,3,4,6-tetra-O-benzyl-E-D-glucopyranoside 
51D 2-Nitrophenyl-2,3,4,6-tetra-O-benzyl-D-D-galactopyranoside 
51E 2-Nitrophenyl-2,3,4,6-tetra-O-benzyl-E-D-galactopyranoside 
52D 2-Nitrophenyl-2,3,4,6-tetra-O-benzyl-D-D-manopyranoside 
53D 4-Cyanophenyl-2,3,4,6-tetra-O-benzyl-D-D-glucopyranoside 
53E 4-Cyanophenyl-2,3,4,6-tetra-O-benzyl-E-D-glucopyranoside 
54D 4-Cyanophenyl-2,3,4,6-tetra-O-benzyl-D-D-galactopyranoside 
54E 4-Cyanophenyl-2,3,4,6-tetra-O-benzyl-E-D-galactopyranoside
55D 4-Cyanophenyl-2,3,4,6-tetra-O-benzyl-D-D-manopyranoside 
56a Tetrakis-2(3),9(10),16(17),23(24)-(2,3,4,6-tetrabenzyl-D/E-D-glucopyranosyl)- 
phthalocyaninato zinc 
56b Tetrakis-2(3),9(10),16(17),23(24)-(2,3,4,6-tetrabenzoyl-D/E-D-glucopyranosyl)- 
phthalocyaninato zinc 
56c Tetra-2(3),9(10),16(17),23(24)-D/E-D-glucopyranosyl-phthalocyaninato zinc 
56d Tetra-2(3),9(10),16(17),23(24)-(1-thio-E-D-glucopyranosyl)-phthalocyaninato 
zinc 
56e Tetra-2(3),9(10),16(17),23(24)-(1-thio-E-D-lactosyl)-phthalocyaninato zinc 
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Abstract 
Abstract 
1. Glycosyl sulfonates have been somewhat neglected in recent years, despite of 
their considerable potential in stereoselective glycosylation. For this reason, the 
generation of glycosyl donors with nonafluorobutanesulfonyl derivatives has been 
studied.  
Using the commercially available nonafluorobutane sulfonyl fluoride, it was found 
that either trehalose or the glycosylated product could be formed depending on the 
order in which the reagents were added. 
The use of 1H-benzotriazole for the transfer of the nonafluorobutane sulfonyl group 
to glucose and the generation of the glycosyl donor was studied. By studying how to 
cleave the nonafluorobutane sulfonyl group from thebenzotriazole moiety with 
phenol, the heterocyclic ring was opened between positions N1 and N2, resulting in 
a new methodology for the formation of azobenzenes. This reaction was exploited in 
phthalocyanine chemistry in case of benzotriazole-substituted phthalocyanines. The 
sulphonated benzotriazole ring could also be opened with phosphor ylides, giving 
new phosphoranylidenes. When mesyl and tosyl benzotriazoles were used, these 
groups were transferred to phenol giving the corresponding esters. Triflyl 
benzotriazole gave first the azo compound and then formed ester. When sugars 
were used as nucleophiles, 1H and 2H-benzotriazole substituted sugars were 
obtained, in the case of tosyl and tryflyl and nonaflyl 1H-benzotriazoles. 
1-hydroxybenzotriazole was also used for this purpose. In theses cases substraction 
of the sulphonate group occurred, giving a sulphonate substituted 1H-1,2,3-
benzotriazoles that could not further be used for glycosilation. 
The mechanisms of all new reactions were investigated. 
2. Carbohydrates attached to porphyrin-like compounds have been previously 
considered for the treatment of cancer with visible light (photodynamic therapy). 
Since phthalocyanines are effective substances in photodynamic therapy, as well, 
the attachment of one carbohydrate to the phthalocyanine ring at the anomeric 
carbon was considered. The tested glycosilation reactions were not successful when 
3,4-dicyanophenol was the substrate. But the substitution of the nitro group in 
4-Nitrophthalonitrile was successful. Mainly Dílinked phenyl glucosides were 
obtained in good yields. More compounds were synthesised with this method and 
several phthalocyanines were formed. This reaction was also studied with dinitro or 
nitrocyano phenyls that need particular conditions for the formation of phenyl 
glycosides. 
Kurzzusammenfassung 
Kurzzusammenfassung 
1. Glycosylsulfonate haben, trotz ihres Potentials für die stereoselektive Synthese, in 
den letzten Jahren wenig Beachtung gefunden. Aus diesem Grunde wurde die 
Synthese von Glycosyldonoren mit Nonafluorbutansulfonyl-Derivaten untersucht. 
Dabei wurde gefunden, dass man unter Verwendung des handelsüblichen 
Nonafluorbutansulfonsäurefluorids entweder Trehalose oder aber das glykosylierte 
Produkt erhalten konnte, abhängig von der Reihenfolge, in der die Reagenzien 
zugegeben wurden. 
Die Verwendung von 1H-Benzotriazol als Überträger der Nonafluorbutansulfonyl- 
Gruppe auf Glucose wurde untersucht. Während der Untersuchungen zur 
Abspaltung der Nonafluorbutansulfonyl-Gruppe vom Benzotriazolrest mittels Phenol, 
wurde der Heterozyklus zwischen den Positionen N1 und N2 geöffnet, woraus sich 
eine neue Synthesemethode für Azobenzole ergab. Diese Methode wurde in der 
Phthalocyaninchemie speziell für die Synthese von Benzotriazol-substituierten 
Phthalocyaninen angewandt. Der Nonafluorbutansulfonyl-substituierte 
Benzotriazolring konnte ebenfalls mit Phosphoryliden geöffnet werden, wobei neue 
Phosphoranylide entstanden. Verwendete man Mesyl- oder Tosyl-Gruppen, wurden 
diese Gruppen auf Phenol übertragen und bildeten die korrespondierenden Ester. 
Triflylbenzotriazole bildeten zuerst die Azokomponente und anschließend die Ester. 
Wenn Zuckerderivate als Nukleophile eingesetzt wurden, erhielt man im Fall von 
Tosyl-, Triflyl- und Nonaflylbenzotriazolen die 1H- und 2H-Benzotriazol-substituierten 
Zuckerderivate. 
Zum gleichen Zweck wurde 1-Hydroxybenzotriazol eingesetzt. Dabei fand eine 
Abspaltung des Sulfonates und das entstandene Sufonat-substituierte 
1H-Benzotriazol konnte nicht weiter zur Glykosylierung verwendet werden. 
Die Mechanismen aller neuen Reaktionen wurden untersucht. 
2. An porphyrinähnliche Substanzen gekoppelte Kohlenhydrate wurden schon früher 
für die Krebstherapie mit sichtbarem Licht (Photodynamiktherapie) in Betracht 
gezogen. Da Phthalocyanine ebenfalls als effektive Wirkstoffe in der 
Photodynamiktherapie eingesetzt werden, wurde geplant, ein Kohlenhydrat mit dem 
anomeren Zentrum an einen Phthalocyaninring anzubinden. Direkte 
Glykosylierungsreaktionen waren nicht erfolgreich, wenn 3,4-Dicyanophenol als 
Gykosylakzeptor verwendet wurde. Allerdings verlief die Substitution der Nitrogruppe 
in 4-Nitrophthalonitril erfolgreich. Als Hauptprodukt wurden Dsubstituierte Glycoside 
in sehr guter Ausbeute erhalten. Mehrere ähnliche Substanzen wurden mit dieser 
Methode synthetisiert und einige Phthalocyanine gebildet. Diese Reaktion wurde 
auch mit 1,2-Dinitrobenzol und 4-Nitrobenzoesäurenitril untersucht, die spezielle 
Bedingungen für die Bildung von Phenylglykosiden benötigen. 
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